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Depression is a major health concern globally, both in isolation and when comorbid with 
other health conditions. The impact extends beyond that of the individual to encompass the 
family and community. There is a clear need for the development of a risk index to estimate 
individuals’ risk for depression. However, depression is a very complex disorder, with a 
wide and varied set of potential risk factors such as early life experiences, diet, lifestyle and 
environment, somatic symptoms and biomarkers. Even though the big data techniques of 
data mining, utilising machine learning algorithms, are relatively new to psychiatric 
research, these techniques can be beneficial if applied to the variable selection process of 
identifying key risk factors for depression to be included in a risk index. Importantly, the 
development of such a risk index requires a systematic and defensible methodological 
approach based on sound prior research. 
The aim of this research was to develop and demonstrate a flexible, modular Risk Index of 
Depression (RID) from epidemiological data using a systematic generalised structural 
equation modelling approach that builds on the research within this study. 
A literature review initially conducted explored both the potential risk factors for depression 
and possibility of blending of data mining and machine learning techniques with the 
traditional statistical techniques for the development of the index. The literature review 
identified a large and heterogeneous number of risk factors for depression that grouped into 
sets of ‘determinants’ (i.e. groups of potential risk factor predictors). 
The United States National Health and Nutrition Examination Survey (NHANES, 2009-
2010) was identified as an appropriate study to use for the development of the RID as there 
was a wide variety of measurements available for data mining. In addition, this non-
institutionalised population-based study data of adults was publicly available, albeit in a 
large number of individual data sets. It was identified that the NHANES study could support 
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the assessment of five key determinants for the RID: demographics, diet, lifestyle and 
environs, biomarkers, and medical symptoms. 
The development of a risk index for depression for this research required integrating a large 
number of heterogeneous data sets. However, there was no existing protocol for this process 
in medical research. Paper 1 presents a Data Integration Protocol In Ten-steps (DIPIT) that 
was developed to provide a systematic approach to integrating this large number of files and 
variables that is not file or software specific. The DIPIT approach consists of a set of 10 
systematic methodological steps and was applied to the NHANES data sets. DIPIT ensured 
the final data are appropriate for the analysis to meet the research objectives, legal and ethical 
requirements. 
Papers 2 to 5 examined the potential risk determinants for the final structural equation model 
for the formulation of the modular Risk Index of Depression (RID). 
Paper 2 explored the key risk factors that informed the latent diet determinant for the 
development of the final structural equation model for the RID. Although this study was 
primarily aimed to investigate the interrelationship among dietary patterns, diabetes and 
depression, a healthy dietary pattern that consisted of fresh fruit and vegetables and whole 
grains was associated with a reduced likelihood of depressive symptoms irrespective of 
diabetes status. This paper utilised traditional Exploratory Factor Analysis (EFA) to identify 
the dietary patterns and traditional binary logistic regression to quantify the reduced odds of 
depression for those with diabetes (OR 0.68, 95% CI [0.52, 0.88], p=0.006) and those 
without diabetes (OR 0.79, 95% CI [0.64, 0.97], p=0.029) (interaction with diabetes 
p=0.048). 
Paper 3 examined the key risk factors that informed the lifestyle-environs determinant for 
the development of the final structural equation model for the RID. An unconstrained 
Machine-learning (ML) algorithm was used to learn, extract, identify and map the 
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underlying patterns to identify groupings of depressed individuals followed by a ML boosted 
regression algorithm to describe the lifestyle-environ factors describing the clusters. 
Traditional multivariate binary logistic regression validated clusters and controlled for 
possible sociodemographic confounders. The results identified one cluster where members 
of the cluster (i.e. participants of NHANES) were significantly more depressed than 
members not contained in the cluster. A positive relationship between membership of the 
cluster (OR: 7.50, P < 0.001) with depression was found, with significant interactions with 
those married/living with partner (P = 0.001). 
Paper 4 explored the key risk factors informing the biomarker determinant for the 
development of the final structural equation model for the RID. This research developed a 
complex three-step hybrid methodology amalgamating multiple imputation, a ML boosted 
regression algorithm and logistic regression, to identify key biomarkers associated with 
depression. Due to the large amount of missing data associated with the NHANES 
biomarkers, 20 imputation data sets were created from multiple chained regression 
sequences. The ML machine learning boosted regression initially identified 21 biomarkers 
associated with depression which were reduced to three after the use of traditional logistic 
regression methods, which controlled for possible confounders and moderators. The final 
three biomarkers consisted of red cell distribution width (OR 1.15; 95% CI 1.01, 1.30), 
serum glucose (OR 1.01; 95% CI 1.00, 1.01) and total bilirubin (OR 0.12; 95% CI 0.05, 
0.28). Significant interactions were found between total bilirubin with the Mexican 
American/Hispanic group (p = 0.016), and current smokers (p<0.001). 
Paper 5 examined the key risk factors that informed the somatic symptoms determinant for 
the development of the final structural equation model for the RID. Depression is commonly 
comorbid with many other somatic diseases and symptoms. A multi-staged methodology 
was utilised blending ML with traditional statistical techniques. The ML algorithm, 
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combined with hierarchical clustering, created participant clusters based on 68 medical 
symptoms. Traditional multivariate binary logistic regression, controlling for 
sociodemographic confounders, identified the key clusters of participants with higher levels 
of depression. A Multiple Additive Regression Tree boosted ML algorithm then identified 
the important medical symptoms for each key cluster within 17 broad categories: heart, liver, 
thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain, blood 
pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels and 
urinary. Five clusters of participants, based on medical symptoms, were identified to have 
significantly increased rates of depression compared to the cluster with the lowest rate: odds 
ratios ranged from 2.24 (95% CI 1.56, 3.24) to 6.33 (95% CI 1.67, 24.02). Three key medical 
condition categories were then identified from the ML boosted regression as being 
significantly more common in these clusters: bowel, pain and urinary symptoms. Bowel-
related symptoms were found to dominate the relative importance of symptoms within the 
five key clusters. 
Paper 6 developed the final theoretical structural equation model for the formulation of the 
modular Risk Index of Depression (RID). This model was developed to provide a flexible, 
modular, Risk Index for Depression (RID) using the five key determinants, identified from 
the previous papers’ methodologies that blended machine-learning with traditional statistical 
techniques using the same NHANES database. As per data mining strategies, the data was 
split 50:50 into training:validation data sets. Generalised structural equation models 
(GSEM), using logistic regression, were developed with a binary outcome depression 
measure and the five previously-identified determinants of depression were incorporated 
into the model. A systematic model building process was applied to the GSEM model. The 
relative importance of the depression determinants were: diet (OR:4.09; 95%CI:2.01,8.35); 
lifestyle-environs (OR:2.15; 95%CI:1.57,2.94); somatic symptoms (OR:2.10; 
95%CI:1.58,2.80); demographics (OR:1.46; 95%CI:0.72,2.95); and biomarkers (OR:1.39; 
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95%CI:1.00,1.93). The final GSEM model was validated using probit regression. The 
relationships between demographics and lifestyle-environs and depression were mediated 
by somatic symptoms and biomarkers. The path from diet was direct to depression. 
This research described the process for the development of the proposed RID, utilising the 
benefits of using a blend of data mining and machine learning with traditional statistics. The 
resulting RID provides a modular methodology with the potential to add/remove 
direct/indirect risk determinants paths to depression, using a structural equation model, on 
data sets that take account of a wide range of known risks. Further studies that have the 
ability to integrate data on other risk factors that were not available in the dataset for this 
research shows great promise for extending the current RID model and for future clinical 
use. In addition, the identification of the most important determinants of depression supports 
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CHAPTER ONE: OVERVIEW OF THESIS 
This thesis by published work builds and describes a methodology for developing a modular 
Risk Index for Depression (RID). Involving a structural equation model, data mining techniques 
and machine learning algorithms are blended with traditional statistical methods and utilised 
data from the well-established extensive cross-sectional United States National Health and 
Nutrition Examination Survey (NHANES) for the years 2009 to 2010. 
The thesis is presented using the following structure: 
Chapter 2 provides an overview of depression and a literature review exploring commonly 
applied statistical methods used to calculate health indices. The definitions, techniques and use 
of data mining and machine learning techniques are explored. Associations with depression are 
identified to inform the statistical methods for the development of the determinants of 
depression for the hypothesised structural equation model of the modular risk index for 
depression. This chapter concludes by outlining the primary and secondary research aims. 
Chapter 3 is the published article describing of the new protocol, DIPIT, used to integrate the 
numerous data sets from the NHANES website for this research and its implementation for the 
current research. 
Chapter 4 is the published article describing of the development of the diet determinant for the 
final structural equation model. Traditional Exploratory Factor Analysis (EFA) was used to 
identify the key variables that are used to derive the latent diet determinant. 
Chapter 5 is the published article describing of the development of the lifestyle-environs 
determinant for the final structural equation model. A blend of unsupervised and supervised 
data mining and machine learning algorithms with traditional statistics were used to identify 
the final key variables for the lifestyle-environs determinant. 
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Chapter 6 is the published article describing the development of the biomarker determinant for 
the final structural equation model. A blend of a supervised data mining and machine learning 
algorithm with traditional statistics were used to identify the final key variables for the 
biomarkers determinant. 
Chapter 7 is the published article describing the development of the somatic symptoms 
determinant for the final structural equation model. A blend of unsupervised and supervised 
data mining and machine learning algorithms with traditional statistics were used to identify 
the final key variables for the somatic symptoms determinant. 
Chapter 8 is the submitted article describing of the final structural equation model for the 
formulation of the modular Risk Index of Depression (RID). 
Chapter 9 discusses conclusions, strengths, limitations and future areas for research. 
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CHAPTER TWO: INTRODUCTION AND LITERATURE REVIEW 
2.1. Introduction 
In 2010, mental disorders globally were estimated to affect more than 450 million sufferers (1), 
making mental health a pre-eminent global issue. The impact of these disorders on the 
individual and society can be far-reaching, affecting psychological, social and economic 
elements of everyday life (2). With three quarters of mental disorders reported to begin in early 
adulthood (3), and the long lasting effects throughout a sufferer’s life (2), the costs to society 
can be significant. Research has found that adolescent suicide victims have a 27 times higher 
likelihood of having a major depressive disorder (MDD) than case controls (4). However, the 
effects of depression on suicide deaths are much weaker in adults, and may be minimal after 
accounting for depression's strong association with suicidal ideation (5). MDD is part of the 
mood disorder group (i.e. MDD, dysthymia, bipolar I and II) and is expected to become the 
number one health concern in terms of prevalence in both the developed and developing nations 
by the year 2030 (6). 
The lifetime prevalence of mood disorders is estimated to be approximately one in five (20.8%), 
with MDD considered the most prevalent individual lifetime disorder (16.6%) (3), varying 
across gender and countries. For example, for Australian women the estimated lifetime 
prevalence of a mood disorder has been estimated as high as 30% (7). The median age of onset 
for mood disorders (30 years) is later than for disorders such as anxiety (age 11 years), impulse-
control (age 11 years) and substance use (age 20 years) and the age range for mood disorder 
onset is also wide (IQR 18-43 years) (3). The projected lifetime risk of mood disorders as of 
age 75 years, based on the age of-onset distributions, is considered 34% higher than lifetime 
prevalence estimates, with mood disorders having the largest increases between prevalence and 
projected risk (3). 
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MDD is a debilitating disorder. Measured in Disability Adjusted Life Years (DALY = Years of 
Lost Life + Years Lost due to Disability), the magnitude of the global burden of depression 
world-wide is considerable, with MDD the second leading cause of global Years Lived with 
Disability (YLD) in 2013 (8), highlighting the importance of prioritising specific programmes 
or interventions for this disorder.  
An individual suffering from clinical depression generally experiences chronic feelings of being 
sad, down and unhappy, over and beyond everyday sadness that lasts a day or so, where the 
individual recovers only after two or more weeks (9). Individuals who experience depression 
often experience severe despondency and dejection. They feel hopeless and inadequate. This 
mental disturbance typically manifests itself in a lack of energy and difficulty maintaining 
concentration and lack of interest in life. Those severely affected by depression experience a 
number of problems such as sleep disturbance (increased or decreased), interest deficit 
(anhedonia) (e.g. loss of interest or pleasure in going out with friends, hobbies, sports, sex, etc.), 
energy and concentration deficit, feelings of guilt (worthlessness, hopelessness, regret), 
changes in appetite (increased or decreased), psychomotor retardation or agitation, unexplained 
physical problems (e.g. headaches, stomach aches, digestive problems), and/or suicidality (10). 
Depression can be triggered by a stressful event, or can occur for no apparent reason. Mood 
disorders frequently arise in the context of a combination of genetic, biological, psychological 
and lifestyle-environ factors.  
The criteria for depression are listed in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5), published by the American Psychiatric Association, to diagnose MDD 
(10). For a patient to be diagnosed with MDD they are required to have more than a two week 
period of change in five of the following: depressed mood, anhedonia, appetite disturbance, 
sleep disturbance, psychomotor disturbance, fatigue or loss of energy, worthlessness or guilt, 
5 
impaired concentration, and suicidal thoughts. In addition, one of the five symptoms must be a 
depressed mood and/or anhedonia and any physical cause must be ruled out. 
However, a structured clinical interview for depression (SCID), based on the DSM criteria, is 
used for the diagnosis of depression and often not feasible for large scale epidemiological 
studies due to limited resources and time constraints. The Hamilton Depression Rating Scale, 
designed by psychiatrist Max Hamilton in 1960, is a clinical tool that measures depression 
severity and gets the clinician to choose the possible responses to each question by interviewing 
the patient and by observing the patient's symptoms. There are a number of available self-report 
scales assessing depressive symptoms available to researchers, such as the Beck Depression 
Inventory, originally designed by psychiatrist Aaron T. Beck in 1961 (11). This scale contains 
21-questions that cover symptoms such as irritability, fatigue, weight loss, lack of interest in 
sex, and feelings of guilt, hopelessness or fear of being punished. Some scales are age-specific, 
such as the Geriatric Depression Scale (GDS) (12) and Zung Self-Rating Depression Scale (13, 
14) for older aged patients, and the Kutcher Adolescent Depression Scale (KADS) (15, 16) and 
Children’s Depression Inventory (CDI) (17, 18) for adolescents and children. 
The Patient Health Questionnaire (PHQ) is a widely used self-report scale of depressive 
symptoms. This scale can be the nine question version (PHQ-9) of the Primary Care Evaluation 
of Mental Disorders (19, 20), or the shorter two question version (PHQ-2), used to assess the 
presence of a depressed mood and a loss of interest or pleasure in routine activities (21, 22). 
The PHQ-9 is a public domain scale, used in many studies and considered a useful tool with 
high concordance with a clinical diagnosis of MDD (23). However, the self-report nature of the 
scale means the PHQ-9 may possibly miss some perhaps less severe cases of depression or pick 
up false positives (24). 
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Even though there are a number of self-report assessments to identify the presence of 
depression, there is currently no broad index or algorithm in use to determine an individual’s 
risk of developing depression. The benefits of an index of this nature has far reaching effects 
for the prevention and management of depression by clinicians and individuals. For example, 
this index has the potential for the development of a depression self-management computer app 
for individuals identified at risk of depression. 
In order to develop a methodology for a Risk Index for Depression (RID), the following 
literature review investigates a number of current methodologies used to develop health risk 
indices and the potential sets of risk factors for the RID which have been defined as 
‘determinants’ (i.e. group of potential risk factor predictors). This chapter then outlines a 
number of possible data mining and machine learning methods available for the methodology 
and implementation in mental health research, concluding with the study aims for this research. 
2.2. Current Health Risk Index Methodologies 
There are a number of health risk indices available such as the Framingham Risk Score (FRS) 
(25), Reynolds Risk Score (RRS) (26), the World Health Organization (WHO) Fracture Risk 
Assessment Tool (FRAX®) (27, 28), PreDx® Diabetes Risk Score (29), Postoperative 
Vomiting (PV) score (30, 31), late-life dementia index (32), and bipolar disorder risk for 
attempting suicide (33). Current methodologies for the development of such health risk indices 
primarily draw on traditional statistical techniques. The difference between a risk index and a 
conventional screening tool is the risk index assesses probability of the condition occurring, 
whereas a screening tool detects the current state of the condition. For example, the 
Framingham Risk Score was developed to measure the ten-year risk of cardiovascular disease 
(34). This index was developed from an epidemiological study of heart disease in Framingham, 
Massachusetts, commencing in 1950, and utilised a logistic regression model for conditional 
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risk using Walker-Duncan estimation (35). The Framingham Heart Study produced sex-specific 
coronary heart disease (CHD) prediction functions for assessing risk. The current version of the 
Framingham Risk Score was published in 2008 in which the updated risk assessment equation 
aimed to provide primary care clinicians with a more accessible version of the Framingham risk 
assessment tool (36). This update utilised Cox proportional-hazards regression to evaluate the 
risk of developing a first cardiovascular event to generate sex-specific multivariable risk 
functions. Even though the initial study related to a white middle-class population, the FRS has 
also been found to be valid for other groups (37). 
The RRS was developed as an alternative to the FRS for cardiovascular risk assessment (26). 
The RRS for women was validated using data from more than 20,000 initially healthy American 
women, followed over 10 years. Two thirds of the study participants were used to derive the 
model and one third for validation. A mix of Cox proportional hazards models, stepwise 
selection procedures and multiple additive regression trees were used to derive a set of models 
and the lowest Bayes Information Criterion (BIC) (38) was used to select the final model. The 
RRS for men used data from more than 10,000 initially healthy non-diabetic American men, 
followed over 10 years (39). The FRS and RRS differ in what measurements to include (e.g. 
RRS does not include current blood pressure medication use) and differ in the endpoints used: 
FFS predicts death or myocardial infarction whereas RRS adds stroke and the need for 
revascularisation (40). The RRS was found to be better calibrated than the FFS using a large 
external validation case-cohort sample of over 3,700 multi-ethnic women (41). The Reynolds 
score also showed improved discrimination overall and in black and white women. 
FRAX® is a web-based diagnostic tool that uses an algorithm to assess the 10-year risk of 
fracture in consultation with a clinician. This tool was developed at Sheffield University in 
collaboration with the WHO. Risks of fracture are calculated as country-specific probabilities 
over a 10-year interval for major fractures (clinical spine, forearm, hip or shoulder) or for hip 
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fracture alone. FRAX® is based on absolute risk rather than relative risk, therefore requiring 
knowledge of the incidence of fracture and death in populations across a range of ages and for 
both men and women. Importantly, FRAX® examines the relationship between the risk factors 
and mortality. 
The PreDx® Diabetes Risk Score (DRS) was developed to ascertain the risk of type 2 diabetes 
mellitus within a five year period (29). The PreDx® DRS used a logistic regression model and 
was validated by using ROC curves to assess the performance on training and validation sets 
(42). 
The PV score was developed from data for over 1,000 patients (30) where data was randomly 
split into an evaluation and validation set of approximately equal size. Binary logistic regression 
was run to develop the risk score, with testing on validation data. The area under a receiver 
operation characteristic (ROC) curve was calculated and the predicted and actual incidences of 
patients were reviewed. 
The late-life dementia index (32) is a mental health index that was developed with the objective 
to accurately stratify older adults into low, moderate, or high risk of developing dementia within 
6 years. This index was developed using more than 3,000 participants in the Cardiovascular 
Health Cognition Study without evidence of dementia at baseline. Logistic regression was 
utilised whereby the logit coefficients from the final model defined a points system (i.e. ≤ 0.75 
scored 1 point; >0.75 scores 2 points). The ROC curve was used to assess discrimination and 
calibration by plotting the predicted probability of dementia and the actual percentages of 
participants who developed dementia by their risk scores. In addition, the final calibrated model 
was validated using a 10-fold cross-validation approach. 
A simple risk-scoring scheme to identify patients with bipolar disorder at risk of attempting 
suicide was developed from the medical files of more than 480 patients diagnosed with bipolar 
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disorder in Thailand (33). Logistic regression was utilised to finalise the set of risk factors and 
a weighted score assigned to each indicator and summed to create a total score. The total risk 
score was then split into low, moderate and high for the risk of suicide. 
Much research has investigated individual risk factors for depression with effects of potential 
confounders removed (e.g. age, gender, socioeconomic status) (43). Yet, to understand the full 
relevance of risk factors and confounders for depression, the complex interplay between 
lifestyle behaviours, biochemical and somatic symptoms requires further in-depth investigation.  
There is a clear and current need for a risk index for depression that takes into account the 
complexity (e.g. potential interactions) and heterogeneity of different risk factors, capable of 
dealing with different data sets and be expanded to include future medical developments. 
2.3. Complexity of Depression 
Depression is a complex disorder. The prevalence of major depression is increased in the 
medically ill, with depression known to amplify the physical symptoms associated with medical 
illness. As impairment in functioning increases, adherence to prescribed regimens tend to fall 
and poor symptom control tends to increase. The odds of non-adherence to medical treatment 
recommendations are three times greater for those meeting criteria for depression compared to 
those who do not (44). These implications increase complications of medical illness, functional 
impairment and mortality. Moreover, there is a bidirectional relationship between physical and 
mental disorders, with common underlying factors and pathways to disease, such as lifestyle 
behaviours. 
Adverse lifestyle behaviours such as poor diet, sedentary lifestyle and tobacco smoking are 
highly prevalent in depression, thereby in turn affecting physical health (e.g. obesity). Mining 
a multitude of variables to uncover patterns of direct interest to depression may provide 
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researchers with further insight into the complexity of interactions between multiple variables 
and their influence on mood disorders. Potential groups of risk factors include demographic, 
lifestyle behaviours, biomarkers, somatic symptoms, early life experiences and harmful 
event(s). 
2.3.1. Risk Factors for Depression 
2.3.1.1 Demographics 
The demographic profile of an individual has been found to impact on the prevalence of MDD 
(45). There is a gender bias, with the ratio of depression for women to men shown to be 
approximately 2:1 in developed countries (46). In addition, research has found that the lesbian, 
gay, bisexual, trans, and/or intersex (LGBTI) groups have an increased risk of depression (47, 
48). Age is also another potential risk factor, with depression having been shown to be less 
prevalent during middle age (49). However, these age and gender differences may be associated 
with education and socioeconomic status. The association between lower socioeconomic status 
and the risk for mental health problems is well established. For example, the odds for mood 
disorders (current) for a low socioeconomic group of Australian women was twice that of a 
middle socioeconomic group (50). In the United States, race has also be considered a potential 
risk factor for depression, with the prevalence of MDD being higher in whites than in African 
Americans and Mexican Americans (51). Finally, occupations involving high job strain have 
been found to be associated with a greater prevalence of MDD (52). 
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2.3.1.2. Lifestyle Behaviours  
Lifestyle behaviours play an important role in the path to, and from, depression. Lifestyle 
behaviours such as diet, tobacco smoking, alcohol consumption, physical exercise and sleeping 
patterns impact on an individual’s risk for depression. 
There is a growing area of literature regarding the influence of an individual’s diet on their 
mental health. Extensive research has investigated the impact of diet quality as a potential risk 
factor for depression (53-56). Differing diets have been investigated such as the western and 
traditional (54), and the gluten-free diet (57). Exploratory factor analysis has been used to 
determine how the types of diet influence depression and anxiety, and encompasses the concept 
of a diet perspective within the field of psychiatry (54). Thus, what an individual consumes in 
their diet may influence their physical and mental health. The link between systemic 
inflammation and low intakes of magnesium, with higher levels of depression and anxiety was 
investigated by Jacka et al (58). Findings of meta-analyses have confirmed an inverse 
relationship between various types of healthy diet and depression (59, 60) suggesting that diet 
should be isolated as a separate risk determinant for depression. Recent evidence from 
randomised controlled trials also reinforces the importance of diet quality to depression (61, 
62). 
Tobacco smoking is disproportionately prevalent amongst psychiatric patients. The odds for 
MDD more than doubles if an individual smokes more than 20 cigarettes per day (63). Whilst 
the direction of the relationship between smoking and psychiatric illness is likely bidirectional, 
there are neurobiological effects of nicotine on mental illnesses and it has become evident that 
the two are linked (63). There is a higher likelihood of an individual with depression having 
smoked during their lifetime. A general population sample from St Louis in the United States 
Epidemiologic Catchment Area (ECA) confirmed the link between MDD and smoking, and 
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even preparedness to stop smoking (64). However, the bidirectional relationship between 
smoking and MDD has been investigated, where long-term nicotine exposure appears to be a 
risk factor for MDD (65), but there is also evidence that nicotine is used for self-medication of 
MDD  (66). A 5-year longitudinal epidemiologic sample of over 1,000 young adults 21 to 30 
years of age found that a bidirectional relationship for smoking and depression is feasible as an 
individual who smokes is at higher risk for MDD and in turn at a higher risk of smoking on a 
daily basis (66). 
An association has been found between alcohol consumption and depression. The consumption 
of alcohol has been shown to increase the risk of depression via lowering serotonin levels in 
the brain, a chemical that helps to regulate mood (67, 68). Research has found that if an 
individual drinks heavily and regularly they are more likely to develop some symptoms of 
depression (69-71). 
Even a moderate amount of daily physical exercise can benefit someone’s physical and mental 
health and quality of life (72-74). Physical activity can potentially benefit mental health by both 
reducing the risk of depression and anxiety and as a therapeutic measure to help treat this 
disorder (73-76). A sedentary lifestyle has adverse effects on mental health. A Sedentary Index 
has been developed consisting of hours per day or week spent watching television or using a 
computer. The largest effect was seen for graduates, where the odds of a mental disorder on 
average were 31% higher for those who spent more than 42 sedentary hours per week watching 
television or using a computer compared to those who spent less than 10.5 hours per week 
watching television or using a computer (77). 
Sleep disturbances (e.g. insomnia) have been shown to be associated with an increased risk of 
depression, as well as being a core symptom (10). The functional reduction of serotoninergic 
neurotransmission associated with depression is a potential reason for its association with sleep 
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disorders (78). However, the effects of sleep disturbance on depression may also be related to 
hormonal regulation (e.g., melatonin, HPA axis) (79, 80). 
There are other potential lifestyle-environs related to depression such as exposure to pollutants. 
The midbrain is sensitive to the neuro-inflammatory effects of sub-chronic air pollution 
exposure (81-83). The age of engagement in adolescent dating and sexual activities is linked to 
greater depressive symptoms (84-86). Unconstrained a priori investigation of a multitude of 
lifestyle-environ factors may uncover more risk factors for depression currently not known. 
2.3.1.3. Biomarkers 
The brain driving the human body’s thoughts and actions has a network of chemical and 
mechanical interactions and during life the body and brain are subjected to many chemical and 
environmental exposures. There is a growing body of evidence focusing on the associations 
between mental health conditions and biomarkers. Biomarkers, such as inflammatory cytokines 
(87), oxidative and nitrosative stress (O&NS) (88) and levels of neurotrophins (89), are 
understood to influence mental illness. For example, research has established a link between 
inflammation, oxidative stress and increased risk for depression (90, 91). However, biomarkers 
have been found to be modulated by lifestyle practices such as diet, smoking, stress and physical 
exercise. Research has suggested that long-term exposure to air pollution, levels typical of 
exposure in major cities, can alter affective responses and impair cognition (92) 
Links of vitamin D deficiency to the seasonal changes in the photoperiod and changes in mood 
have been proposed (93, 94). The seasonal effects of summer and winter on the incidence of 
vitamin D deficiency have been attributed to the varying exposure to ultraviolet light. However, 
the seasonality of mood, mainly due to the photoperiod, has now been linked to levels of vitamin 
D. The vitamin D receptor activates enzymes 1-alpha-hydroxylase, which is associated with 
brain function. This enzyme has been found to be especially deficient in the elderly, where 
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exposure levels to ultraviolet light is often low, and those with low levels have a higher 
prevalence of depression. 
2.3.1.4. Genetics 
There have been many studies investigating the role genetics plays in the risk for depression. A 
meta-analysis in 2000 confirmed that major depression is a familial disorder almost entirely 
due to genetics (95) and estimated an odds ratio for increased risk for depression in first-degree 
relatives of depression probands of 2.84. However, precise genetic analysis of this mood 
disorder is challenging due to its complexity and the contribution of non-shared environment 
(96). 
2.3.1.5. Comorbid Physical Illness  
Mental health issues do not occur in isolation, often co-occurring with other physical and mental 
health problems (97). There have been numerous studies on the comorbidity of depression with 
other mental health conditions (98) and between physical illness and mood disorders (99), such 
as angina, arthritis, asthma, and diabetes (100). MDD has been found to be an independent risk 
factor for mortality at 6 months for patients who have been hospitalised with myocardial 
infarction (101). MDD is commonly comorbid with chronic illness. For example, it has been 
reported that between 15-32% of people with MDD have heart disease, 11-12% have diabetes 
and 10-20% have chronic obstructive pulmonary disease (COPD). This disorder is especially 
high in patients with neurological illness with lifetime prevalence 40-50% for Parkinson’s 
disease, 19-54% for Multiple sclerosis, 30-50% for Alzheimer’s disease and 20-72% for post 
stroke (102). Depression has a profound impact on health compared to other chronic conditions 
(100). When depression is combined with other chronic conditions, an individual’s health 
worsens by comparison to when depression is not present (100). 
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2.3.1.6. Other Mental Disorders and Personality Traits 
Certain personality traits have been found to be associated with depression (103). The Clark 
and Watson tripartite model of anxiety and depression (104) has influenced research into the 
relationship between personality and depression. Depression is defined by high levels of 
negative affect and this affect is strongly linked to neuroticism and extraversion (105), with 
neuroticism being found to correlate with both concurrent and recalled depression (106). Those 
exhibiting low self-esteem are also at higher risk of depression (107, 108). However, external 
factors may influence self-esteem and depression risk. For example, authoritative mothering 
was found to relate to higher self-esteem and lower depression in adolescents (109). 
Another important risk for depression is the history of other mental health disorders, such as 
anxiety disorder (7, 110), eating disorders or post-traumatic stress disorder (PTSD). Anxiety 
has been found to be frequently comorbid with depression and particularly contributes to high 
medical utilization in the primary care setting (111).  
Depression has often been identified as a comorbidity of eating disorders, but this relationship 
is complex as it may be bidirectional, a secondary effect, or related to genetics or familial 
transmission (112). Depression and PTSD are commonly comorbid (113), especially in the 
presence of war-related psychic trauma (114). Personality disorder also influences risk for 
depression (115). 
2.3.1.7. Traumatic or Stressful Events 
Traumatic or stressful events, such as physical or sexual abuse, marital breakdown, the death 
or loss of a loved one, or financial problems have been found to be associated with elevated 
depressive symptoms (116-119), and can differ across gender (119). Adverse childhood 
experiences (ACE) are highly associated with the onset of depression in later life. Childhood 
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abuse has been associated with the subsequent development of depression (120, 121) and 
research has found that adolescents and young adults with a history of ACE are three times 
more likely to become depressed or suicidal compared with individuals without such a history 
(122). Events such as childhood physical abuse, neglect, sexual abuse, and psychological or 
emotional abuse have each been associated with an increased prevalence of depression (123, 
124). In addition, stressful life events (SLEs) such as unemployment, significant health 
problems, financial hardship, and relationship problems have been associated with the onset of 
MDD (116, 117, 125) and have been shown to affect biological factors such as serotonergic 
functioning (126). 
Thus, the large volume and complexity of potential risk factors for depression makes variable 
selection a crucial process in the derivation of a depression risk index. 
2.4. Data Mining Methods and Machine Learning Algorithms 
Data mining methods for uncovering underlying known and unknown patterns in mental health 
data show potential for gaining a greater understanding about the multitude of risk factors 
associated with depression. To date there is no specific risk index for depression for the general 
population. There is an opportunity for a flexible modular risk index, developed by blending 
the big data mining and machine learning algorithms with traditional statistical techniques, for 
the variable selection needed to define blocks of determinants of depression. 
The origins of data mining methods could be considered ubiquitous as there has been some 
conjecture in the literature as to when these originated. Like many research techniques, data 
mining techniques have some of their origins based in traditional statistical techniques. Many 
traditional statistical techniques for data exploration, visualization (e.g. scatters), reduction and 
model building (e.g. logistic regression) have been employed for data mining. In addition, data 
mining harnesses techniques from computer science and artificial intelligence (e.g. neural 
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networks) and database management. Definitions for data mining vary according to the nature 
of the data mining exercise, and conflicting literature exists as to exactly when and where the 
term “Data Mining” originated (127). In 1995, the first International Conference on Knowledge 
Discovery and Data Mining was held (128) where a number of definitions were discussed and 
this may have been the origin of the phrase data mining. Yoo et al (129) distinguishes statistics 
from data mining according to the nature of the analysis; statistics deals with primary analysis, 
whereas data mining deals with secondary analysis where it may be possible to uncover 
undiscovered patterns. One of the broadest concepts for data mining came from Friedman et al 
(127) who considered it part of “learning from data”. Thus, the term Knowledge Discovery and 
Databases (KDD) is often synonymous with data mining and suites of data mining techniques. 
Machine Learning (ML) is the algorithm component of the data mining process. These 
computer algorithms learn by improving performance “through experience” (130). The learning 
element occurs when at each iteration the algorithm adapts to perform the next iteration of the 
task more effectively continuing until no effective benefit is gained. Thus, this is a data driven 
learning task. This technique differs from the traditional scientific statistical method where a 
hypothesis is generated, an experiment is then designed, representative data is gathered, and 
finally traditional statistical techniques test the hypothesis. 
KDD extracts knowledge from databases using an array of statistics, pattern recognition, 
machine learning, and graphical visualization. Even though workshops for KDD were being 
run as early as 1989 (128), data mining techniques were not really considered by many as an 
element of KDD until the 1990’s. Many books and literature offer a differing number of steps 
in the KDD process, and exactly where data mining sits within these steps depends on the steps 
defined. Tan et al (131) provide a simplistic three step explanation, with data mining sitting 
between the pre-processing and post-processing stages of KDD. Fayyad et al (132) considered 
the KDD process to include six steps to knowledge, with data processing lying between 
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transforming the data and establishing the patterns or data models or structures. Shmueli et al 
(133) outlined eight generic steps to data mining without distinguishing it from the KDD 
process. 
In health research, there is potentially a vast array of data to mine, varying in nature and 
magnitude. Thus, the preparation of health data for KDD often requires greater emphasis on the 
data integration preparation stage prior to the mining exercise. To ensure a systematic approach 
to data integration is undertaken, one that is easily replicated, there is a need for an industry 
protocol for integrating health data sets. 
The steps to gaining knowledge from health data sets could be viewed as a continuous loop 
along the road to defining, acquiring, disseminating, and re-defining knowledge (Figure 1). 
 
Figure 1. Proposed KDD Process 
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The strengths of data mining analytical tools in the KDD cycle traditionally lie in their ability 
to recognize and visualize patterns in big data and utilize machine learning algorithms. For 
example, websites such as Amazon.com use sophisticated algorithms to instantaneously present 
a number of similar selections as originally chosen to purchase (i.e. “Frequently Bought 
Together”, “Customers Who Bought This Item Also Bought”). In IT, data mining and machine 
learning techniques are commonly used in the detection of spam emails. In health, examples of 
data mining and machine learning algorithms are those used by the large Pennsylvanian health 
insurer company Highmark to reduce costs by detecting potentially fraudulent customers and 
to detect undiagnosed patients (129). 
The data mining methods and machine learning algorithms applied to a data set depend on the 
nature of the objectives of the mining exercise. Data mining methods and the machine learning 
algorithms used can be split into two main categories: supervised learning; and unsupervised 
learning techniques (133). The main distinction between the two techniques lies with the 
intended purpose. If the objective of the data mining exercise is to establish the main inputs to 
predict known values, then supervised learning techniques are used as a direct analytical 
approach. For example, this would be applied in a model to describe known patterns or values. 
However, if the objective is to uncover previously unknown patterns and clusters within the 
data set, without any a priori model defined, then unsupervised learning data mining techniques 
are used as an undirected analytical approach. 
The process of data mining analysis initially involves allocating observations into two or three 
sub-data sets for the purposes of training and validating (133). One data set is used to formulate 
or train the data mining model for which the second or third data sets are used to validate and 
test the data mining analysis. This is analogous to an individual learning from a past experience 
to replicate an action. A simple example of this may be learning to serve a tennis ball, where an 
individual practices this action, then validates it in a competitive environment. For data mining, 
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the result of the data mining exercise lies with measures of error or degree of inaccuracy 
obtained and evaluated (131).  
Some of the most common functions among currently used data mining techniques are 
association rule mining, classification, clustering, regression, sequence and link analysis and 
dependency modelling. In psychiatric research, there has been a tendency to focus on specific 
groups of risk factors without investigating the potential complex interplay between groups of 
risk factors together such as the interplay between groups of diet, biomarker and somatic 
symptoms risk factors. This type of research methodology may have been due to inadequate 
computing power or technology in the past. However, the recent advances and increased use of 
data mining in other fields of medicine (134) has opened the door to use these techniques to 
unravel the multiple risk factors together, as opposed to in isolation. Blending various 
supervised and unsupervised data mining methods and machine learning algorithms provides 
the potential to further explain and identify common mental health disorders. 
2.4.1. Supervised Classification 
Classification techniques usually represent a supervised learning area used to build meaningful 
models with the objective to assign objects to one of a number of predefined categories. These 
techniques have been thought of as “pervasive” due to their broad application across a larger 
number of disciplines, and addressing varying objectives (131). For example, these procedures 
have been extensively used in marketing research to segment customers (135-137) into known 
categories. In medical research these techniques have been used to classify cells as malignant 
or benign from Magnetic Resonance Imaging scans (131) and in the analysis and diagnosis of 
Ischaemic Heart Disease (138). Supervised classification has been considered as “the most 
important data mining technique”, especially in the area of medical diagnosis (139). However, 
these techniques have not been widely used in mental health research. 
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The task of classification uses a categorical outcome variable y (i.e. binary, ordinal, or nominal) 
and a set of predictor attributes. It is possible to use classification for both descriptive and 
predictive purposes: distinguishing features between different categories of y; or predicting 
each category of y based on the attribute set (𝑥1, …, 𝑥5). 
Commonly used methods for classification include discriminant analysis, logistic regression, 
decision trees, neural networks, k-Nearest Neighbour (k-NN) and Bayesian classification. 
There have been a few authors who have evaluated different data mining classification 
techniques on differing medical data sets (139-142). The success of each technique depended 
on the nature of the data used and algorithm chosen. This was highlighted by Srimani et al (139) 
who applied eight different data mining classification algorithms across five medical data sets: 
Prima Indians predisposed to diabetes (n=768); Statlog Heart (n=270); Bupa liver (n=345); 
Hepatitis (n=155); and Thyroid (n=215). It was evident that the selection of the appropriate 
classification algorithm significantly affected the results produced. Evaluation of classification 
models essentially lies with how well the model predicts the target variable y. 
2.4.1.1. Decision Tree Analysis 
Discriminant and logistic regression techniques are used widely in health research, but 
primarily in a traditional statistical framework. Decision tree analysis has been widely used as 
a data mining technique due to its versatility. The models produced are visually easy to explain 
and understand as a set of rules (Figure 2). Decision trees used for classification are often 
referred to as classification trees, with regression trees for prediction of metric responses (133). 
This technique makes no assumptions regarding the distribution of the data and is appropriate 
for both categorical and continuous predictors. Traditional transformations of data, due to 
distributional skewness (e.g. logarithmic, squared), are not required, as it is considered desirable 
to keep the variables as simple as possible for interpretation purposes. Furthermore, the 
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presence of missing data does not impede the method as it can still classify based on the other 
non-missing attributes. Another advantage of these techniques is they accommodate non-
linearity and interaction effects between predictor variables. The analysis builds a collection of 
hierarchical rules to split the data into successively smaller sets, with each set becoming more 
similar to the target variable. The resulting sub-sets become more homogeneous in terms of the 
target outcome. The root is at the top of the tree and the leaves at the bottom. A record starts at 
the root node and answers a question and, based on the answer, the record can enter a child 
node. Decision tree analysis can be used for classification, estimation and prediction (143) and 
has been used to explore a variety of data sets across many disciplines. Simple classification 
decisions are based on the majority class in the terminal child node. There are a number of 
mathematical algorithms that can be selected to split classification trees (i.e. make branches) 
such as the Gini Index (CART), Chi-Square Automatic Interaction Detection (CHAID), 
reduction in variance, F-test and entropy (143-145). 
  
Figure 2. Example decision tree 
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An advantage of this procedure is that it does not require the removal of irrelevant attributes as 
the trees performs this task automatically due to the nature of how the tree is built. Decision 
tree analysis had been found to be the best predictor of breast cancer survivability using the 
large United States SEER cancer incidence dataset for the years 1973 to 2000 compared to the 
other data mining techniques of artificial neural networks and logistic regression (140). In 
mental health decision tree analysis has been applied to a prospective cohort study from a large 
regional centre in New South Wales in Australia to investigate potential predictors of suicidal 
ideation in a community-based sample of older adults (146). This study focussed on the role of 
physical, social, and psychological risk factors and the data mining analysis identified that 
baseline psychological distress was the most important predictor of follow-up suicidal ideation. 
2.4.1.2. Boosted Regression Tree Methods 
The boosted regression tree methods, such as the Multiple Additive Regression Trees (MART) 
boosting algorithm (147, 148) implemented by Schonlau (149), have been recognised as 
particularly good for variable selection (150). These methods are easy to interpret (151, 152) 
and can accommodate any type of predictor variable (continuous, categorical, censored), and 
any type of likelihood loss function (Gaussian, Binomial, Poisson, and robust) which must be 
minimised in order to optimise model fit. A great benefit of these techniques is that they can 
deal with highly correlated predictors (153), which is often evident in health data (e.g. 
biomarkers). Boosting was invented by Freund and Schapire for regression trees (154) and 
translated to the logistic regression model by Hastie, Tibshirani, and Friedman (147). The steps 
in the boosted regression technique include: 1) create an initial guess for the predicted outcomes 
and compute the residuals are based on the current model; 2) for each regression tree, fit a 
regression tree to the residuals, predict the outcome of the residuals for each terminal node and 
use the regression tree to predict the new set of residuals; 3) update the boosting regression 
model to reflect the current regression tree, applying regularization using a shrinkage parameter 
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to the last regression tree of residuals to reduce overfitting; 4) apply model to the validation 
data and if there is an improvement in predictive accuracy over the results for the previous 
iteration then continue to the next iteration, but if not, then training stops and no more iterations 
are executed and no more residual trees are developed. 
In order to improve the robustness of the final model of the boosted regression without 
introducing bias ‘bagging’ is regularly used (148). Bagging was developed by Breiman as a 
method for creating multiple versions of a predictor to form an aggregated predictor (155). 
Boosting with bagging means that the bagging randomly selects a proportion of the residuals at 
each iteration to build a new tree. While not all observations are used in each iteration, all 
observations are eventually used across all iterations. Thus, the tree analysis is run on multiple 
similar datasets, and the aggregate results are used to construct the final model and relevant 
statistics. Bagging with 50% of the database has been the usual recommended split (148). No 
probability values (p-value) are produced from the boosted regression algorithm, but a relative 
importance of variables is used to pick likely predictors (148). Each variable is assigned a 
relative importance percentage or contribution to outcomes values, where the sum adds to 100 
and therefore the higher the value indicates stronger contributions to outcomes values.  This 
value is calculated from the number of times a variable is selected for splitting, weighted by the 
squared improvement to the model fit achieved from each such split, averaged over all trees. 
Boosted regression has been used in studies involving animal ecology (156), for example to 
build predictive models for fish and coral metrics (147), and to identify factors predicting the 
reproductive success of dominant pairs of clown anemonefish (157). In psychiatry, this method 
has been used in the development of the Chicago Adolescent Depression Risk Assessment 
(CADRA) index from an array of baseline social and cognitive vulnerability and mood risk 
factors (158). Boosted regression performed better than the traditional logistic model to identify 
variables that predict treatment outcomes in a study that applied pooled data from 12 
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randomised clinical trials of those treated with duloxetine and suffering from an acute 
depressive episode (159). 
2.4.1.3. Naïve Bayes Method 
The naïve Bayes method is named after the English mathematician Reverend Thomas Bayes 
(1702 - 1761). The naïve Bayesian classifier is a simple, but powerful data mining tool, based 
on Bayes’ theorem to calculate the probability of each class given the values of all the attributes, 
and assuming the conditional independence of the attributes (i.e. naïve, probability of event A 
given that event B has occurred = P(A|B)). The naïve Bayes procedure assigns observations to 
a class with the highest probability value for the set of predictor values involved. 
Due to the simplicity of the naïve Bayesian classifier a large number of attributes can be used 
and only a relatively small training data set is required to develop accurate parameter estimates 
(160). This technique assumes all attributes are independent of each other. The naïve Bayesian 
classifier has been found to perform well even when this assumption has been violated (160), 
often outperforming more complex classifiers (133). For this reason, there is a reasonable 
amount of literature surrounding the use of this data mining method in health research. Bayes 
theorem has been used as early as the 1980’s when authors such as Diamond et al (161) 
employed the computer program CADENZA (Computer Assisted Diagnosis and Evaluation of 
Coronary Artery Disease) to implement Bayes theorem to calculate the probability of coronary 
artery disease and disease prevalence. The naive Bayesian classification technique has also been 
used for a web based application for heart disease prediction where a historical heart disease 
database is used to predict patients with heart disease (162). The naïve Bayes classifier of free 
form or unstructured text triage diagnosis was used to detect cases of acute gastrointestinal 
syndrome in light of a potential public health epidemic by Ivanov et al (163). Although Ivanov 
et al used this method with free-text data, the flexibility and improved sensitivity of this method 
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compared to another method called the bigram Bayes classifier or ICD-9 code classifier 
warrants attention. The naïve Bayesian classifiers have been found to be tolerant to the noisy 
data of the pharmaceutical industry, and especially when trying to predict the protein activity 
inhibition by small molecules (i.e. Absorption, Distribution, Metabolism, and Excretion 
(ADME) (164) recognized. This method has been compared with neural network and decision 
tree techniques to predict the survival rate of breast cancer patients using the United States 
SEER Public-Use-Data (165). The performance of each model was calculated on the basis of 
accuracy, precision and recall, derived from the confusion matrix (165). The naïve Bayes model 
performed the worst of the three techniques on all three measures. However, their data excluded 
missing data, which potentially biased their results. 
The potential problem with the naïve Bayesian data mining technique occurs when the training 
data set does not cover many of the attribute values, making it difficult to classify some of the 
test observations (133). To overcome this problem it is possible to implement the multiple 
estimation approach for estimating probabilities outlined by Pang-Ning et al (131). 
Unfortunately, the performance of the naïve Bayesian method may also become degraded when 
the attributes are correlated, which is often the case with health data. This method is best used 
for classification purposes or ranking of records, where its performance is generally good. Due 
to potential bias it is best to avoid this technique if the objective is to obtain class membership 
probabilities. In this instance it is best to use another method such as logistic regression. For 
example, the naïve Bayes classifier did not perform as well as a logistic regression model for a 
study that investigated models for assessing the risk for treatment resistance among outpatients 
with major depressive disorder (166). However, in a study examining the causes of depressive 
symptoms from genetic, environmental, and sociobehavioral factors the Naive Bayes model 
performed the best across a number of machine learning algorithms in those subsets that 
included only environmental and sociobehavioral factors. (167). 
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2.4.1.4. Artificial Neural Networks (ANN) 
Artificial Neural Networks (ANN) can be used for both data mining classification, estimation 
and prediction. This data mining technique is based on the analogy of the neurological functions 
of the human brain and is primarily designed to mimic the network of neurons that link the 
brain’s ability to learn via changes in the strength of the synaptic connection between neurons 
(168). This data mining technique has been claimed by Smueli et al (133) to have high 
predictive performance, with an ability to capture complex relationships between a criterion 
and its inputs. 
An ANN is an interconnected group of nodes, similar to the vast network of neurons in a human 
brain. Typically with this type of analysis there are three layers with the first consisting of 
input/predictor variable nodes, the second consisting of transformed agglomerations of input-
predictor variables and the third consisting of outcome categories or variables. There are a 
number of different forms of neural networks, but the most common are perceptrons (model of 
just two types of nodes: input attribute nodes and output criterion node) and multi-layer 
perceptrons (i.e. containing input, hidden and output layers) (Figure 3) (131, 143). With the 
multi-layer perceptrons model each hidden or output node has an activation function that 
consists of a combination function and a transformation function. A typical combination 
function is simply the weighted sum of the input values (i.e. ∑ 𝑤𝑖𝑗𝑋𝑖 + 𝜃𝑗). Typical transfer 
functions are the linear (i.e. straight line), tanh (S shape hyperbolic tangent) and sigmoidal (i.e. 
S shape sigmoid curve) functions. Feed-forward and back-propagation multi-layer perceptions 
can be used, with the latter being recently preferred due to superior performance (129). Back 
propagation of errors is used to optimise the model weights. Using existing weights in the 
training network to estimate outputs the error between the calculated result and the actual target 
value is calculated and fed back into the network to adjust the weights, using the generalized 
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delta rule, developed by Rumelhart, Hinton & Williams in 1986 (169), to minimise the error. 
This process is repeated until the weights converge or until there is no further improvement in 
model fit found in the validation data. 
 
𝑁𝑜𝑡𝑒: 𝑗 = 𝑛𝑜𝑑𝑒 𝑛, 𝑤𝑖𝑗
= 𝑤𝑒𝑖𝑔ℎ𝑡 𝑎𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑒𝑑 𝑤𝑖𝑡ℎ 𝑖𝑛𝑝𝑢𝑡 𝑋𝑖 𝑎𝑛𝑑 𝜃𝑗𝑖𝑠 𝑎 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡, 𝑎𝑗𝑖𝑠 𝑡ℎ𝑒 𝑜𝑢𝑡𝑝𝑢𝑡 𝑓𝑟𝑜𝑚 𝑢𝑛𝑖𝑡.  
Figure 3. Multilayer feed – forward neural network 
Typically, the steps for running a neural network for prediction are to 1) identify the input and 
output features; 2) define the appropriate topology or number of hidden layers, hidden nodes 
and architecture; 3) train the network; 4) validate the trained network; and 5) apply the 
generated model to predict the outcome on test data. 
One of the pitfalls with ANN is that the procedure is sensitive to the inputs selected and the 
training process can be very time consuming (i.e. especially for large numbers of hidden nodes). 
Moreover, the black box non-transparent nature of the ANN result can make it difficult to 
explain and gain acceptance from health professionals (129, 131, 133, 143, 170). A considerable 
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weakness of the ANN technique is the risk of overfitting the data, resulting in a very large error 
rate when run on the validation data set (136). Limiting the number of training epochs or steps 
so as to limit the risk of overtraining the data is preferable. 
ANN has been tested in a number of health research domains, such as in the diagnosis of 
ischaemic heart disease (138) and predicting breast cancer survivability (165). ANN’s have 
been used for a number of years in mental health research. In 1996, Zou et al used ANN’s to 
see if this analysis could assist the psychiatric diagnosis of the Composite International 
Diagnostic Interview (CIDI) (171). The study utilised patients from two Beijing mental 
hospitals and found that the use of ANN’s showed potential. However, the performance of 
ANN’s has been shown to be of a lesser standard than some of the other data mining techniques 
in terms of accuracy. 
2.4.1.5. K-Nearest Neighbor (KNN) Technique 
The K-Nearest Neighbor (KNN) cluster classification technique is a supervised machine 
learning algorithm that utilises the idea that the nearest neighbour of a data point (observation) 
tends to belong to the same cluster or grouping as the data point itself (i.e. concept of similarity 
(143)). This technique does not use any model to fit the data and is purely based on memory, 
using either a majority vote (i.e. most frequent) or an average. This technique can be used for 
both classification using a categorical outcome, or the prediction of a numeric outcome. The 
method finds similar k observations in the training data to the new observation. It then uses 
these neighbours to work out a classification or prediction for the new record by voting for 
classification, or averaging for prediction. This nonparametric method makes no assumptions 
about the nature of the relationship between the class membership and the input variables, 
performs no estimations, but simply takes into consideration similarities between the data points 
(observations). 
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The most popular distance measure is the Euclidean distance between two observations, which 
will be explained later. It is preferred to standardize the inputs performed prior to running this 
analysis to ensure all inputs are treated equally (133). This is done by calculating the mean and 
standard deviation across all data points, then taking the mean from the data point and dividing 
by the standard deviation. This produces a standard score with a mean of zero and a standard 
deviation of one.  
The simplest scenario is the k=1 Nearest Neighbour rule. In this situation, the observation that 
is the closest is used for classification (i.e. closest neighbour). This simple rule has been 
considered quite powerful by Shmueli et al (133) when dealing with a large number of 
observations in the training data set. However, if k is too small (i.e. 1) there is the potential for 
poor performance. Extending to k>1, then the nearest k neighbours to an observation are found, 
and the observation is classified as part of the majority class for these k neighbours. Thus, using 
k>1 can reduce the problem of overfitting from noisy training data. However, if k is too large, 
then there is the possibility of not truly representing the cluster patterns present. A choice of k 
depends on the nature of the data being used. Values often fall between 1 and 19, and often an 
odd number is preferred. The recommended method is to test a number of values and select the 
one that yields the best classification performance by reviewing the error rate from the training 
data. 
KNN techniques have been used at Duke University Medical Center in understanding 
mammograms to better detect abnormalities by clustering “normal” versus “abnormal” cases 
(143). The technique has been widely used in non-mental health areas, such as by Li et al (172, 
173) and Sigh et al (174) in gene expression, and by Horton et al (175) for the classification of 
E.coli and yeast protein sequences based on cellular localization sites.  
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2.4.2. Unsupervised Classification 
There are a number of unsupervised classification (clustering) techniques available (176). When 
running clustered analysis only the key factors of interest only (e.g. somatic symptoms) are 
included. Once the clusters are formed, other variables such as demographics are used to help 
explain the clusters. All unsupervised classification methods require a careful choice of 
variables in order to ensure that the clusters produced are fit for the intended purpose. If 
measurement scales differ for these variables, variable standardisation is appropriate, otherwise 
variables with larger variance will be more influential in the clustering process.  
2.4.2.1. Hierarchical Clustering 
Hierarchical clustering is characterized by the development of a hierarchy or tree-like structure 
of a related set of clusters, and can be broken into two methods: agglomerative or divisive 
clustering (177). For agglomerative clustering, each data point (observation) is initially 
considered as a single-element cluster. At each step of the algorithm, the two clusters that are 
the most similar are combined into a new bigger cluster and this procedure continues until all 
data points are members of just one single big cluster. This clustering method is good at 
identifying small clusters and the process is represented as a tree structure, and plotted in a 
figure called a dendrogram (Figure 4). 
 
Figure 4. Example dendrogram from hierarchical clustering. 
32 
Divisive hierarchical clustering is an inverse order of the agglomerate method: all data points 
(observations) start in a single cluster, then at each step of iteration, the most heterogeneous 
cluster is divided into two clusters. This process continues until all objects are in their own 
cluster. As with agglomerate methods, divisive hierarchical clustering is represented using a 
dendrogram, however this method is good at identifying large clusters. 
A number of cluster linkage methods are available such as single linkage, complete linkage, 
average linkage, centroid linkage, and Wards’ method clustering (178). The single linkage 
clustering is based on minimal distance or nearest neighbour rule whereas the complete linkage 
clustering is the other extreme, being based on farthest neighbour rule. The average linkage 
clustering uses the average similarity or dissimilarity of observations between the groups as the 
between groups measure, whereas the centroid linkage clustering merges groups whose means 
are closest at each step of the clustering, such that the centroid of a group is the component wise 
mean and can be interpreted as the “centre of gravity for the group”. The median and weighted-
average linkage clustering methods are variations on the centroid and average linkage methods 
and the differences lie in how unequal group sizes are treated when merged. In average linkage 
and centroid linkage each observation carries the same weight, so this process is unweighted, 
as larger groups have a larger influence. The median linkage and weighted-average linkage 
methods are said to be weighted as observations from smaller groups carry more weight that 
observations from larger groups: large and small groups are weighted equally in determining 
the combined group. The Wards’ method joins the two groups that result in the minimum 
increase in the error sum of squares. For each cluster the means for all the variables are 
compared and the squared Euclidean distance to the cluster means is calculated for each object. 
These distances are then summed up for all the objects and, at each stage, the two clusters with 
the smallest rise in the overall sum of squares within cluster distances are combined. 
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Hierarchical clustering methods have been used in a variety of medical research arenas, such as 
producing molecular portraits of breast tumours in humans (179), analysis of manic states (180) 
and clustering personality profiles in perinatal depression (181). 
2.4.2.2. K-Means Clustering 
K-means clustering is another unsupervised machine learning method for classification or 
clustering. This clustering method breaks observations into a distinct number of non-
overlapping groups. A major advantage of this technique over a hierarchical clustering 
technique (182) lies in its ability to handle large data sets and the speed at which it develops 
clusters. The major disadvantage to the K-means clustering method is that the number of k 
clusters and seeds for each of these clusters must be specified by the researcher. In K-Means 
clustering the researcher specifies the number of clusters (k) to be created using an iterative 
process. Each observation is assigned a group whose mean is closest, and new group means are 
calculated based on the categorization until no observations are left to move to a group. The 
algorithm begins with k seed values, which act as the k group means or centroids, and there are 
many ways to specify the initial seed value. The centroid for a cluster is simply the mean value 
of all cluster variables for the observations in the cluster (183). 
The aim of this clustering method is to minimise the sum of squared distances between the 
observations and their cluster centroids. There are basically four steps involved in K-Means 
clustering which are repeated until convergence occurs: establish the centroid coordinates for 
K clusters; determine the distances of each observation to each of the K centroids; assign each 
observation to the closest of the K centroids; recalculate the cluster centroids using the 
observations assigned to each cluster. The most common distance measure used is the Euclidean 
distance (i.e. straight line distance between two points). The Euclidean distance between two 
points is defined as the square root of the sum of squared differences in values for each variable. 
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Unfortunately, since the numbers of clusters are predefined, it is possible to obtain an empty 
cluster if nothing is allocated to a cluster during the assignment step. However, there are 
strategies, such as selecting a point farthest away from any current centroid, to deal with this 
situation (131). This technique is also influenced by outliers that can impact on the clusters 
found. Thus, appropriate data cleaning is an important preparation step when using this 
technique. 
K-means analysis has been widely used in medical research. For example, Calvano et al (184) 
used this method as an initial step to visualize the gene expression profiles of circulating 
leukocytes in humans after administering a bacterial endotoxin infusion. Although the main 
purpose of this study was to expand the cluster analysis to reveal not just the changes in the 
gene expression, but the biological processes and signalling networks from the inflammatory 
response, it highlights the benefit of initially using this technique to group sets of differing 
profiles. Newby et al (185) reviewed 35 studies using cluster analysis to empirically derive 
eating patterns across a number of countries and continents since 1980. Their research 
proclaimed that most studies used either K-Means or Ward’s method (i.e. a hierarchical cluster 
analysis method most suitable to small samples of generally below 100), with derived clusters 
ranging from 2 to 8, and the majority being 5 or 6 clusters. 
2.4.2.3. Self-Organizing Maps (SOMs) 
Self-organizing maps (SOMs) are a variant of artificial neural networks and were introduced 
by Kohonen in 1995 (186) for unsupervised classification or clustering. SOMs provide a simple 
and effective unsupervised machine learning algorithm for clustering, visualizing and 
dimension reduction of high dimensional data, without any reliance on distributional 
assumptions. Clusters are represented on a q-dimensional plane, with data points “similar” to 
each other in the original multidimensional data space mapped onto nearby areas of the q-
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dimensional output space. SOMs combine competitive learning with dimensional reduction by 
smoothing the clusters with respect to an a priori grid. The steps involved in the SOM 
competitive machine learning algorithm involve initially assigning random vector weights to 
each node (or position on the grid), then randomly choosing data points (respondents) from the 
training data and presenting them to the SOM. The “Best Matching Unit” (BMU) in the map is 
the node with a vector weight most similar to a data point and nodes within the “neighbourhood” 
of each BMU are found. With each iteration, the size of this neighbourhood decreases. The 
vector weights of nodes in the BMU neighbourhood are adjusted closer to their associated data 
points. The size of these adjustments decrease with each iteration and the magnitude of these 
adjustments is proportional to the proximity of the node to the BMU. These steps are repeated 
for N iterations or until the vector weights for all the nodes converge to their final values. SOMs 
have been used in many diverse applications across a variety of fields including bioinformatics, 
engineering, financial analysis, experimental physics, and psychiatry (187, 188). 
This research project will utilise a combination of clustering methods. This approach has also 
been used to explore DNA microarray expression patterns (189). 
2.5. Data Mining and Machine Learning in Mental Health Research 
Over the last two decades there has been a steady rise in the use of machine learning techniques 
across a variety of disciplines, including mental health research. Machine learning algorithms 
have been extensively utilised within the big data framework of data mining to discover 
meaningful patterns in data (190). Large quantities of data can be explored and modelled in 
order to discover patterns, unsuspected relationships and useful rules for a specific purpose. 
Often novel unsuspected interpretation of the data (serendipity) are uncovered.  
Commercially, data mining and machine learning have been used successfully for businesses 
to learn from their transaction data about the behaviour of their customers to improve their 
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business model by exploiting this knowledge. Thus, in this environment these tools have been 
predominantly used for financial benefit (i.e. cost saving, sales opportunity) (143). In the 
financial industry, data mining and machine learning techniques have been used for a number 
of years for practices such as fraud detection, credit scoring, and customer risk evaluation. 
Retailers have been using these techniques to segment customers and to best layout their stores 
to maximise sales. 
The growth of data mining and machine learning literature in general could be viewed as 
exponential since the early 1990s. The number of published books, encompassing data mining 
and machine learning techniques extends into the thousands, but the main focus remains on the 
application of these techniques to the areas of commerce and business. 
Due to the vast number available on the well-known public website Amazon.com, a sample of 
over 400 Data Mining books was selected in August 2015 that highlighted the growth in the 
field of data mining across all disciplines (Figure 5). As expected, the majority of the literature 
to date relates to data mining for the commercial or business environment compared to being 
specific to health. A search of the PubMed database from the United States National Library of 
Medicine, which indexes millions of citations for articles from 1947 to 2015, depicts a sudden 
growth in data mining from the late 2000’s. However, this rate of growth is not seen when a 
search of data mining publications in psychiatry is explored (Figure 5). 
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Figure 5. Growth in data mining and machine learning publications 
Note: Drop in PubMed publications at end of graph due to search not across full year. 
There has been a delayed growth of data mining and machine learning methods in medical 
literature in general, and psychiatry in particular, which has been attributed to the difficulty in 
these techniques gaining acceptance from physicians (134). There is the additional likelihood 
that the lack of relevant large data sets that include robust psychiatric measures, lack of research 
questions that cannot be tested using existing statistical methods, or broader lack of capacity in 
mental health research may also be contributing factors to the delayed acceptance of these 
techniques. It is not surprising that the predominant use of data mining techniques has primarily 
been in genetics ahead of clinical areas such psychiatry and cardiology (134). 
  
38 
Data mining techniques have recently emerged in neuroscience and biomedicine (191, 192). 
However, psychiatry has only recently started to utilize the benefits of these techniques to gain 
further insights (193). These techniques have been used to investigate area such as the genetic 
makeup of mental illnesses (194), the patterns of hippocampus related to Alzheimer’s Disease 
(AD) (195), the clinical patterns related to suicidality among patients with mood disorders 
(196), and to build statistical models from clinical data to classify patients likely to respond to 
a specific antidepressant (197). 
2.6. Conclusion 
In conclusion, the literature reveals both the need and feasibility for the development of a risk 
index for depression. The large volume and complexity of the many risk factors for depression 
demands the use of big data mining methods with machine learning algorithms at the variable 
selection stage. However, the literature has shown there are many benefits to blending big data 
techniques with traditional statistical techniques in order to gain the understanding and 
acceptance of the medical fraternity by including statistical techniques familiar to this group. 
This literature review supports the benefits of the risk index to be structured in a modular 
fashion so that determinants of depression can be isolated. This will allow for the flexibility of 
grouping key risk factor attributes for suitable statistical analysis. Since the number of 
determinants for depression is a function of the data available, it is acknowledged that not all 
determinants can be modelled in this study (i.e. early life events and harmful event(s)). 
However, the literature has shown that a methodology for the development of a risk index for 
depression (RID) needs to accommodate the addition and removal of determinants at a later 
date for the purpose of strengthening the structural equation model for the RID. 
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2.7. Study Aims 
The overarching aim of this research study is thus to blend data mining and machine learning 
techniques with traditional statistical techniques in order to develop and demonstrate a modular 
Risk Index of Depression (RID) for future clinical use and to refine public health 
recommendations for the prevention of depression. 
In order to achieve this primary aim, the secondary aims are to: 
 establish an appropriate protocol for the integration of a large number of data sets 
 establish the most appropriate machine learning and/or traditional statistical 
techniques for defining the risk determinants for depression 
 identify significant and meaningful relationships within and across the determinants 
of depression 
 develop and demonstrate an appropriate structural equation model framework for the 
risk index for depression 
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CHAPTER THREE: PAPER ONE: THE DEVELOPMENT OF THE 
DATA INTEGRATION PROTOCOL 
This chapter presents the published work that addresses the secondary aim to establish an 
appropriate protocol for integrating a large number of data sets the purposes of the data mining 
for the proposed study. 
The chapter concludes with the Supplementary information relating to the DIPIT table and 
flowchart for the NHANES data used for this research. 
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Introduction: The exponential increase in data, computing power and the availability of readily accessible
analytical software has allowed organisations around the world to leverage the beneﬁts of integrating
multiple heterogeneous data ﬁles for enterprise-level planning and decision making. Beneﬁts from
effective data integration to the health and medical research community include more trustworthy
research, higher service quality, improved personnel efﬁciency, reduction of redundant tasks, facilitation
of auditing and more timely, relevant and speciﬁc information. The costs of poor quality processes elevate
the risk of erroneous outcomes, an erosion of conﬁdence in the data and the organisations using these
data. To date there are no documented set of standards for best practice integration of heterogeneous
data ﬁles for research purposes. Therefore, the aim of this paper is to describe a set of clear protocol
for data ﬁle integration (Data Integration Protocol In Ten-steps; DIPIT) translational to any ﬁeld of
research.
Methods and results: The DIPIT approach consists of a set of 10 systematic methodological steps to ensure
the ﬁnal data are appropriate for the analysis to meet the research objectives, legal and ethical require-
ments are met, and that data deﬁnitions are clear, concise, and comprehensive. This protocol is neither
ﬁle speciﬁc nor software dependent, but aims to be transportable to any data-merging situation to min-
imise redundancy and error and translational to any ﬁeld of research. DIPIT aims to generate a master
data ﬁle that is of the optimal integrity to serve as the basis for research analysis.
Conclusion: With linking of heterogeneous data ﬁles becoming increasingly common across all ﬁelds of
medicine, DIPIT provides a systematic approach to a potentially complex task of integrating a large num-
ber of ﬁles and variables. The DIPIT protocol will ensure the ﬁnal integrated data is consistent and of high
integrity for the research requirements, useful for practical application across all ﬁelds of medical
research.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
The exponential increase in available data, computing power
and the availability of readily accessible analytical software has
allowed organisations around the world to leverage the beneﬁts
of integrating multiple heterogeneous data ﬁles for enterprise-
level planning and decision making [1]. The growth of data
analytics [2] has meant that organisational information ﬂows have
become more targeted and focussed. Beneﬁts from effective data
integration include more trustworthy research, higher service
http://dx.doi.org/10.1016/j.ymeth.2014.07.001
1046-2023/ 2014 Elsevier Inc. All rights reserved.
Abbreviations: DIPIT, Data Integration Protocol In Ten-steps; CSV, comma
separated variable; EM, expectation–maximisation; ML, maximum likelihood;
MPI, Master Patient Index; NHMRC, National Health and Medical Research Council;
SDS, stepwise deterministic linkage strategies; SPSS, SPSS proprietary statistical
software; SSN, Social Security Number; TXT, ﬁxed ascii text format; UPI, Unique
Patient Index.
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quality, improved personnel efﬁciency, reduction of redundant
tasks, facilitation of auditing and more timely, relevant and speciﬁc
information. Considerable resources are being invested in quality
initiatives surrounding data integration; however, poor quality
processes underpinning these analytics elevate the risk of errone-
ous outcomes. The result can be wasted resources and, ultimately,
an erosion of conﬁdence in the data and the organisations using
these data. The sharing of information can potentially improve
policy-making and integrated public services [1,3].
Data ﬁle integration has enhanced knowledge across a broad
spectrum of health and medical research, such as health employee
research [4], behavioural survey data [5], social sciences [2], patient
hospital records [4,6–8], cancer and other health research [9,10]
and in bio molecular systems [11–14], genetics and genomics
[15,16]. In the ﬁeld of health and medical science it is becoming
an increasing requirement to integrate or merge extensive hetero-
geneous data ﬁles for research purposes, and data ﬁles can be linked
from multiple providers to perform complex analyses [17–19]. For
example, patient data are compiled from both institutional and
community settings, including patient records, digital scans, obser-
vational surveys, behavioural surveys and ofﬁcial records, and these
are often available in diverse and fragmented formats [6].
The plethora of analytical functions required to effectively and
accurately integrate heterogeneous data ﬁles is challenging and
sometimes overwhelming. Often signiﬁcant funds are invested in
quality initiatives that rely on data integration, but variable
methodology and thus quality underpinning these analytics ele-
vates the risk of erroneous outcomes. However, to date there are
no documented set of standards for best practice integration of
heterogeneous data ﬁles for research purposes. Therefore, the
aim of this paper is to describe a set of clear operational protocol
for data ﬁle integration (Data Integration Protocol In Ten-steps;
DIPIT).
1.1. The practice of data ﬁle integration
Even though the concept of integrating many ﬁles to form a sin-
gle data ﬁle for analysis [20] appears relatively straightforward, the
actual integration requires careful preparation and a systematic
approach to ensure the resulting data are in the correct format,
appropriate for the analytical task.
The management process involved in producing a reliable and
robust integrated data set from multiple sources, with varying het-
erogeneous formats, is fraught with potential traps. Large organisa-
tions, dedicated to providing data ﬁle integration services, have
proliferated over the last few decades. The potential to enrich
knowledge rises as data integration complexity increases, and with
this, potential pitfalls increase. As data ﬁles expand in volume and
complexity, problems can compound to negatively inﬂuence the
quality of the ﬁnal integrated data. The requirements for careful
management of the merging and organisational processes are often
underestimated, but imperative for reliable results. Many data ﬁles
often exhibit considerable noise or meaningless data, missing
information and unstructured text. All these problems need to be
addressed when integrating data [6].
2. Methods and results
The DIPIT approach consists of a set of systematic methodolog-
ical steps (Table 1) to ensure that: the ﬁnal data are appropriate for
the analysis to meet the research objectives; legal and ethical
requirements are met; and that data deﬁnitions are clear, concise,
and comprehensive. This protocol is neither ﬁle speciﬁc nor soft-
ware dependent, but aims to be transportable to any data-merging
situation to minimise redundancy and error. It aims to facilitate the
generation of a master ﬁle that is of the optimal integrity to serve
as the basis for analysis.
2.1. DIPIT step 1: deﬁne the data requirements
It is fundamental to deﬁne an hypothesis [21] as data are com-
piled appropriately and/or analysed in order to test these hypoth-
eses. For example, hypothesis tests determine if a novel treatment
is efﬁcacious compared to a control treatment [22]. Costs, in terms
of outcomes for individuals, plus time, dollars and credibility for
governments and organisations, can be high if the ﬁndings are
founded on bad data. Thus, part of the initial step in the assessment
of the research data requirements is to establish what data are
needed and evaluate the quality requirements for the analytical
task, as the ﬁnal quality of the data may inﬂuence the outcomes.
Poor quality and fragmented data are often a result of the com-
pilation of a combination of both manual paper transcribing and
electronic entry (i.e., mixed mode). In medicine for example, both
paper and electronic medical records are still used in some organ-
isations, which results in fragmented data information [23]. On the
other hand, good quality data positively correlates with its use –
the better it is, the more it will be used; ‘‘data quality and data
use are interrelated’’ [24]. This underscores the importance of
assessing the quality of the data to be integrated, and the align-
ment of the available data to the research objectives, before com-
mencement of the integration process.
2.2. DIPIT step 2: establish ethical, legal and privacy issues
Once the ﬁle requirements are established, it is important to
ensure that legal, ethical and privacy issues are understood and
met. For example, the management of personal records are gov-
erned by a broad array of guidelines, national and international,
speciﬁc to different areas and with different levels of authority
[25–30]. Neutal [26] highlights potential civil and criminal
penalties for violating an individual’s privacy, as the public’s per-
ception of integrating their own data with many sources is seen
as potentially ‘‘high risk’’. Ensuring that the data ﬁles used in the
integration process comply with standards relevant to the data
source is also very important to the public conﬁdence [31]. The
imperative for responsible research, sensitive to the rising public
awareness of an individual’s rights to privacy, has resulted in the
establishment of local and international research standards. In
Australia, The Australian Code for the Responsible Conduct of Research
by the National Health and Medical Research Council (NHMRC)
provides for responsible research practices and promotes research
integrity [32]. This code endeavours to promote integrity in
research and deﬁne community expectations. The NHMRC code
stipulates that clear and accurate records of the research methods,
approvals, grants, and data sources during and after the research
process be kept, indexed and easily retrieved if needed. Therefore,
it is imperative that data management be performed and docu-
mented in accordance to the ethical protocols and relevant legisla-
tion related to each ﬁle.
2.3. DIPIT step 3: order the ﬁles to integrate
After establishing the nature and legitimacy of the required
ﬁles, establish a ﬂowchart for the order of the ﬁles to integrate.
The ﬂowchart serves as a fundamental document from which the
other DIPIT steps feed to catalogue or document the integrated
data.
Flowcharts are an invaluable tool regularly used in the ﬁelds of
Information Technology (IT), Biology, Chemistry and other
disciplines for explaining complex mechanisms [33]. Flowcharts
simplify complex tasks, and improve comprehension and accuracy
238 J.F. Dipnall et al. /Methods 69 (2014) 237–246
[34,35]. Crews [36] studied the effect that ﬂowcharts had on novice
computer programmers, ﬁnding the incorporation of a ﬂowchart
reduces error and project time.
Since ﬂowcharts are an effective tool for clearly explaining com-
plex models in a comprehensible manner, they lend themselves
easily to the documentation of the integration of complex hetero-
geneous data ﬁles and the associated syntaxes. Many statistical
computer programs require some form of programming syntax
for complex merging requirements (e.g., SAS [37], Stata [38]) and
a ﬂowchart of the integration process will develop the appropriate
processes. Often computer syntax is used to create the ﬁnal ﬁle
efﬁciently and accurately, ensuring reproducibility (e.g., Stata do
ﬁles, SPSS sps ﬁles). For example, suppose a government health
organisation conducted a study of a speciﬁc cohort of patients in
hospitals across the nation. Hospitals collected three sets of sepa-
rate information on each patient. There are two resulting types
of data to analyse:
 Data from patient scans consisting of two data ﬁles <ScanA-
Filename> and <ScanB-Filename>, and
 Behavioural data from a national postal survey <SurveyA-
Filename> of hospital patients, and patient structured clinical
interviews conducted by hospital doctors <SurveyB-Filename>.
The objective is to integrate these four ﬁles into onemaster data
ﬁle called <Master-Filename> for analysis and a ﬂowchart is estab-
lished to represent the ﬁles to integrate (example shown in Fig. 1).
2.4. DIPIT step 4: establish the ﬁle formats
Once the ﬁles to integrate have been established, the formats of
each ﬁle are identiﬁed. Data ﬁle formats range from the simple
symmetrical text format, comma separated variable format or
matrices, relational databases, to a more complex proprietary
program-based format (e.g., Stata, SAS) and digital imaging (e.g.,
DICOM) [37–40]. Some computer programs allow the user to inte-
grate in different ﬁle formats [41,42], but it is often simpler to
manage and debug if all the ﬁles are converted to the same format.
However, many computer applications require input data from
multiple sources be in a speciﬁc format before the data can be inte-
grated [41,43].
In the previous example, suppose each of the four source data
ﬁles had varying formats:
 The two medical scan ﬁles have comma separated variable
(CSV) and ﬁxed ascii text format (TXT).
Table 1




1 Deﬁne the data
requirements
 Deﬁne research hypotheses
 Establish ﬁles to integrate
 Assess data quality





Establish ethical, legal and privacy issues for each data
ﬁle to integrate
Documentation of standards met
3 Order the ﬁles to
integrate
Set up a ﬂowchart for all ﬁles to be integrated,
incorporating all ﬁle names
Flowchart of ﬁle hierarchy
4 Establish the ﬁle
formats
Amend the ﬂowchart in step 3 to document the ﬁle
format for each ﬁle integrated and the ﬁnal master ﬁle
Inclusion of all ﬁle formats in ﬂowchart
5 Deﬁne the variables
of interest
Create a table containing the variable of interest for
research containing as a minimum:
 Final variable name
 Original variable name
 Source ﬁle of variable
 Preliminary ﬁle(s) for variable
 Description of variable
Table of variables of interest for research incorporating a standard naming
format, structured order and identiﬁcation of ﬁle source
6 Set up link(s) for
integration
Create a table containing the variable(s) links and
linkage method(s) used containing as a minimum:
 Link variable(s)
 Method of linkage
 Automation used (if applicable)
Table of data ﬁle links, variables used and linkage method
7 Document the
integration path
Document the structure of the path take for integration
to include as a minimum:
 The integration of the primary ﬁles
 The saving of the Master ﬁle format in a standard
ﬁle naming structure
 The variables of interest to be retained
 The variables standard naming format
 The merging of all ﬁles into the Master ﬁle
 A log of statistics of the key variables, and missing
data analysis
Documentation of path of data ﬁle integration hierarchy incorporating
primary and secondary ﬁles, logs and naming convention
8 Flowchart the type of
integration





Method of integration included in ﬂowchart and linkages used
9 Document the
integration outcome
Deﬁne linkage quality measure.
Table of mismatches of records by variable to contain as
a minimum:
 Variable name
 Source of mismatch
 Reason for mismatch
Documentation of degree of variable mismatches (e.g., log): which
variables, percentage matched/mismatched.
Document linkage quality measure (e.g., F-measure graphs)
10 Check variables and
missing data
Initial data inspection to include as a minimum:
 Analysis of key variable(s)
 Missing data analysis
Document initial investigation of variables.
Deﬁne minimum percentage of missing data acceptable for research based
on industry convention and document future handling of missing data
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 The other two survey ﬁles is in CSV format and SPSS proprietary
statistical (SPSS) ﬁle format.
The objective is to integrate the four ﬁles into one Master
integrated ﬁle of the proprietary statistical format for analysis. This
statistical program merge function only merges using its proprie-
tary data ﬁle format, so the four hypothetical heterogeneous data
ﬁles will be converted to the proprietary ﬁle format. The ﬁnal stage
will integrate these preliminary data ﬁles into the Master data ﬁle.
2.5. DIPIT step 5: deﬁne the variables of interest
Large data ﬁles often contain an array of variables of differing
importance and label formats. In large data mining exercises there
are potentially thousands of variables available for data mining.
Avoid including extraneous data that would result in an unneces-
sarily large Master data ﬁle. Establishing which variables are of
interest and discarding the rest speeds up processing and minimis-
es errors. Eliminating unnecessary variables make the ﬁnal data ﬁle
more efﬁcient to search, manage and analyse [44]. So, once the ﬁle
formats are compiled and documented in the ﬂowchart, the next
step is to identify and name the variables of interest.
As with paper records, it is often best if electronic records are
well-organised and labelled correctly to ensure ease of identiﬁca-
tion and accountability. Accurate ﬁle naming aligns with the efﬁ-
cient management of the integration of electronic ﬁles [44].
Deﬁne a global naming convention that easily identiﬁes the source
of each variable as this will ease tracking and auditing. As with
other electronic libraries, an essential aspect of a well-organised
strategy for this step is to standardize ﬁlenames used in the
integration process. [45].
The variables of interest should be stored and named according
to the pre-deﬁned naming convention. Accountability via
documentation is an important aspect of DIPIT. A table of variable
translations for future reference is established containing at least
four columns (example Table 2):
 Final variable name to be stored in the Master ﬁle and used in
the analysis.
 Original variable name so that it is always possible to track the
source of the variable.
 Source ﬁle of variable to identify where the variable was origi-
nally merged from
 Preliminary ﬁle(s) for variable (if applicable).
 Description of variable, including units of measurement.
2.6. DIPIT step 6: set up link(s) for integration
Effectively merging data ﬁles requires the ﬁles involved to have
one or more common links, whilst ensuring the privacy of a
respondent. Linking ﬁles with minimal inaccuracy or error is a
challenge [29,46–48]. When multiple merge ﬁles have the same
single unique identiﬁer, the linkage process is straightforward.
Complexity arises when there is no single unique identiﬁer and/
or missing data associated with link(s). Data ﬁles can be purpose-
fully or accidentally corrupted and/or heterogeneous in nature,
causing matching to become an empirical, statistical and often
complex challenge [46].
In some instances, integration of data records from different
areas, sometime ubiquitous in nature, is a necessary requirement.
The National Institute of Standards in the United States of America
has recognised the importance of establishing a Unique Patient
Index (UPI) and funded research to accelerate the development
Fig. 1. Example of a data integration ﬂowchart for DIPIT step 3.
Table 2
Example Table of variable translations. File extensions included where applicable (e.g., ‘‘.dta’’ for Stata ﬁle format).
Final name(s) Original name(s) Source ﬁle(s) Preliminary ﬁle(s) Description
ID ID ALL ALL Unique patient identiﬁer
Scan_larm Larm ScanA.csv ScanA.dta Scan of left arm
Scan_Rarm Rarm ScanA.csv ScanA.dta Scan of right arm
Scan_mri Mri ScanB.txt ScanB.dta MRI
Survey_sex Gender SurveyA.csv SurveyA.dta Gender of patient
Survey_dob DOB SurveyA.csv SurveyA.dta Date of birth
Survey_Q10a to survey_Q10s Q10a to Q10s SurveyB.sav SurveyB.dta Q10 physical exercise items
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of a ‘‘massively distributed’’ Master Patient Index (MPI), equivalent
to a UPI [29]. However, the ability to link and integrate one or more
heterogeneous data ﬁles for research purposes can be hampered by
the lack of a common identiﬁer. String variables, such as name,
time and date can be difﬁcult to collect correctly and often ambig-
uous by deﬁnition. Inconsistencies in details would deem that data
as an unreliable as a link variable (e.g., incorrect date, transcription
error) [49,50]. In health research, linking a patient’s clinical charac-
teristics to service utilisation can be challenging [6]. The lack of
standardization, degree of incomplete information and/or contra-
dictory nature of service information can distort the analysis.
It is important to document the links used for integration for
each process and record whether a manual or an automated
method was used. Several automated methods have been
developed over recent decades to deal with ﬁle linkage, such as fre-
quency ratios [51], stepwise deterministic linkage strategies (SDS)
[19,52], probabilistic maximum likelihood linkage models [18,53],
expectation–maximisation (EM) algorithms [48] and distance-
based metrics [54]. It is safe to assert that as the number of ﬁles
to integrate increases, the linkage challenge compounds and the
potential for missing data rises. Weiner et al. [17] proposed a
‘‘practical, deterministic method of linking Medicare claims’’ to a
large United States clinical database. In the absence of the main
United States Social Security Number (SSN) unique patient identi-
ﬁer, an algorithm was used that incorporated a combination of
patient attributes (e.g., sex, date of birth, elements of name) to link
the data ﬁles. In the late 1980s and early 1990s the United States
Bureau of the Census developed a record-linkage methodology
and automated software system [48] using a linear sum assign-
ment model.
2.7. DIPIT step 7: document the integration path
Once the ﬁle linkage deﬁnitions have been established, the
existing ﬂowchart should be expanded to incorporate the system-
atic hierarchy of the integration process. Most computer programs
allow for user-written syntax to manage and automate the analyt-
ical process [37,38,55,56]. Designing a logical systematic set of
syntax ﬁles for merging ensures that all required merging steps
will be undertaken and the results will be reproducible.
There are many beneﬁts of using syntax ﬁles [37,38]. The syntax
ﬁle is an automatic documentation of the integration process that
increases efﬁciency and productivity, whilst ensuring reproducibil-
ity of results.
As a minimum the structure of the syntax ﬁle should include:
 The integration of the primary ﬁles.
 Saving the Master ﬁle format in a standard ﬁle naming
structure.
 The variables of interest to be retained.
 The variables standard naming format.
 Merging of all ﬁles into the Master ﬁle.
 A valuable log of statistics of the key variables, and missing data
analysis.
An example of a ﬂowchart of the integration process is
presented in Fig. 2.
2.8. DIPIT step 8: ﬂowchart the type of integration
Even though there are a multitude of ways data ﬁles can be
related or matched [57], the consensus is that there are fundamen-
tally four integration scenarios, characterised by how observations
relate to each other amongst the data sets [37,38,58]. A simple
example of each of these scenarios is shown in Fig. 3 based on a
small number of ﬁle records.
These scenarios assume that there is common information
amongst the multiple sources of input data, either at the physical
or logical level. Often the Merge and Master data ﬁles do not have
the same number of variables. Once integrated, the variables not
present in the data ﬁles should be coded as missing in the com-
bined master data set. The common integration scenarios are as
follows:
 One-to-one matching: this is the most straightforward of the
matching scenarios where a single observation in one data set
is related to a single observation from another, based on the val-
ues of one or more selected variables. For example, in Fig. 3,
One-to-one based on one variable the ID001, ID002 and ID005
are a perfect match. Those IDs that do not match create missing
data in the Master ﬁle (e.g., ID003, ID006). However, many
integration tasks do not have this straightforward matching.
One-to-one based on two variables, ID001 and ID002 match per-
fectly, but those IDs that do not match again create missing data
in the Master ﬁle (e.g., ID001 ACD, ID003 ABC).
 One-to-many and many-to-one matching: this implies that one
data set has at most one observation with a speciﬁc variable
or combination of variables, but the other input data set can
have duplicates of each value or combination of values. How-
ever, the opposite scenario is where there is a many-to-one
matching situation. The merge ﬁle contained multiple occur-
rences contained and the master ﬁle contains only a single
record of each unique identiﬁer, hence the many-to-one
scenario.
 Many-to-many matching: by default the nature of this type of
merging implies that multiple observations from each merge
ﬁle are related based on values of one or more common vari-
ables. The developers of the Stata statistical software state: ‘‘is
difﬁcult to imagine an example of when it would be useful’’
and do not recommend this type of merging [38] as there are
no variables that uniquely identify the observations in either
the merge or master data ﬁles. However, many-to-many match-
ing still considered a valid form of matching by in other sys-
tems, such as SAS [37,58] and SQL. Moreover, this form of
matching has been utilised in healthcare insurance, where
insurance claims are merged with an enrolment database in
order to identify the eligibility of the service using the member
number as the unique link. Since a member potentially has
multiple claims during a certain time period and also many
enrolment records, many-to-many match is used in this
instance [59].
2.9. DIPIT step 9: document the integration outcome
Matching records is simple in theory, but can be complex and
tedious in practice. The complexity of mismatching records multi-
plies when more ﬁles and/or merge keys increase, and possibly a
mix of scenarios (i.e., one-to-many, many-to-one). A systematic
and traceable approach is required so that at any point the origins
of the ﬁnal master data ﬁle can be traced and explained.
Assessing the quality of any linkage algorithm used entails
determining how many truly matched and non-matched records
have resulted. One valid method for evaluating record mismatches
in one where each record has a merge identiﬁer indicating its
merge status one for integration process. There are many quality
measures that can be used, such as accuracy, precision, recall, F-
measure graphs and false positive rate [60]. For example, Xu
et al. utilised a probabilistic data linkage method to link data ﬁles
in order to investigate major depressive disorders in the perinatal
period; in this case they utilised the false positive and false nega-
tive rates from a random sample of 1000 [61,62].
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Fig. 2. Example hierarchical syntax ﬁles for integration ﬂowchart and document integration path for DIPIT step 7.
Fig. 3. Examples of record matching types for ﬁle integration process.
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2.10. DIPIT step 10: check variables and missing data
Once the ﬁnal master data ﬁle has been created, an initial
inspection of the data is necessary to ensure the integration has
been successful, quantify the degree of missing data and to develop
the best way forward for analysis. An initial inspection of the ﬁnal
variables integrated, to check such indices as bases, ranges and dis-
tributions, is mandatory [63]. Missing data is a common problem
with data ﬁle integration and affects the statistical analysis per-
formed (e.g., reduces statistical power, increases type I error, intro-
duces bias) [64]. Woods et al. identiﬁed 71 randomized controlled
clinical trials, of which 89% reported having some form of missing
outcome data, and emphasised the importance of reporting both
the amount and handling of the missing outcomes [65]. Thus, this
ﬁnal step involves performing basic inspection of the key variables
and assessing the impact of missing data generated from the merg-
ing process(s). This important inspection can be both analytical
and graphical, as the reporting of research studies should encom-
pass the details and percentage of missingness [65–67].
Should the integrated data ﬁles be mutually exclusive, it is rec-
ommended as part of the merging process that the amount and
nature of missing data in each of the data ﬁles be identiﬁed and
documented. Often the ﬁnal integrated master ﬁle is heteroge-
neous, extensive and complex. Therefore, initially identifying the
degree of missing data in stages has the advantages of:
 Providing a methodical process of missing data identiﬁcation
and documentation.
 Simplifying each task by breaking the task into small steps.
 Minimising the potential for error.
Should the data ﬁles not be mutually exclusive, then it is recom-
mended to perform the integration ﬁrst then review the missing
data. This would be relevant if the handling of the missing data
is dependent on a multiple set of variables across the integrated
data ﬁles.
Missing data are ‘‘ubiquitous to all clinical studies’’ [64] and this
fact raises the issue of how to accommodate for the inadequacy of
any given data set (e.g., imputations, mixed-effects regression
models [68–70]). Reduced statistical power and potentially biased
measures (e.g., parameter estimates, measures of central ten-
dency), caused by losing data due to missing cases, can seriously
affect the integrity of the study [71–73]. In medicine, gene research
[74], self-reported medical scales [75] and longitudinal clinical tri-
als [69] have experienced issues with missing data when running
analyses.
There are many methods of handling missing data, such as (i)
deleting observations with missing data on any variable (i.e., list-
wise deletion); (ii) deleting observations with missing data on only
the two variables of interest (i.e., pairwise deletion); (iii) substitut-
ing the missing value with the mean of the values of that variable
(i.e., mean substitution); (iv) substituting the missing value with a
predicted value from regression (i.e., regression imputation); (v)
substituting the missing value with the expected value based on
maximum likelihood (ML) estimation; and (vi) performing a simu-
lation-based procedure in order to handle missing data in a way
resulting in valid statistical inference (i.e., ML) [38]. The choice of
method used to deal with missing data can inﬂuence the analysis
performed (e.g., the size and direction of the correlation coefﬁ-
cient). However, Tabachnick and Fidell believe the choice of
method used for dealing with missing data less important when
the proportion of missing data is less than 5% [63]; however, as
the proportion of missing rises, then the choice of technique
becomes more important.
There have been a number of missing data procedures sug-
gested in the literature over the last several decades [71,76–79].
The multiple imputation framework of inference for missing data
was developed by Rubin [78] in application to survey nonresponse
and Schafer [69] ML estimation is sometimes used to treat missing
data as random variables taken out of the likelihood function as if
not sampled.
Fig. 4. Example of graphical data representations of missing data for a particular set of 58 variables.
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It is also possible to graphically represent missing data to
review. Various graphical tools can be used to further understand
the nature and degree of missing data. Fig. 4 presents graphical
representations of missing data for a particular set of 58 variables.
From this image the degree of complete and missing data across all
variables can be identiﬁed: 73 complete with no missing variables
and 22 with all 58 variables missing. Alternatively, there is also an
example of using data mining graphical techniques to scan the
complete integrated ﬁle and produce a surface plot of the missing
data. The white areas represent missing data and there is a clear
missing data pattern across approximately one third of this set of
data requiring further analysis. These graphical tools identify if
the missing data is symptomatic of the integration process (e.g.,
a distinct unnatural pattern) or due to the underlying nature of
the study (e.g., gender ﬁlters in a survey).
3. Example use of DIPIT
DIPIT was used to integrate data ﬁles from the National Health
and Nutrition Examination Surveys (NHANES), a United States
population-based cross-sectional study, with the research
objective to study selected demographic, examination and labora-
tory risk factors for depression. Table 3 outlines the tools used at
each DIPIT step for the integration of the selected 80 demographic,
examination and laboratory data ﬁles downloaded from the
NHANES website based on the guidelines provided [80]. Primary
NHANES data ﬁles were in SAS format and converted into Stata for-
mat for the integration process and the ﬁnal Stata master ﬁle used
for future statistical analysis. Microsoft Excel and PowerPoint were
used for the DIPIT documentation and ﬂowchart purposes.
All DIPIT steps were followed for the data ﬁle integration
process. This example demonstrated that using DIPIT:
 Legal and ethical requirements were met.
 A systematic and comprehensive approach was followed.
 Processes of data ﬁle integration were documented and thus
reproducible for scientiﬁc rigor.
 The origin of all variables in the master ﬁle were documented to
ensure traceability.
 Missing variable data was quantiﬁed for future research
analysis.
 Data deﬁnitions will be clear, concise, and comprehensive.
Table 3




1 Deﬁne the data
requirements
 Deﬁne research hypotheses
 Establish ﬁles to integrate
 Assess data quality
To establish most important demographic & laboratory predictors for depression
All NHANES data ﬁles for the years 2005–2008 with consistent variables to be
integrated. 80 data ﬁles were integrated




Establish ethical, legal and privacy issues for each
data ﬁle to integrate
NHANES 2005–2006: protocol #2005-06
NHANES 2007–2008: continuation of protocol #2005-06
3 Order the ﬁles to
integrate
Set up a ﬂowchart for all ﬁles to be integrated,
incorporating all ﬁle names
Flowchart NHANES-JobDep1-FL001.ppt in Microsoft PowerPoint format
4 Establish the ﬁle
formats
Amend the ﬂowchart in step 3 to document the ﬁle
format for each ﬁle integrated and the ﬁnal master
ﬁle
All original ﬁles were SAS ﬁles, initially transferred into Stata format for
integration. Consistent primary ﬁle names between SAS and Stata
5 Deﬁne the
variables of interest
Create a table containing the variable of interest for
research containing as a minimum:
 Final variable name
 Original variable name
 Source ﬁle of variable
 Preliminary ﬁle(s) for variable
 Description of variable
Microsoft Excel ﬁle named NHANES-JobDep1-EXC001.xlsx of variables excluded
6 Set up link(s) for
integration
Create a table containing the variable(s) links and
linkage method(s) used containing as a minimum:
 Link variable(s)
 Method of linkage
 Automation used (if applicable)




Document the structure of the path take for
integration to include as a minimum:
 The integration of the primary ﬁles
 The saving of the Master ﬁle format in a stan-
dard ﬁle naming structure
 The variables of interest to be retained
 The variables standard naming format
 The merging of all ﬁles into the Master ﬁle
 A log of statistics of the key variables, and miss-
ing data analysis
Documentation of path of data ﬁle integration stored in Stata syntax .do ﬁles with
one ‘‘Master’’ integration .do ﬁle named NHANES-JobDep1-Master-Integrate.do
used to run all subsequent syntax ﬁles
A log ﬁle of all key variable and missing data stored in the name NHANES-JobDep1-
Stats1.txt
8 Flowchart the type
of integration










Deﬁne linkage quality measure.
Table of mismatches of records by variable to
contain as a minimum:
 Variable name
 Source of mismatch
 Reason for mismatch
All merge variables contained details of mismatches and source at each stage of
integration. Merge variables denoted by merge_[ﬁleID] in Master Stata data ﬁle
10 Check variables
and missing data
Initial data inspection to include as a minimum:
 Analysis of key variable(s)
 Missing data analysis
Only those with a depression score were included and criterion >50% non-
missing. Microsoft Excel ﬁle named NHANES-JobDep1-VAR001.xlsx for ﬁnal set of
integrated variables
Note: actual ﬁle names altered from original.
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 A transparent, accountable data trail resulted.
4. Conclusion
The integration of 80 selected demographic, examination and
laboratory data ﬁles, downloaded from the NHANES website, has
been used to highlight how DIPIT ensures that the ﬁnal data ﬁle
was appropriate for the research objectives, that the legal and eth-
ical requirements are met, that data deﬁnitions are clear, concise,
and comprehensive, and that linkage quality and missing informa-
tion was identiﬁed and addressed.
The linking of as set of heterogeneous ﬁles is becoming increas-
ingly common across all ﬁelds of medicine. This paper presents a
protocol, called DIPIT, to provide a systematic approach to a
potentially complex task of integrating a large number of ﬁles
and variables. Ten steps are proposed in a table format. At each
step tools such as tables, ﬂowcharts and log ﬁles are required to
ensure the integration process is clearly documented and easily
reproduced, affording a useful protocol for the accurate and efﬁ-
cient integration of large datasets.
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SUPPLEMENTARY INFORMATION 
DIPIT Table using NHANES 2009-2010 data integration 
DIPIT 
STEP 
Action Strategy Standard 
1 Define the data 
requirements 
 Define research hypotheses 
 Establish files to integrate 
 Assess data quality 
To establish most important demographic & laboratory 
predictors for depression. 
All NHANES data files for the years 2009-2010 with 
consistent variables to be integrated. 100 data files were 
initially integrated across all determinants. Data quality high 
as pre-processed prior to public access. 
2 Establish ethical, 
legal and privacy 
issues 
Establish ethical, legal and privacy issues for 
each data file to integrate 
NHANES received approval from the National Center for 
Health Statistics (NCHS) research ethics review board and 
informed consent was obtained from all participants. Use of 
data from the NHANES 2009–2010 database is approved by 
the National Center for Health Statistics Research Ethics 
Review Board (Continuation of Protocol #2005-06) 
3 Order the files to 
integrate 
Set up a flowchart for all files to be 
integrated, incorporating all file names 
Flowchart of determinant integration 
nhanes_DIPIT_Flowchart.pptx. 
4 Establish the file 
formats 
Amend the flowchart in step 3 to document 
the file format for each file integrated and the 
final master file 
All original files were SAS files, initially transferred into 
Stata format for integration. Consistent primary file names 
between SAS and Stata. 
5 Define the 
variables of 
interest 
Create a table containing the variable of 
interest for research containing as a 
minimum: 
 Final variable name 
 Original variable name 
 Source file of variable 
 Preliminary file(s) for variable 
 Description of variable 
Microsoft Excel file named NHANES-2009-2010-DIPIT.xlsx 
of variables integrated. 
6 Set up link(s) for 
integration 
Create a table containing the variable(s) links 
and linkage method(s) used containing as a 
minimum: 
 Link variable(s) 
 Method of linkage 
 Automation used (if applicable) 
All linkages were based on the one seqn variable as per 
NHANES requirements using 1:1 linkage method with Stata 
merge command. 
7 Document the 
integration path  
Document the structure of the path take for 
integration to include as a minimum: 
 The integration of the primary files 
 The saving of the Master file format in a 
standard file naming structure 
 The variables of interest to be retained 
 The variables standard naming format 
 The merging of all files into the Master 
file 
 A log of statistics of the key variables, 
and  missing data analysis 
Documentation of path of database integration stored in Stata 
syntax .do files with one “Master” do file named nhanes-
2009-2010-[determinant]-MASTER.do per determinant. This 
outlines key syntax files including integration. Ascii log files 
are created under each determinant under a Logs folder. 
8 Flowchart the type 
of integration 
Document on flowchart type of integration: 
 one-to-one 
 many-to-one 
 one-to many 
 many-to-many 
All integration one-to-one merge based on unique sequential 
number for variable seqn. 
9 Document the 
integration 
outcome 
Define linkage quality measure. 
Table of mismatches of records by variable to 
contain as a minimum: 
 Variable name 
 Source of mismatch 
 Reason for mismatch 
All merge variables contained details of mismatches and 
source at each stage of integration. Merge variables denoted 
by merge_[ID] in determinant data file. 
10 Check variables 
and missing data 
Initial data inspection to include as a 
minimum: 
 Analysis of key variable(s) 
 Missing data analysis 
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a b s t r a c t
Background: Type 2 diabetes and depression are commonly comorbid high-prevalence chronic disorders.
Diet is a key diabetes risk factor and recent research has highlighted the relevance of diet as a possible
risk for factor common mental disorders. This study aimed to investigate the interrelationship among
dietary patterns, diabetes and depression.
Methods: Data were integrated from the National Health and Nutrition Examination Study (2009–2010) for
adults aged 18þ (n¼4588, Mean age¼43 yr). Depressive symptoms were measured by the Patient Health
Questionnaire-9 and diabetes status determined via self-report, usage of diabetic medication and/or fasting
glucose levels Z126 mg/dL and a glycated hemoglobin level Z6.5% (48 mmol/mol). A 24-h dietary recall
interview was given to determine intakes. Multiple logistic regression was employed, with depression the
outcome, and dietary patterns and diabetes the predictors. Covariates included gender, age, marital status,
education, race, adult food insecurity level, ratio of family income to poverty, and serum C-reactive protein.
Results: Exploratory factor analysis revealed ﬁve dietary patterns (healthy; unhealthy; sweets; ‘Mexican’
style; breakfast) explaining 39.8% of the total variance. The healthy dietary pattern was associated with
reduced odds of depression for those with diabetes (OR 0.68, 95% CI [0.52, 0.88], p¼0.006) and those
without diabetes (OR 0.79, 95% CI [0.64, 0.97], p¼0.029) (interaction p¼0.048). The relationship between
the sweets dietary pattern and depression was fully explained by diabetes status.
Conclusion: In this study, a healthy dietary pattern was associated with a reduced likelihood of depressive
symptoms, especially for those with Type 2 diabetes.
& 2014 Elsevier B.V. All rights reserved.
1. Background
Diabetes is a chronic disease with serious complications, affect-
ing approximately 347 million people worldwide (Danaei et al.,
2011) and 29.1 million children and adults in the United States (US)
(9.3% of the US population) (Centers for Disease Control and
Prevention, 2014). Type 2 diabetes is the most common type, with
risks related to lack of regular physical activity, unhealthy eating
and excess weight. Throughout the western world, obesity and
prevalence of Type 2 diabetes are rising, with substantial associated
costs to individuals and society. According to the Center for Disease
Control and Prevention, one in 10 U.S. adults has diabetes in 2014,
with the number of new diabetes cases each year predicted to
increase 87% from 8 per 1000 people in 2008, to 15 per 1000 in
2050 (Boyle et al., 2010).
Diabetes is highly comorbid with major depression (Anderson
et al., 2001; Egede and Ellis, 2010) compounding health care use
and expenditure (Egede et al., 2002). Depressive disorders now
rank second in terms of global disability burden and are expected
to be the number one health concern in both developed and
developing nations by 2020 (Lim et al., 2013; Mathers and Loncar,
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2006; Murray and Lopez, 2013). Sufferers of both Type 2 diabetes
and depression are at greater risk for complications over ﬁve years
(Lin et al., 2010), including mortality (Katon et al., 2005; Roglic and
Unwin, 2010), compared to those without depression. Given the
bidirectional relationship (Mezuk et al., 2008) and comorbidity
between depression and diabetes, it is not surprising that many of
the same poor lifestyle factors associated with Type 2 diabetes,
speciﬁcally diet and physical activity, are also associated with
depression (Strine et al., 2008; Weber et al., 2000).
Diet is a major lifestyle factor implicated in, and used to manage
Type 2 diabetes, and has also been shown to be associated with risk
for depression. A systematic review and meta-analysis of the
relationship between dietary patterns and depression (Lai et al.,
2014) highlighted the variety of dietary patterns investigated with
respect to depression, such as healthy (e.g. Mediterranean, Japa-
nese), and unhealthy (e.g. western), and conﬁrmed that a healthy
dietary pattern is associated with a reduced prevalence of depres-
sion. Healthy diets such as the Mediterranean diet (Psaltopoulou
et al., 2013; Rienks et al., 2012; Sánchez-Villegas et al., 2009, 2013);
a diet high in vegetables, meat, poultry, and dairy (Meyer et al.,
2013); a diet high in fruit and vegetables (Kronish et al., 2012); the
Japanese diet (fruit, vegetables, green tea, and soya) (Nanri et al.,
2010); and a ‘traditional’ diet of vegetables, fruit, ﬁsh and unpro-
cessed meat (Jacka et al., 2011, 2010) have all been shown to have
an inverse relationship with depression. A meta-analysis examining
the association between adherence to a healthy style Mediterra-
nean diet and the risk of stroke, depression, cognitive impairment,
and Parkinson disease (Psaltopoulou et al., 2013) also concluded
that adherence to a Mediterranean diet was associated with a
reduced risk for these brain disorders. At the same time, an
unhealthy style diet high in processed foods (sweets, fried food,
processed meats, reﬁned grains, and high fat diary) (Akbaraly et al.,
2009); ‘western’ (Chocano-Bedoya et al., 2013; Jacka et al., 2010;
Nanri et al., 2010); meat and processed (Rienks et al., 2012); and
biscuits and snacking (Samieri et al., 2008) have all previously been
found to be associated with increased odds for depression.
While these studies and reviews were based on observational data,
the possible preventive utility of a Mediterranean diet on depression
risk was recently assessed in a randomized controlled trial. Using data
from a large, multicentre, randomized, primary prevention ﬁeld trial of
cardiovascular disease (PREDIMED), community-dwellers aged 55
years and over and at high risk of cardiovascular disease were
randomized to one of three dietary interventions, followed for at least
three years. The results demonstrated that the Mediterranean diet
combined with nuts reduced the risk for depression, particularly in
people with Type 2 diabetes (Sánchez-Villegas et al., 2013). In addition,
the Japanese diet has also been found to play a complex role in the
development of Type 2 diabetes, where an increased risk was
associated with greater rice intake among women and among
physically inactive men and decreased risk was associated with greater
ﬁsh/seafood intake amongst men, and depression risk in Japanese
men and women decreased with higher intake of vegetables, fruit,
mushrooms, and soy products (Nanri, 2013). As such, the aim of this
research was to investigate the interrelationship among dietary
patterns, diabetes and depression using a population-based represen-
tative sample of US citizens.
2. Methods
Cross-sectional, population-based data from the National Health
and Nutrition Examination Surveys (NHANES) (2009–2010) (Centers
for Disease Control and Prevention National Center for Health Sta-
tistics, 2013) were utilized for this research study. Approximately
5000 non-institutionalized US civilians aged 20–75 per annum res-
ponded to a detailed home based interview and physical examinations
at mobile examination centers across the country. The sampling
methodology involved a stratiﬁed, multistage probability process, with
data collected annually but released in blocks of two years. Relevant
NHANES data ﬁles were downloaded from the website and integrated
using the Data Integration Protocol In Ten-Steps (DIPIT) (Dipnall et al.,
2014). Across the two years studied, markers of depressive symptoms
were available for 4656 participants, and 4588 of these were identiﬁed
with or without diabetes and thus were included in this study.
NHANES received approval from the National Center for Health
Statistics research ethics review board and informed consent was
obtained for all participants.
3. Measures
3.1. Depression
The Patient Health Questonnaire-9 (PHQ-9) (Kroenke and Spitzer,
2002; Kroenke et al., 2001; Martin et al., 2006) was used to assess
depressive symptoms. The PHQ-9 comprises depression modules taken
from the larger PRIME-MD Patient Health Questionnaire (Spitzer et al.,
1999). The nine items used incorporate key depressive disorder
diagnosis criteria from the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association,
2000; Kroenke and Spitzer, 2002; Kroenke et al., 2001). There are a
variety of valid measurement tools for depression and depressive
symptoms (Holt et al., 2014), one of the most commonly used being
the PHQ-9. This is a well-validated measure for detecting and monitor-
ing depressive symptoms (Kroenke et al., 2010) and has sufﬁcient
concordance with clinical diagnosis of major depressive disorder (MDD)
(Eaton et al., 2007). The nine items consisted of a 4-point scale
indicating the degree of severity from 0 (not at all) to 3 (nearly every
day). These items were then summed to form a total severity score
ranging from 0 to 27. A dichotomous identiﬁer was then ascribed
whereby those with a total score of 10 or more were considered
depressed (i.e. moderately to severely depressed (Kroenke et al., 2001)).
3.2. Diabetes
Participants were identiﬁed as having Type 2 diabetes if they
(1) reported that either a doctor or health professional had told
them they had diabetes or sugar diabetes (other than during
pregnancy); (2) consistent with Mezuk et al. (2013), reported the
use of hyperglycemic agents, with the medication bottle seen by
the interviewer; and/or (3) diabetes based on their fasting blood
glucose and glycated hemoglobin tests.
In 1997, the diagnosis of diabetes was re-deﬁned by the American
Diabetes Association (ADA) and the World Health Organization
(WHO) as a fasting plasma glucose level of 126 mg/dL (7.0 mmol/L)
as this is the level at which a unique microvascular complication of
diabetes, retinopathy, becomes detectable (Alberti and Zimmet, 1998;
American Diabetes Association, 2010; World Health Organisation
(WHO), 1999). Since this test only reﬂects glycemia at the moment
the sample was taken, there are some disadvantages relying just on
this test that may bias the results (Inzucchi, 2012). For this reason the
second blood test that measured glycohemoglobin (A1C test), or
hemoglobin A1c, HbA1c test, was also used. The A1C test is a blood
test that provides information about average levels of blood sugar (or
glucose), over the past 3 months (Nathan et al., 2008) and has been
primarily test used for diabetes management and diabetes research
(Patel and Macerollo, 2010) and may serve as a better biochemical
marker of diabetes and more reliable measure of chronic glycemic
levels (International Expert Committee, 2009). The test is a marker of
long-term glycemia but has some disadvantages, predominantly
relating to its reliability in people with such illnesses as anemia, after
recent transfusion renal disease, racial and ethnic differences.
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However, for best results only those with the diagnostic cutoff point
for diabetes is a fasting plasma glucose level of 126 mg/dL (7.0 mmol/
L) and more or a glycated hemoglobin level of 6.5% or more (i.e.
Z48 mmol/mol) was considered to have diabetes.
3.3. Diet
The nutritional assessment component of NHANES included a
24-hour dietary recall interview for participants of all ages,
conducted in person by trained dietary interviewers (Beaton et
al., 1979; Posner et al., 1982; Thompson and Byers, 1994). Respon-
dents reported the volume and dimensions of the food items
consumed in order to estimate portion sizes. A second dietary
interview for all participants who complete the in-person recall
was collected by telephone approximately 3–10 days later. These
dietary interviews yielded information on the regular consump-
tion of 25 items (Table 1); these data were used to determine
dietary patterns.
3.4. Covariates
Initial covariates included both categorical and continuous vari-
ables. Gender, age group, marital status, education, race, smoking
status, a level of individual food security, and BodyMass Index (BMI,
kg/m²) were grouped into categories. The ratio of family income to
Table 1
Dietary items.
Item: How often eat/drink……?
Cold or hot breakfast Tomato-based salsa
Milk or on breakfast Tomato sauce
Regular soft drinks Red meat
100% fruit juice Processed meat
Sweetened coffee/tea Cheese
Fruit/sports/energy Whole grain bread
Fruit Cooked whole grains







Weighted demographic and clinical characteristics by depressiona status, aged 18 years and above.
Total Not depressed Depressed Total p-Value
91.91 8.09 100.00
Diabetesa
No diabetes 92.81 85.83 92.26 –
Diabetes 7.19 14.17 7.74 0.002
Gendera
Male 51.64 36.46 50.41 –
Female 48.36 63.54 49.59 o0.001
Age (yr)a
18–34 33.53 29.95 33.24 –
35–44 20.66 21.49 20.73 0.346
45–54 21.58 27.26 22.04 0.032
55–64 17.35 18.91 17.48 0.168
65þ 6.87 2.39 6.51 0.003
Marital statusa
Never married 19.25 23.46 19.60 –
Married/living with partner 66.32 50.01 64.98 0.006
Widowed/divorced/separated 14.43 26.53 15.42 0.006
Educationa
Grades 11 and below 15.93 30.84 17.15 –
High school/GED equivalent 22.59 22.39 22.57 o0.001
Some college/AA/college or above 61.48 46.77 60.27 o0.001
Race/ethnicitya
Mexican American/Hispanic 14.40 18.55 14.74 0.004
Non-Hispanic White 67.67 59.72 67.03 –
Non-Hispanic Black 11.04 16.58 11.48 o0.001
Other race—including multi-racial 6.89 5.15 6.75 0.517
Smokinga
Current 20.12 41.80 21.89 o0.001
Former 22.78 16.67 22.28 0.968
Never 57.10 41.54 55.83 –
Adult food insecuritya
Full food security: 0 78.60 49.91 76.29 –
Marginal food security: 1–2 9.60 14.66 10.01 0.001
Low food security: 3–5 6.43 17.26 7.30 o0.001
Very low food security: 6–10 5.38 18.17 6.40 o0.001
Body Mass Index (BMI) categoryb
Normal 29.84 25.70 29.51 –
Underweight 1.79 2.43 1.84 0.457
Overweight 33.58 25.73 32.94 0.470
Obese 34.79 46.15 35.71 0.025
Ratio of family income to povertyc 3.11 (1.63) 2.14 (1.84) 3.03 (1.67) o0.001
C-reactive protein (CRP) (mg/dL)c 0.35 (0.67) 0.45 (0.71) 0.36 (0.67) 0.021
Note: Mental health respondents in the 5–17 years age group are not included. p-Values from simple binary logistic regression using survey sample estimation, with p-Values
less than α¼0.05 in bold. Reference category in italics.
a Weighted percentages.
b BMI categories: Underweight BMI o18.5; Normal BMI 18.5-24.9, Overweight BMI 25.0–29.9; and Obese BMI Z30.0.
c Weighted mean and standard deviation in brackets.
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poverty and a measure of C-reactive protein (CRP, mg/dL) were
retained as continuous variables.
Marital status was collapsed into three groups: never married,
married/living with a partner and widowed/divorced/separated.
Race was collapsed into four groups: Mexican American and other
Hispanic, Non-Hispanic White, Non-Hispanic Black, and other.
Smoking status was categorized into those who have never smoked,
former smokers, and current smokers. Education was collapsed into
three groups: grades 11 and below, high school/General Educational
Development equivalent, and some college/Associates degree (AA)/
college or above. Food insecurity refers to limited or uncertain
access to food resulting from inadequate ﬁnancial resources. Given
the established association between food insecurity and obesity
(Wilde and Peterman, 2006) and diabetes (Berkowitz et al., 2013;
Seligman et al., 2007), the individual adult food security measure
from the NHANES study was included as a covariate. Individual-
level food security items were administered to all adults 16 years
and over in the households that afﬁrmed any Food Security Survey
Module (FSSM) item during the household interview after the 24-
hour dietary recall in the Mobile Examination Center (MEC).
Afﬁrmative responses were tallied for the 10 food security questions
and categorized into four groups: full food security (no afﬁrmative
response in any of the 10 items); marginal food security (1–2
afﬁrmative responses); adult low food security (3–5 afﬁrmative
responses); and adult very low food security (6–10 afﬁrmative
responses).
All survey participants were eligible for the body measurement
component and were collected in the MEC by trained health
technicians. BMI was calculated from the respondent's weight (kg)
and standing height (cm) using the standard formula (kg/m²) and
grouped into four categories: underweight (BMI under 18.5); normal
(BMI between 18.5 and under 25); overweight (between 25 and
under 30); and obese (BMI 30 or above). The weighted information
for each covariate and its signiﬁcance to depression are presented in
Table 2.
4. Statistical analysis
Initial dietary results were analyzed using exploratory factor
analysis (EFA), with correlations matrix as input. Factorability of R
was examined using four key measures (Tabachnick and Fidell,
2012): 1) Sample size; 2) Inspection of item correlations; 3) Kaiser–
Meyer–Olkin (KMO) test of sampling adequacy; 4) Bartlett's test
of sphericity. Factor analysis was deemed appropriate as the unw-
eighted sample size was large, with a ratio of 179 observations per
item. There were also several correlations above 0.3, the KMO was
greater than 0.6, and Bartlett's test of sphericity was statistically
signiﬁcant (po0.001, α¼0.05). Kaiser's rule (retaining factors with
eigenvalues 41), Cattell's scree test (Cattell, 1978, 1965, 1988),
parallel analysis (Horn, 1965), and Minimum Average Partial (MAP)
correlation tests (Velicer, 1976; Velicer et al., 2000, 1982; Watkins,
2005) were used to assess dimensionality of the item set. Parallel
analysis and MAP tests were carried out using a computer program
developed by O’Connor (2000).
Following recommendations of Pett et al. (2003), initial factor
solution utilized principal components extraction, with an oblique
direct oblimin rotation. An oblique rotation was chosen as it was
expected that different diets would be correlated. Interpretability of
solutions retaining different number of factors was assessed using
pattern coefﬁcients, with loadings 40.3 interpreted as statistically
signiﬁcant.
Solutions retaining a different number of factors were assessed on
the following criteria: conceptual meaningfulness of factors; simple
structure (Thurstone, 1947); factor reliability (at least 3, preferably 4,
variables deﬁning each factor); a reasonable amount of the total
variance explained; and communalities a minimum of 0.2. Exam-
ination of assumptions of EFA revealed no contraindications for
factor analysis. The sample used was in excess of a minimum
sample of 200 recommended for EFA (MacCallum et al., 1996, 1999).
The determinant was 40.00001 (0.164), indicating that there were
no problems with collinearity (Field, 2009). Visual inspection of
scatterplots for pairs of randomly chosen items showed no evidence
of non-linearity, and there were no univariate outliers. All items
were measured on a metric scale with a number positively skewed
but no transformations were performed on the items.
A multiple binary logistic regression analysis (Dupont, 2009;
Hilbe, 2009; Hosmer et al., 2013; Long and Freese, 2006) was
performed, where the logit is the natural logarithm of the odds of
depression, taking the range of values potentially between 1
and 1, in order to investigate the relationship of the different
diets with depression, taking into account the multistage survey
nature of the NHANES data for point estimation, model ﬁtting and
variance estimation (Heeringa et al., 2010; Wolter, 2007). Further
testing was performed on the ﬁnal model to take into considera-
tion possible confounding, mediation and moderation.
All statistical procedures were performed using Stata V13
software (StataCorp., 2013).
5. Results
5.1. Exploratory factor analysis for the diet factors
Visual inspection of correlations matrix identiﬁed several correla-
tions more than 0.3 (Appendix 1). For the 26 items, KMO was 0.70
and Bartlett's test was signiﬁcant (χ² (300)¼317,378,113.4, po0.001),
supporting factorability of the 25 item set. Results of dimensionality
tests disagreed on the number of factors potentially underlying the
dietary item set: Kaiser's criterion identiﬁed 8 factors with eigenva-
lues above 1, scree test suggested the presence of 3, 5 or 8 factors
(Fig. 1), parallel analysis suggested 7 factors, and MAP test suggested
2 factors. The initial 8 factors retained explained 47% of the total
variance in the data.
A systematic approach was used to solution reﬁnement, with
maximum likelihood and principal factor extractions methods eval-
uated and the optimal solution was a 5 factor solution with four
items removed one step at a time (popcorn, sweetened tea/coffee,
fruits/sports/energy drinks, and then ﬁnally 100% fruit juice). Var-
imax rotation was used with the ﬁnal solution as it yielded the
strongest loadings on each of the ﬁnal 5 factors with the most
meaningful interpretation. The ﬁnal 5 factor solution using PCA
extraction with varimax rotation explained 39.8% of the total
Fig. 1. Scree plot for the 25 weighted dietary items.
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variance. Each of the 5 rotated diet factors explained 9.7%, 8.8%, 7.7%,
7.0% and 6.6% of the total variance. All communalities were above
0.2 for the ﬁnal 21 items in the analysis.
The ﬁnal solution was close to a simple structure as there were
no signiﬁcant cross loadings across any of the 5 factors. With the
exception of factor 5, there were at least three food items that
signiﬁcantly loaded on each factor. There were only two food items
signiﬁcantly loading on factor 5, but the two loadings were each
strong enough, and the food items made good theoretical sense to
justify the inclusion of this factor. The items signiﬁcantly loading
on the ﬁnal 5 diet factors are summarized in Table 3, along with
the communalities on each food item.
Factor 1, a Healthy Diet, was characterized by vegetables, leafy/
lettuce salad, fruit, cooked whole grains, and whole grain bread.
Factor 2, an Unhealthy Diet, was characterized by the consumption
of fried potatoes, cheese, red meat, processed meats, pizza, non-
fried potatoes, and regular soft drinks. Factor 3, a Sweets Diet, was
characterized by the consumption of cookies/cake, chocolate or
candy, ice cream, and pastries foods. Factor 4, a ‘Mexican’ Style Diet,
was made up of beans, tomato-based salsa, and tomato sauce.
Factor 5, a Breakfast Diet, was made up of cold or hot breakfast and
milk. Higher scores on these dietary patterns represented increased
consumption of these types of foods. After removal of outliers on
the ﬁve diet factors the scales were transformed into a standardized
variable (μ¼0, σ¼1) for use in the multiple binary logistic regres-
sion analysis.
5.2. Binary logistic regression
Bivariate logistic regression was performed initially and revealed
that only two of the ﬁve diet factors had a signiﬁcant bivariate
relationship with depression: the healthy diet and the sweets diet
(Table 4).
Table 3
Rotated coefﬁcients for a 5‐factor solution of the Diet Questionnaire using principal components extraction and varimax rotationa.
h² represents communalities. Principal components extraction with varimax rotation and Kaiser normalization. Unweighted sample of 4643 weighted to the NHANES MEC
two year weights.
a Signiﬁcant loadings (40.3) are in bold red italics.
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Initially, simple multivariate models were tested with the inclu-
sion of each of the two diet factors separately to investigate the
relationship between diabetes and depression. The initial relation-
ship observed between the sweets diet factor and depression was
fully explained by the relationship between diabetes and depres-
sion. Once a person's diabetes status was included in the simple
bivariate logistic regression model, the sweets diet factor was no
longer signiﬁcant OR 1.11, 95% CI [0.93, 1.32], p¼0.221) as a person's
diabetes status explained the major proportion of the relationship
between the sweets diet factor and depression (diabetes OR 2.17,
95% CI [1.44, 3.29], p¼0.001). Although the healthy diet factor
remained a signiﬁcant predictor of depression with the inclusion of
diabetes status (OR 0.70, 95% CI [0.60, 0.83], po0.001), along with
diabetes (OR 2.14, 95% CI [1.40, 3.28], p¼0.002), signiﬁcant inter-
action was found between the healthy diet factor and diabetes on
depression (OR 0.78, 95% CI [0.61, 0.99], p¼0.045). The relationship
between the healthy factor diet and depression signiﬁcantly dif-
fered according to diabetes status.
For the ﬁnal multiple binary logistic model, after controlling for
covariates, the signiﬁcant interaction between the healthy diet and
diabetes status remained (Table 5). After controlling for a person's
sweets diet factor score, gender, age, marital status, education,
race, smoking status, level of food security, ratio of family income
to poverty, and serum CRP, the relationship between the healthy
diet factor score and depression differed according to a person's
diabetes status. BMI status was excluded from ﬁnal model due to
its negative inﬂuence on the goodness of ﬁt test for the ﬁxed
effects model, with its exclusion not inﬂuencing the relationship of
the diets to depression and the signiﬁcance of the interaction
between the healthy diet factor and diabetes. The ﬁnal model ﬁt
was acceptable, yielding an insigniﬁcant test for goodness of ﬁt for
depression (F(9,8)¼0.800, p¼0.627) (Archer and Lemeshow, 2006).
Of interest is the difference in the impact of the two diet factors
on the probability of depression for each gender is shown in Fig. 2.
The more a person eats a healthy diet the lower the probability of
depression, irrespective of gender. However, the sweets diet has an
opposite effect on the probability of depression: the more a person
eats a sweets rich diet the higher the probability of depression.
The results suggest that for those with diabetes, a healthy diet
dramatically reduces their probability of depression compared to
Table 4
Bivariate relationships between depression and covariates1.
Bivariate logistic Odds Ratio p-Value 95% CI
Depressed Lower Higher
Healthy Diet 0.68 o0.001 0.59 0.80
Sweets Diet 1.15 0.045 1.00 1.33
Unhealthy Diet 1.10 0.161 0.96 1.27
Mexican Diet 1.09 0.099 0.98 1.20
Breakfast Diet 1.08 0.337 0.92 1.26
Diabetes status
No 1.00
Yes 2.13 0.002 1.38 3.30
Gender
Male 1.00
Female 1.86 o0.001 1.40 2.47
Age group
18–34 1.00
35–44 1.16 0.346 0.84 1.62
45–54 1.41 0.032 1.03 1.93
55–64 1.22 0.168 0.91 1.63
65þ 0.39 0.003 0.22 0.70
Marital status
Never married 1.00
Married/living with partner 0.62 0.006 0.45 0.86
Widowed/divorced/separated 1.51 0.006 1.15 1.98
Education
Grades 11 and below 1.00
High school/GED equivalent 0.51 o0.001 0.38 0.69
Some college/AA/college or above 0.39 o0.001 0.27 0.58
Race/ethnicity
Non-Hispanic White 1.00
Mexican American/Hispanic 1.46 0.004 1.15 1.85
Non-Hispanic Black 1.70 o0.001 1.32 2.20
Other 0.85 0.517 0.50 1.44
Smoking status
Never 1.00
Current 2.86 o0.001 2.36 3.46
Former 1.01 0.968 0.75 1.35
Adult food insecurity
Full food security: 0 1.00
Marginal food security: 1–2 2.41 0.001 1.49 3.89
Low food security: 3–5 4.23 o0.001 2.68 6.67
Very low food security: 6–10 5.32 o0.001 3.81 7.43
Body Mass Index (BMI) category
Normal 1.00
Underweight 1.57 0.457 0.45 5.55
Overweight 0.89 0.470 0.64 1.24
Obese 1.54 0.025 1.06 2.23
Ratio of family income to poverty 0.70 o0.001 0.63 0.78
C-reactive protein (mg/dL) 1.17 0.021 1.03 1.34
Reference categories highlighted in italics. Signiﬁcant covariates bold, po0.05.
Table 5
Final Multivariate Logistic Regression Model for depressiona.






Yes 2.29 0.001 1.50 3.51
Healthy Diet 0.80 0.050 0.65 1.00
Interaction diabetes status and Healthy Diet
No 1.00
Yes 0.81 0.048 0.66 1.00
Sweets Diet 1.14 0.237 0.91 1.42
Gender
Male 1.00
Female 1.89 0.001 1.35 2.64
Age group (yr)
18–34 1.00
35–44 1.37 0.120 0.91 2.06
45–54 1.65 0.052 1.00 2.73
55–64 1.43 0.082 0.95 2.15
65þ 0.51 0.129 0.21 1.24
Marital
Never married 1.00
Married/living with partner 0.64 0.013 0.46 0.90
Widowed/divorced/separated 0.98 0.904 0.65 1.48
Education
Grades 11 and below 1.00
High school/GED equivalent 0.80 0.276 0.52 1.22
Some college/AA/college or above 0.95 0.818 0.59 1.53
Race
Non-Hispanic White 1.00
Mexican American/Hispanic 0.90 0.431 0.67 1.19




Current smoker 1.91 0.001 1.38 2.63
Former smoker 1.13 0.399 0.84 1.50
Adult food insecurity
Full food security: 0 1.00
Marginal food security: 1–2 1.56 0.207 0.76 3.21
Low food security: 3–5 2.36 0.006 1.32 4.22
Very low food security: 6–10 2.84 0.001 1.69 4.79
Ratio of family income to poverty
(PIR)
0.84 0.024 0.72 0.97
C-reactive protein (mg/dL) 1.04 0.629 0.88 1.22
Constant 0.06 o0.001 0.03 0.12
a Reference categories highlighted in italics. Signiﬁcant covariates bold,
po0.05. Unweighted sample was 3779, weighted population 150,252,443 (15
Stratum, 31 Primary Sampling Units).
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those without diabetes (Table 5). This is not the case with the
sweets diet, where the probability of depression for those with
diabetes is consistently higher than for those without the condi-
tion (Fig. 3).
A sensitivity analysis was performed, where the ﬁnal model
was run across both diabetes subpopulation status (Table 6). The
only signiﬁcant predictors of depression for those with diabetes
were the healthy diet factor, education (High school/GED Equiva-
lent; Some College/AA/College or Above) and ratio of family income
to poverty. For those without diabetes the signiﬁcant predictors
of depression were the healthy diet factor, gender (Female), age
(45–55 years), smoking status (Current smoker), and adult food
insecurity (Low food security; Very low food security).
Thus, the impact of the healthy diet factor was found to be
strongest in those with diabetes than those without the condition.
This result further conﬁrms the potential impact of the healthy
diet factor for sufferers of diabetes on their relationship between
their disease and the probability of depression.
6. Discussion
This study supports previous research in showing that a
healthy diet is associated with a reduced probability of depressive
symptoms or depression, particularly in those with Type 2 diabetes
(Lai et al., 2014; Psaltopoulou et al., 2013; Sánchez-Villegas et al.,
2013). However, it extends the extant literature in suggesting that
one important mechanism linking diabetes and depression is diet
quality. This ﬁnding is consistent with the results of the recent
PREDIMED study, which demonstrated the beneﬁt of a
Mediterranean diet with nuts on the risk for depression in people
with Type 2 diabetes (Sánchez-Villegas et al., 2013). Our results
also support those from another recent dietary intervention in
which incident episodes of major depression over two years of
follow-up were prevented in older adults with elevated depressive
symptoms (Reynolds et al., 2014). In this study, it is notable that
the mean BMI of participants was greater than 30, although no
data were presented on participants' diabetes status. Finally, our
results are concordant with the ﬁndings of recent meta-analyses
conﬁrming an inverse relationship between various types of
healthy diet and depression (Lai et al., 2014; Psaltopoulou et al.,
2013).
We also observed that the initial positive relationship between
the sweets diet factor and depression was attenuated by the
introduction of diabetes as a covariate; this warrants some discus-
sion. As this study utilized cross-sectional data, it is not possible to
determine the temporality of the relationships between these three
factors. One possibility is that diabetes is on the causal pathway
between a diet high in sugar and depression. In other words, high
sugar diets predispose to diabetes, which in turn prompts the
development of depression. Another possibility is that a high sugar
diet is an explanatory factor in the diabetes–depression relationship.
There are observational data to show that unhealthy ‘western’ diets
are risk factors for depression (Akbaraly et al., 2009; Jacka et al.,
2014, 2011) and the noxious impact of western dietary components
(i.e. saturated fat and reﬁned carbohydrates) on the brain, as well as
obesity, is also well described (Kanoski and Davidson, 2011). As
such, it may be the case that an unhealthy diet is a key risk
Fig. 3. Relationship between diet factors on probability of depression by diabetes
status.
Fig. 2. Relationship between diet factors on probability of depression by gender.
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factor for both diabetes and depression. There are multiple poten-
tial pathways that may explain why a healthy diet may inﬂue-
nce the relationship between depression in those with diabetes.
Other factors such as insulin (McNaughton et al., 2008), leptin
(Mohammadzadeh and Zarghami, 2013; Pasco et al., 2008), ghrelin,
level of obesity (Beydoun and Wang, 2010), inﬂammation and
oxidative stress that have been reported for Type 2 diabetes may
also play a role as they are known to impact on the risk for
depression (Pasco et al., 2010).
6.1. Strengths and limitations
The ﬁndings of this study should consider the nature of the
data utilized and the study limitations. NHANES is a cross-
sectional study, restricting the ability to infer the direction of the
relationship among diet, depression and diabetes. Even though the
data used for the construction of the diet factors were limited to
those derived from a 24 hour recall, available research suggests
this method can produce accurate and reproducible estimates of
the mean intake of groups of individuals if standardized proce-
dures and close interviewer monitoring are used during data
gathering (Posner et al., 1982).
The self-report instrument of depression, the PHQ-9, may have
missed less severe cases of depression (Kroenke and Spitzer, 2002;
Kroenke et al., 2001). Even though our measure of diabetes was
derived from a number of different sources in the NHANES,
without additional clinical data we cannot exclude the possibility
that some cases were not identiﬁed. The self-reported measure of
diabetes had a strong relationship with the medications observed
by the interviewer, with diabetic medication usage noted in 68.2%
of those stating they had been told they had diabetes. However,
there are some participants who reported they had not been told
they had diabetes, but in whom diabetic medication usage was
documented (0.35%).
The severity and type of diabetes may also have inﬂuenced their
relationship to depression (Mezuk et al., 2013) and the researchers
were unable to conﬁrm each case was clinically Type 2 diabetes
rather than Type 1 diabetes. However, the average age of diabetes
cases in the sample used was approximately 55 years, which is
consistent with cases in the general adult population with Type
2 diabetes; it is also the case that Type 2 diabetes account for more
than 90% of all diabetes cases (World Health Organisation, 1999).
Even though this study acknowledged a possible role of
inﬂammation in the relationship between diabetes and depression
by controlling for serum CRP, there is an extensive body of the
literature to suggest several other possible biological mechanisms
for the association (e.g. sympathetic nervous system activation)
(Champaneri et al., 2010).
Table 6
Multivariate Logistic Regression Model stratiﬁed by diabetes status1.
Multivariate model—stratiﬁed by diabetes status
Depressed With diabetes Without diabetes
Odds Ratio p-Value 95% CI Odds Ratio p-Value 95% CI
Lower Higher Lower Higher
Healthy Diet 0.68 0.006 0.52 0.88 0.79 0.029 0.64 0.97
Sweets Diet 1.17 0.436 0.77 1.79 1.13 0.294 0.89 1.45
Gender
Male 1.00 1.00
Female 2.45 0.096 0.84 7.14 1.81 0.001 1.35 2.42
Age group (yr)
18–34 1.00 1.00
35–44 1.66 0.487 0.37 7.54 1.31 0.202 0.85 2.03
45–54 0.54 0.431 0.11 2.70 1.82 0.027 1.08 3.05
55–64 0.66 0.531 0.16 2.65 1.50 0.164 0.83 2.69
65þ 0.25 0.087 0.05 1.26 0.51 0.241 0.16 1.65
Marital status
Never married 1.00 1.00
Married/living with partner 0.94 0.911 0.31 2.89 0.62 0.011 0.44 0.88
Widowed/divorced/separated 1.52 0.265 0.70 3.31 0.96 0.861 0.58 1.60
Education
Grades 11 and below 1.00 1.00
High school/GED equivalent 0.54 0.045 0.29 0.98 0.87 0.509 0.55 1.36
Some college/AA/college or above 0.30 0.004 0.14 0.65 1.16 0.540 0.70 1.94
Race
Non-Hispanic White 1.00 1.00
Mexican American/Hispanic 0.61 0.329 0.21 1.73 0.98 0.869 0.71 1.34
Non-Hispanic Black 1.61 0.232 0.71 3.65 0.98 0.871 0.71 1.34
Other 0.55 0.412 0.12 2.47 0.88 0.693 0.44 1.75
Smoking status
Never smoked 1.00 1.00
Current smoker 1.19 0.390 0.78 1.81 2.07 o0.001 1.48 2.90
Former smoker 0.83 0.707 0.29 2.39 1.17 0.483 0.74 1.83
Adult food insecurity
Full food security: 0 1.00 1.00
Marginal food security: 1–2 1.82 0.287 0.57 5.81 1.54 0.277 0.68 3.47
Low food security: 3–5 0.53 0.234 0.18 1.58 2.90 0.001 1.63 5.17
Very low food security: 6–10 2.15 0.071 0.93 4.95 3.04 0.001 1.73 5.35
Ratio of family income to poverty (PIR) 0.59 0.014 0.39 0.89 0.87 0.062 0.75 1.01
C-reactive protein (mg/dL) 0.90 0.580 0.60 1.35 1.07 0.454 0.89 1.28
Constant 0.90 0.902 0.16 5.16 0.05 0.000 0.02 0.10
Note: Signiﬁcant covariates bold, po0.05. Reference category is highlighted in italics.
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6.2. Conclusion
The results of this study are concordant with previous research
in demonstrating inverse relationships between healthy diet and
the probability of depressive symptoms, but also point to the
particular importance of healthy diets to those with diabetes. A
healthy dietary pattern in this study was associated with a
reduced odds of depression, especially among those with Type
2 diabetes. These data suggest that adhering to a healthy diet may
be particularly important for avoiding depression among those
with diabetes. The results of this study are relevant to the clinical
care of people with diabetes and support the current recommen-
dations for the management of Type 2 diabetes with respect to
diet. There is evidence to suggest at least a short-term beneﬁt of
clinicians teaching those with diabetes strategies to manage their
condition (Norris et al., 2001, 2002). The normative role of dietary
counselling amongst those with diabetes may be reinforced by
highlighting the importance of dietary improvement to the mental
health of patients.
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A B S T R A C T
Background: Key lifestyle-environ risk factors are operative for depression, but it is unclear how risk
factors cluster. Machine-learning (ML) algorithms exist that learn, extract, identify and map underlying
patterns to identify groupings of depressed individuals without constraints. The aim of this research was
to use a large epidemiological study to identify and characterise depression clusters through ‘‘Graphing
lifestyle-environs using machine-learning methods’’ (GLUMM).
Methods: Two ML algorithms were implemented: unsupervised Self-organised mapping (SOM) to create
GLUMM clusters and a supervised boosted regression algorithm to describe clusters. Ninety-six
‘‘lifestyle-environ’’ variables were used from the National health and nutrition examination study
(2009–2010). Multivariate logistic regression validated clusters and controlled for possible sociodemo-
graphic confounders.
Results: The SOM identiﬁed two GLUMM cluster solutions. These solutions contained one dominant
depressed cluster (GLUMM5-1, GLUMM7-1). Equal proportions of members in each cluster rated as
highly depressed (17%). Alcohol consumption and demographics validated clusters. Boosted regression
identiﬁed GLUMM5-1 as more informative than GLUMM7-1. Members were more likely to: have
problems sleeping; unhealthy eating;  2 years in their home; an old home; perceive themselves
underweight; exposed to work fumes; experienced sex at  14 years; not perform moderate recreational
activities. A positive relationship between GLUMM5-1 (OR: 7.50, P < 0.001) and GLUMM7-1 (OR: 7.88,
P < 0.001) with depression was found, with signiﬁcant interactions with those married/living with
partner (P = 0.001).
Conclusion: Using ML based GLUMM to form ordered depressive clusters from multitudinous lifestyle-
environ variables enabled a deeper exploration of the heterogeneous data to uncover better
understandings into relationships between the complex mental health factors.
 2016 Elsevier Masson SAS. All rights reserved.
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1. Introduction
Psychiatric health data for lifestyle-environ factors are cha-
racterised by diversity and heterogeneity, often impacting on the
use of traditional statistical techniques in identifying hidden
patterns. There is thus enthusiasm surrounding the use of big data
and machine-learning (ML) techniques and algorithms to unearth
key patterns and interactions in mental health data [1,2]. These ML
algorithms, pioneered by among others, Arthur Samuel [3] and
William Belson [4] as early as the 1950s, exist to learn, extract and
identify underlying patterns, providing potential insight to the task
at hand [5]. The beneﬁts of these techniques is their ability to map
multidimensional data onto lower dimensional subspaces in which
two dimensional maps unearth similarities without constraints
[6–8]. ML techniques could reduce dimensionality from a
multitude of lifestyle and neighbouring environ variables with
potential to allow researchers to visualise and interpret previously
indecipherable data and thereby generate new, testable serendipi-
tous hypotheses regarding depression.
ML algorithms are computer programs that improve perfor-
mance at some task through experiential learning [9]. ML
techniques can be split into two main categories: supervised
and unsupervised learning techniques [10]. The main distinction
between these techniques lies with the intended purpose.
Supervised ML techniques are implemented when the objective
is to develop, test and validate a model for a particular outcome
using appropriate input variables. Unsupervised ML techniques are
implemented to uncover previously unknown patterns and
clusters within the data set, without any a priori model deﬁned,
as an undirected analytical approach ML algorithms have been
used to help predict events including suicidal behaviour [11,12]
and renal failure in patients with bipolar disorder treated with
lithium [13]. ML has been used for classiﬁcation purposes to
separate cognitive behavioural therapy (CBT) responders from
non-responders [14]. However, many of the ML techniques have
been supervised techniques focussing on predictive power [15]
rather than as a means of clustering groups of individuals with
similar patterns of behaviour. Unsupervised ML techniques have
the potential to provide a valuable methodological tool to better
understand and visualize the composition of lifestyle-environ
clusters for those with psychiatric disorders.
Depression is a complex and serious illness. Depression can
arise in association with a combination of genetic, biochemical,
psychological, lifestyle and environmental factors [16,17]. Diet,
exercise and sleep have all been identiﬁed as risk factors for
depression [18,19]. Neighbouring or environ factors that take place
in everyday lives (i.e. not directly related to brain function,
genomes, medical illnesses etc.) appear related to depression. The
challenge when investigating lifestyle-environ links to depression
lies in the ability to cluster or group these heterogeneous factors
together and make sense of the underlying patterns, associations
and interactions. As such, previous studies have investigated only a
small number of lifestyle-environ variables. However, ML techni-
ques have the ability to cluster much broader canvas of lifestyle-
environ variables.
Clustering is a common statistical technique for partitioning or
segmenting a set of objects into a collection of mutually disjoint
subsets [20]. There are many available methods of clustering, such
as hierarchical agglomerate methods, clumping methods and
inverse factor-analysis methods [21]. Mid last century, clustering
methods were used to create classiﬁcations of depression [22–24]
and the advent of more powerful ML clustering methods has since
invigorated these processes [25]. Simple yet powerful ML
algorithms now have the ability to reduce complex problems
down to easily interpreted self-organising data mappings with a
spatial representation [26]. This cluster method has the beneﬁt of
handling very large data sets [20] and has been shown to perform
better than other clustering methods [27].
The aim of this research was to use data from a large
epidemiological study to identify depression clusters, based on a
large array of lifestyle-environ characteristics, through ‘‘Graphing
lifestyle-environs using machine-learning methods’’ (GLUMM)
and to then use the power of supervised ML techniques to help
describe the differences across the resultant clusters.
2. Methods
2.1. Study design and participants
Cross-sectional, population-based survey data of 18- to 80-
year-old non-institutionalised U.S. civilians (n = 10,000) from the
National health and nutrition examination survey (NHANES)
(2009–2010) [28] were utilised for this study. NHANES applies a
complex four-stage sampling methodology: counties; segments
within counties; households within segments; and, individuals
within households. Data were collected from 15 locations across
50 US states. Oversampling of subgroups of the population of
particular public health interest was performed to increase the
reliability and precision of population estimates [28]. Question-
naire data from the NHANES website were downloaded and
integrated using the Data integration protocol in ten steps (DIPIT)
[29].
Variables from the questionnaire component of the NHANES
study were categorised according to type (i.e. medical or lifestyle-
environ) and initially selected if considered a lifestyle-eviron
factor. A number of missing data scenarios across the selected
lifestyle-environ variables were tested and the ﬁnal set of variables
were chosen according to the minimal amount of missing data that
covered the broadest group of lifestyle-environ variables. This
resulted in a ﬁnal set of 96 dichotomous lifestyle-environ variables
and an unweighted sample size of 2123 for initial clustering in this
research study. No signiﬁcant difference was found in the
percentage depressed (7%) in the lifestyle-environ sample
compared to the total sample depressed (8%).
NHANES received approval from the National center for health
statistics (NCHS) research ethics review board and informed
consent was obtained from all participants. Use of data from the
NHANES 2009–2010 database is approved by the National center
for health statistics research ethics review board (continuation of
protocol #2005–2006).
2.2. Study measurements
A nine-item, self-reported Patient health questonnaire-9 (PHQ-
9) [30] was used to assess depressive symptoms (‘‘depression’’).
Those with a total score of 10 or more were considered moderately
or severely depressed [31].
The 96-lifestyle-environ self-report variables covered a broad
cross-section of categories: work status, physical activity, health-
care usage, sleep, smoking, blood donation, sexual activity, drug
usage, diet, grocery shopping habits, meal habits, pesticide usage,
air quality, and home attributes.
The alcohol self-report variables ‘‘Ever have 5 or more drinks
every day?’’ and ‘‘Average number of alcoholic drinks/day -past
12 months’’ were excluded from the analysis as inclusion reduced
the sample size by 12% due to missing data. Instead, these variables
were used to validate the clusters because it was not feasible to do
this by testing the model ﬁt with fresh NHANES data. It was
anticipated, consistent with previous research [32,33], that
clusters with higher proportions of depressed members would
have higher proportions of alcohol usage.
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The self-report demographic and socio-economic variables
from the NHANES demographic and questionnaire data compo-
nents were utilised [34].
2.3. Statistical methodology
This research implemented two ML algorithms: an unsuper-
vised algorithm to create the GLUMM clusters and a supervised
algorithm to identify key variables and describe each cluster.
Finally, due to the complex sampling methodology of the NHANES
data, traditional multivariate logistic regression was implemented
to validate the clusters and control for possible sociodemographic
confounders.
2.3.1. GLUMM clusters
Self-organizing maps (SOMs) [35] are a variant of artiﬁcial
neural networking used in many diverse applications. SOMs
provide a simple and effective unsupervised ML algorithm for
clustering, visualizing and dimension reduction of high dimen-
sional data.
The SOM identiﬁes clusters by effectively packing the dataset
onto a q-dimensional plane, usually two-dimensional (i.e. q = 2).
Data points ‘‘similar’’ to each other in the original multidimen-
sional data space are then mapped onto nearby areas of the q-
dimensional output space. SOMs combine competitive learning
with dimensionality reduction by smoothing the clusters with
respect to an a priori grid. The SOM is called a topology-preserving
map because multidimensional input data is represented by a two
dimensional ‘‘map’’ of nodes where topological properties of the
input space are maintained in the map. Competitive ML algorithm
steps are detailed in Fig. 1.
The beneﬁts of SOMs lie in their ability to handle large data sets,
not relying on distributional assumptions, allowing their use in a
wide variety of disciplines. SOMs have been previously employed
in psychiatry as a means to implement automated seizure
detection [36], to conﬁrm that the EEG’s of subjects with
depression and schizophrenia differ from those of healthy controls
[37], and to detect affective states [38].
For this study, a hexagonal topology was used, with ﬁve SOM
grids tested (10  10, 15  15, 20  20, 25  25, 30  30) to
establish a map with similar nodes. The ﬁnal solution utilised a
20  20 grid with a learning rate for weight adjustment declining
linearly from 5% to 1% over 100 iterations.
Hierarchical clustering using the complete linkage method [39]
was then utilised to group nodes with similar ﬁnal weights,
identifying the clusters within each SOM. The dendogram is a
commonly used visual tool which is used with hierarchical
clustering for deciding how many clusters are present in the data
[20]. However, this tool is only effective when there are a relatively
small number of observations. An alternative approach for large
samples is to use a SOM for preclustering of the data and then to
use hierarchical clustering to determine the optimum number of
clusters. The SOM provides a very efﬁcient method for achieving
this preclustering, as more efﬁcient than k-means and also
provides a 2-dimensional map which can be used to visualise
alternative choices for the optimum number of clusters. This
method does not automate the critical decision regarding the ﬁnal
number of clusters, which requires human judgement, but it does
automate the preclustering. A number of cluster solutions were
run and those indicating clear delineation chosen for further
investigation.
An advantage of the SOM algorithm and the associated cluster
analysis lie in their ability to expose underlying observation groups
using multiple highly correlated variables. These analyses use
distance measures that are robust in the face of multicollinearity.
2.3.2. Boosted regression for clusters
To best understand the differences across the GLUMM clusters,
supervised ML boosted regression [40] translated to the logistic
regression [41], was implemented (Fig. 2). This technique has been
effectively used to detect biomarkers associated with depression
using NHANES [42]. Boosted regression, with depression as a
binary indicator, was performed on the original data (n = 2123)
using Friedman’s multiple additive regression trees (MART)
boosted algorithm [43–45]. This technique was chosen as it takes
into account complex interactions, provides an easy to understand
variable importance metric, and was found to be effective in
variable reduction with a large set of biomarkers using the
NHANES data [42]. This technique has been used on an array of
baseline social and cognitive vulnerability and mood risk factors in
the development of the Chicago adolescent depression risk
assessment (CADRA) index [46].
Fig. 1. Steps for self-organizing maps (SOM).
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This ML technique uses an initial guess for the predicted
outcome, and then ﬁts a regression tree to the residuals, allowing
the initial predictions to be updated. Another regression tree is
ﬁtted to the residuals from this updated model, updating
predictions and residuals, and this cycle continues until conver-
gence is achieved. The learning rate is controlled by applying a
shrinkage factor to the residual predictions at each successive
update stage, in order to improve the robustness of the ﬁnal model
without introducing bias [47]. Convergence is tested by applying
each successive updated model to the fresh validation data. If there
is no improvement in predictive accuracy convergence is assumed
and the learning process stops. With this method, there are no odds
ratios to measure the contribution of each input variable. Instead,
each input variable was is assigned a relative importance value in
accordance with its contribution to each successive regression tree,
averaged over all the trees. For each input variable, the
contribution for a speciﬁc tree relates to the improvement in
classiﬁcation accuracy achieved at all internal nodes where this
variable was chosen as a splitting variable.
Consistent with previous research [42], validation was per-
formed using a random split of each data set into 60% training and
40% validation, a shrinkage parameter of 0.001, with 50% of the
residuals used to ﬁt each successive tree (50% bagging) [43]. The
maximum number of boosting interactions (i.e. number of terminal
nodes plus 1) allowed was six, being marginally higher than the
default (i.e. ﬁve) and within the recommended range [41]. This
technique was used for variable reduction to identify the major
variables explaining the GLUMM cluster solutions using an iterative
selection process based on the relative importance of the lifestyle-
environ variables [43]. Higher values of importance indicate
stronger contributions to cluster formation. Using this technique
for variable reduction has been recognised as effective [48].
Those variables explaining 75% of the total log likelihood
variation across clusters were used to run a second boosted
regression to identify the most important variables for explaining
50% of the total log likelihood variation across clusters.
2.3.3. Multivariate logistic regression for depression
Demographic covariates and signiﬁcant interactions were
included in a multivariate logistic regression model, accounting
for the complex survey design of NHANES and moderation effects,
controlling for potential confounders, and quantifying the impact
of the clusters on the probability of depression. Depression was
used as the outcome and the clusters as potential predictors.
Algorithms for generating SOMs are available in many software
packages including R, IBM SPSS Modeler, SAS Enterprise Miner and
Weka. The SOMs and hierarchical clustering for this study were
performed in R with the SOM using the kohonen package [7]. The
boosted regression and multivariate logistic regression statistical
procedures were performed using Stata V14 software (StataCorp.,




As SOM training iterations progress, the distance from each
node’s weights to the sample of people represented by that node
was reduced to a minimum plateau, indicating that no more
iterations were required (Fig. 3). The Counts plot indicated a
reasonable distribution of observations across the map and the
neighbour distance plot indicated the distances between each
node and its neighbours were mostly similar with only a few
dissimilar nodes, later identiﬁed as outlying clusters (Fig. 3).
Four, ﬁve, six and seven cluster solutions were tested (Fig. 4). Only
ﬁve and seven cluster solutions were retained for further investiga-
tion, as clearly discriminated nodes were in separate groupings.
The ﬁve GLUMM cluster solution (GLUMM5) contained two
dominant clusters and the seven GLUMM cluster solution
(GLUMM7) had three dominant clusters (Table 1). The dominant
clusters for GLUMM5 were labelled as GLUMM5-1 and GLUMM5-
2, while the dominant clusters for GLUMM7 were labelled as
GLUMM7-1, GLUMM7-3 and GLUMM7-4. GLUMM7-3 and
GLUMM7-4 were obtained by splitting the GLUMM5-2 into two
new clusters. The remaining clusters were relatively small and
have therefore been ignored.
3.2. ML boosted regression for clusters
The ﬁnal boosted regression analysis for GLUMM5 selected
12 top variables explaining 51% of the total log likelihood for
Fig. 2. Boosted regression with bagging and shrinkage. SOM refers to self-organizing map.
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GLUMM5-1 and 14 top variables explaining 50% of the total log
likelihood for GLUMM5-2. The ﬁnal boosted regression analysis
for GLUMM7 selected 8 top variables explaining 52% of the
total log likelihood for GLUMM7-1, 11 top variables explaining
52% of the total log likelihood for GLUMM7-3, and 7 top
variables explaining 53% of the total log likelihood for
GLUMM7-4.
The GLUMM clusters were described according to the propor-
tion of depressed members, adjusted to take account of the
complex survey sample for NHANES. Seventeen percent of the
GLUMM5-1 were depressed compared to 5% for GLUMM5-2, which
was marginally lower than for the total sample (7%). Seventeen
percent of the GLUMM7-1 were depressed compared to 5% for
GLUMM7-3 and 6% for GLUMM7-4.
GLUMM5-1 was more informative, having a clearer lifestyle-
environ delineation than GLUMM7-1 (Table 2). Members of the
GLUMM5-1 were more likely to have problems sleeping, per-
ceptions of being underweight, having unhealthy salty snacks and
soft drinks in their home, living for a short time in their home, have
an old home (i.e. pre-1960), being exposed to fumes at work, being
young when ﬁrst experiencing sex (i.e.  14 years), and less likely
to perform moderate recreational activities.
3.3. Cluster validation
For descriptive purposes and consistency demographic varia-
bles were categorised to investigate differences between the
GLUMM clusters [49–51]. Consistent signiﬁcant differences were
found across the two GLUMM solutions between marital status,
education, poverty status and monthly family income for both
cluster solutions (Table 3). Members of the GLUMM5-1 were less
likely to be married and more likely to be less educated and living
below the ofﬁcial poverty threshold, with a lower monthly family
income. Interestingly, GLUMM5-2 was virtually a mirror image of
GLUMM5-1, providing validation for GLIMM5-1 as a more
depressed grouping.
The GLUMM clusters were further validated using the two
alcohol variables (Table 3). The more depressed GLUMM5-1 and
GLUMM7-1 clusters had a higher proportion for ‘‘ever had 5 or
more drinks every day (ever drunk)’’ and a higher mean for
Fig. 4. Self-organizing maps (SOM) GLUMM cluster options.
Fig. 3. Training progress and self-organizing map (SOM) plots with a 20  20 grid. Grids represent mean distance for person input values to weights of closest node.
Table 1
Frequency of GLUMM5 and GLUMM7.
GLUMM5 GLUMM7
1 2 3 4 5 6 7 Total
1 337 23 0 0 0 0 0 360
2 0 0 1286 446 0 0 0 1732
3 0 0 0 0 1 0 0 1
4 0 0 0 0 0 7 0 7
5 0 0 0 0 0 0 23 23
Total 337 23 1286 446 1 7 23 2123
Bold ﬁgures represent major clusters.
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‘‘average number of alcoholic drinks/day in the past 12 months
(drinks/day)’’ than for the other GLUMM clusters.
3.4. Multivariate logistic regression for depression
To validate the use of GLUMM5, multivariate logistic regression
results were obtained for GLUMM5 and GLUMM7 key clusters and
found to be consistent (Table 4). The same multivariate logistic
regression models for all GLUMM solutions were used, taking
account of non-linearity, interactions and potential confounders.
GLUMM5-1 and GLUMM7-1 both found a positive relationship
with depression. Conversely, GLUMM5-2 and GLUMM7-3 and
GLUMM7-4 found a negative relationship with depression. The
ﬁnal models took account of the complex survey data of NHANES
and the test for goodness of ﬁt were not signiﬁcant for all models
indicating a good ﬁt to the data [52].
At all age levels, the predicted probability of depression was
higher for GLUMM5-1 (Fig. 5). There was a signiﬁcant interaction
between marital status and the GLUMM5 clusters (Fig. 5). The
probability of depression was highest for those members of
GLUMM5-1 who had never been married, followed by those
widowed/divorced/separated and ﬁnally lowest for those married.
This was not the case for those not in the GLUMM5-1: highest
probability of depression for those members never married, but
very little difference between those widowed/divorced/separated
and those married.
4. Discussion
The results of this study validated the potential of this machine
learning approach to clarify the complex interaction of risk factors
associated with depression. Problems relating to sleep, a known
risk factor for depression [53], were a dominant variable for the
more depressed GLUMM5-1 cluster. Sleep disorders are a core
symptom of depression, and the relationship between diet and
mental health [54,55] was also conﬁrmed by this study, as
unhealthy snacks in the home were a feature of GLUMM5-1.
Unhealthy dietary behaviours are thought to impact on depressive
symptoms, as well as being a feature of depression. In parallel,
traditional healthy dietary patterns are associated with a reduced
probability of depressive symptoms [55,56]. The lack of physical
recreational activity found as a feature of the GLUMM5-1 more
depressed cluster is also in line with previous research [57–
59]. Exposure to fumes at work may have a possible link to
depression as the midbrain is sensitive to the neuro-inﬂammatory
effects of subchronic air pollution exposure [60–62], although this
may be a proxy of other factors. With inﬂammation linked to
Table 2
GLUMM5 and GLUMM7 lifestyle-environ variables selected using ML boosted regression.
Lifestyle-environ variable GLUMM5-1 GLUMM5-2 GLUMM7-1 GLUMM7-3 GLUMM7-4
Sleep
Told doctor had trouble sleeping +  +  NS 
Told by doctor had sleep disorder +  NS + 
How much sleep do you get (hours), up to 4 hours sleep  
Perception of weight
Age when heaviest weight – 50+ years  NS  NS
Consider their weight – Underweight ++ ++
How do you consider your weight – overweight +
Diet
Heard of MyPyramid  NS
Salty snacks available at home – Always/most of time + NS ++ +
Salty snacks available at home – Sometimes/rarely
Soft drinks available at home – Always/most of time ++
Cooking habits
Time spent cooking dinner/cleaning up – < 1 hour 
Grocery shopping habits




Moderate recreational activities  +  +
Vigorous recreational activities +
Moderate work activity  NS
Work status
Work status prior week – usually work + +
Work status prior week – Not currently working  
Home attributes
Family lived in home 2 years or less ++ ++
Home – Old (< 1960) +
Home rented  
Home owned or being bought ++
Air quality
Had work exposure to other fumes ++  + 
Medical status
Overnight hospital patient in last year + NS
Covered by health insurance ++
Sexual activity
Age when ﬁrst had sex – child (14 years or less) ++  +
Age ﬁrst had sex – adolescence (15–19 years) = NS
Drug status
Ever used cocaine/heroin/meth  
Tabulations comparing clusters taking account of complex sample of NHANES (15 stratums, 31 PSUs).
Pearson x2 statistic with the Rao and Scott second-order correction was used to account for the complex multi-stage survey design and /+ = P < 0.05, /++ = P < 0.001; ns
means not signiﬁcant.
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depression [63], occupations involving exposure to fumes may be
associated with an increased risk of depression.
Tobacco smoking has regularly been associated with mood
disorders [64] but was not found to be a key feature of the more
depressed GLUMM5-1 cluster. Although there is a link between
nicotine and mental illness [64], the exact nature of the
relationship between smoking and psychiatric illness, and
neurobiological effects of nicotine on mental illnesses, is still
unclear.
Having lived for only a short period of time in the home
( 2 years) was identiﬁed as a risk factors and may be an indication
of instability in home and/or working life. Studies in women found
that they related their impaired mood to factors such as loneliness,
ﬁnancial stress and marital issues rather than the move itself
[65]. The older age of the home was found to be signiﬁcantly
related to the lower monthly family income.
The more depressed GLUMM5-1 cluster had a high proportion
of household members who had their ﬁrst sexual experience at
14 years or younger. Engagement in adolescent dating and sexual
activities is linked to greater depressive symptoms [66–68]. Previ-
ous research has predominantly considered adolescent girls,
however, in this study, the main cluster had a higher proportion
of males (61%) compared to females (39%). This ﬁnding warrants
further investigation. There has also been research highlighting the
Table 3
GLUMM5 and GLUMM7 demographic and alcohol variables.
Demographic and alcohol variables GLUMM5-1 GLUMM5-2 GLUMM7-1 GLUMM7-3 GLUMM7-4
Gender
Male 49% 47% 49% 45% 53%
Female 51% 53% 51% 55% 47%
P-value = 0.729a P-value = 0.187
Age
18–24 years 13% 8% 14% 7% 14%
25–34 years 18% 17% 18% 14% 31%
35–44 years 22% 23% 21% 22% 26%
45–54 years 23% 25% 23% 27% 16%
55+ years 24% 27% 24% 31% 13%
P-value = 0.365 P-value = 0.005
Marital status
Never married 14% 9% 15% 8% 14%
Married/living with partner 70% 83% 69% 85% 74%
Widowed/divorced/separated 16% 8% 16% 7% 11%
P-value = 0.001 P-value < 0.001
Race
Mexican American/hispanic 5% 11% 5% 7% 26%
Non-hispanic white 81% 76% 81% 81% 56%
Non-hispanic black 12% 7% 12% 7% 9%
Other 2% 6% 2% 6% 9%
P-value = 0.336 P-value = 0.005
Education
Grades 11 and below 25% 11% 25% 8% 23%
High school/GED equivalent 36% 20% 35% 20% 20%
Some college/AA/college or above 39% 69% 40% 72% 57%
P-value < 0.001 P-value < 0.001
Family size
Single family 11% 4% 10% 3% 8%
Dual family 29% 33% 29% 35% 23%
3+ member family 60% 63% 61% 62% 69%
P-value = 0.185 P-value = 0.049
Poverty statusb
Below ofﬁcial poverty
threshold (poverty index 0–0.99)
20% 6% 20% 3% 17%
Above ofﬁcial poverty
threshold (poverty index  1.00)
80% 94% 80% 97% 83%
P-value < 0.001 P-value < 0.001
Low (poverty index  1.85) 45% 19% 46% 13% 44%
Middle (poverty index > 1.85–3.50) 24% 26% 24% 24% 34%
High (poverty index > 3.50) 31% 55% 30% 63% 22%
P-value < 0.001 P-value < 0.001
Monthly family income
$0–$1249 per month 19% 7% 19% 5% 18%
$1250–$2899 per month 37% 17% 38% 13% 35%
$2900–$5399 per month 23% 31% 21% 31% 33%
> $5399 per month 21% 44% 22% 52% 14%
P-value = 0.001 P-value < 0.001
Ever had 5 or more drinks every day?
Yes 29% 71% 30% 12% 15%
No 71% 39% 70% 88% 85%
P-value < 0.001 P-value < 0.001
Average no. of alcoholic drinks/day in
past 12 months
Mean 3.52 2.50 3.53 2.29 3.43
Tabulations comparing clusters taking account of complex sample of NHANES (15 stratums, 31 PSUs). Pearson x2 statistic with the Rao and Scott second-order correction was
used to account for the complex multi-stage survey design.
aSigniﬁcant difference P < 0.05.
b NHANES analytic guidelines.
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Table 4
Multivariate logistic regression models for depression.
Depression GLUMM5-1 GLUMM5-2 GLUMM7-1 GLUMM7-3 GLUMM7-4




















Not in GLUMM cluster* 1.00 1.00 1.00 1.00 1.00
GLUMM cluster 7.50 <0.001 3.18 17.68 0.14 <0.001 0.06 0.34 7.88 <0.001 2.91 21.35 0.26 0.015 0.09 0.74 0.40 0.118 0.13 1.29
Marital status
Widowed/divorced/separated* 1.00 1.00 1.00 1.00 1.00
Never married 1.42 0.413 0.58 3.47 1.09 0.852 0.43 2.78 1.57 0.270 0.68 3.64 0.97 0.920 0.47 1.97 0.94 0.765 0.60 1.46
Married/living with partner 0.90 0.698 0.50 1.60 0.16 <0.001 0.07 0.37 0.88 0.655 0.48 1.60 0.21 0.001 0.09 0.49 0.41 0.006 0.23 0.75
Cluster  marital status interaction
Cluster  widowed/divorced/
separated*
1.00 1.00 1.00 1.00 1.00
Cluster  never married 0.83 0.800 0.17 3.99 1.02 0.360 0.73 0.25 0.57 0.445 0.13 2.59 1.54 0.540 0.36 6.61 1.19 0.826 0.23 6.30
Cluster  married/living
with partner
0.19 0.001 0.09 0.44 2.25 4.770 0.00 2.70 0.18 0.001 0.08 0.42 5.43 0.003 1.94 15.20 0.95 0.936 0.25 3.64
Gender
Male* 1.00 1.00 1.00 1.00 1.00
Female 1.60 0.004 1.19 2.15 1.59 0.005 1.18 2.15 1.56 0.009 1.139 2.144 1.49 0.011 1.11 2.00 1.42 0.028 1.04 1.93
Age (years) squared 1.00 0.015 1.00 1.00 1.00 0.017 1.00 1.00 1.00 0.022 0.997 1.000 1.00 0.040 1.00 1.00 1.00 0.061 1.00 1.00
Age (years) 1.17 0.017 1.03 1.33 1.17 0.019 1.03 1.33 1.17 0.027 1.021 1.335 1.16 0.045 1.00 1.34 1.14 0.074 0.99 1.31
Education
Grades 11 and below* 1.00 1.00 1.00 1.00 1.00
High school/GED equivalent 0.24 0.014 0.08 0.72 0.25 0.016 0.08 0.75 0.25 0.012 0.09 0.71 0.26 0.018 0.09 0.77 0.24 0.014 0.08 0.72
College/AA/college or above 0.43 0.038 0.19 0.95 0.42 0.035 0.19 0.93 0.42 0.039 0.18 0.95 0.37 0.021 0.16 0.84 0.33 0.006 0.16 0.69
Race
Non-hispanic white* 1.00 1.00 1.00 1.00 1.00
Mexican American/hispanic 1.54 0.066 0.97 2.44 1.47 0.095 0.93 2.34 1.49 0.080 0.95 2.35 1.16 0.492 0.74 1.82 1.43 0.163 0.85 2.42
Non-hispanic black 1.28 0.382 0.71 2.30 1.30 0.351 0.73 2.31 1.25 0.421 0.70 2.23 1.22 0.433 0.73 2.04 1.22 0.383 0.76 1.94
Other 0.52 0.402 0.11 2.57 0.51 0.388 0.11 2.52 0.51 0.382 0.10 2.49 0.39 0.240 0.08 2.00 0.50 0.351 0.11 2.31
Poverty index 0.57 0.004 0.41 0.81 0.57 0.004 0.40 0.81 0.57 0.003 0.41 0.80 0.57 0.006 0.40 0.83 0.54 0.004 0.37 0.79
Poverty Index x Education Interaction
Poverty Index x grades
11 and below*
1.00 1.00 1.00 1.00 1.00
Poverty index x high school/GED
equivalent
1.76 0.040 1.03 3.02 1.73 0.049 1.00 2.97 1.75 0.031 1.06 2.88 1.67 0.053 0.99 2.81 1.69 0.055 0.99 2.90
Poverty index x college/AA/
college or above
1.34 0.097 0.94 1.89 1.33 0.108 0.93 1.88 1.34 0.085 0.96 1.87 1.31 0.113 0.93 1.85 1.35 0.096 0.94 1.93
Family size
Large family* 1.00 1.00 1.00 1.00 1.00
Single family 2.62 0.014 1.25 5.48 2.72 0.010 1.32 5.62 2.79 0.004 1.47 5.30 2.97 0.005 1.47 6.02 2.88 0.004 1.49 5.59
Dual family 1.54 0.167 0.82 2.88 1.55 0.157 0.83 2.92 1.54 0.158 0.83 2.88 1.54 0.171 0.81 2.92 1.64 0.105 0.89 3.01
Constant 0.01 0.004 0.00 0.15 0.05 0.045 0.00 0.92 0.01 0.008 0.00 0.24 0.04 0.061 0.00 1.18 0.06 0.068 0.00 1.27
Goodness of ﬁt test ([F9,8] =0.23, P=0.978) (F[9,8] =0.42, P=0.889) (F[9,8] =1.76, P=0.220) (F[9,8] =0.32, P=0.944) (F[9,8] =0.18, P=0.990)





































relationship between divorce/separation/never having married/
cohabited and sexual abuse before age 17 [69] and the interaction
found between the GLUMM clusters and marital status may be an
indication of this relationship with depression.
This study has several strengths. This research embraced the
potential beneﬁts of both unsupervised and supervised ML
techniques to identify using a very large number of heterogeneous
lifestyle-environ variables a key cluster of more depressed
individuals; which otherwise may have remained hidden using
traditional statistical techniques. This approach has been validated
in that the expected depression relationships with sleep, diet,
physical activity, fumes, housing, income and adolescent sexual
activity was consistent with extant literature.
The NHANES data utilised a complex four-stage sampling
methodology to collect data for 96 lifestyle-environ variables The
limitations of these cross-sectional data restrict the ability to infer
causality. The self-report instrument used to diagnose depression,
the PHQ-9, may have missed less severe cases of depression [30,31]
exaggerating the imbalance in the data. The complexity of the
sample and its design has been addressed in this analysis and the
imbalance of depressive diagnosis in the data set has been
addressed by using a well-populated more depressed cluster in
order to identify the important predictors of depression, hence
reducing the impact of this imbalance on prediction bias.
5. Conclusion
Supervised ML techniques used in this research highlighted
sleep, perceptions of body weight, poor diet, home characteristics,
fume exposure, sexual activity, and low physical activity as key
delineating variables of the high depressive cluster, patterns
primarily concordant with literature. These results support the use
of unsupervised GLUMM to form ordered depressive clusters from
multitudinous lifestyle-environ variables to better explore the
heterogeneous data associated with mental health problems with
the potential to unearth covert results.
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Atheoretical large-scale data mining techniques using machine learning algorithms have
promise in the analysis of large epidemiological datasets. This study illustrates the use of a
hybrid methodology for variable selection that took account of missing data and complex
survey design to identify key biomarkers associated with depression from a large epidemio-
logical study.
Methods
The study used a three-step methodology amalgamating multiple imputation, a machine
learning boosted regression algorithm and logistic regression, to identify key biomarkers
associated with depression in the National Health and Nutrition Examination Study (2009–
2010). Depression was measured using the Patient Health Questionnaire-9 and 67 bio-
markers were analysed. Covariates in this study included gender, age, race, smoking, food
security, Poverty Income Ratio, Body Mass Index, physical activity, alcohol use, medical
conditions and medications. The final imputed weighted multiple logistic regression model
included possible confounders and moderators.
Results
After the creation of 20 imputation data sets from multiple chained regression sequences,
machine learning boosted regression initially identified 21 biomarkers associated with
depression. Using traditional logistic regression methods, including controlling for possible
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confounders and moderators, a final set of three biomarkers were selected. The final three
biomarkers from the novel hybrid variable selection methodology were red cell distribution
width (OR 1.15; 95% CI 1.01, 1.30), serum glucose (OR 1.01; 95% CI 1.00, 1.01) and total
bilirubin (OR 0.12; 95% CI 0.05, 0.28). Significant interactions were found between total bili-
rubin with Mexican American/Hispanic group (p = 0.016), and current smokers (p<0.001).
Conclusion
The systematic use of a hybrid methodology for variable selection, fusing data mining tech-
niques using a machine learning algorithm with traditional statistical modelling, accounted
for missing data and complex survey sampling methodology and was demonstrated to be a
useful tool for detecting three biomarkers associated with depression for future hypothesis
generation: red cell distribution width, serum glucose and total bilirubin.
Background
Over the last two decades there has been a steady rise in the use of data mining techniques
across a number of disciplines. Data mining incorporates a path to knowledge discovery and is
a meaningful process for discovering patterns in data by exploring and modelling large quanti-
ties of data [1, 2]. The distinction between statistics and data mining has been attributed to the
nature of the analysis; statistics deals with primary analysis, whereas data mining deals with
secondary analysis [3] that learns from data [4]. Data mining incorporates machine-learning
algorithms to learn, extract and identify useful information and subsequent knowledge from
large databases [2].
For a number of years, data mining techniques incorporating machine learning algorithms
have been used for ‘big data’ analytics in both marketing and finance (i.e. cost saving, sales
opportunity) [5]. Supervised machine learning techniques have been successfully used in these
industries for feature or variable reduction to produce highly predictive models [6]. However,
it has only been over the last 10 years that data mining techniques have been used in medical
research, primarily in neuroscience and biomedicine [7, 8]. More recently, psychiatry has
begun to utilize the benefits of these techniques to gain further insight into the genetic makeup
of mental illness [9]. However, the implementation of data mining techniques in large epidemi-
ological studies has not been fully explored.
Epidemiological observational studies are based on a particular study population, often fol-
lowed over a period of time, and usually involving no intervention other than the administra-
tion of questionnaires and the carrying out of medical and laboratory or biomarker
examinations. These studies have been used to quantify prevalence and risk factors for diseases
within the population [10]. Sample sizes for these types of studies often comprise of some thou-
sands of individuals. Incorporating a methodology involving data mining techniques using a
machine learning algorithm with traditional statistics for variable selection in these studies
would augment the effective knowledge discovery processes of data mining and rigors of
machine learning algorithms with the well-established metrics of traditional statistics. A hybrid
methodology as such could take account of common analytical issues associated with these
types of studies, such as large numbers of variables, a complex survey design and missing data.
For these reasons, the aim of this study was to develop a systematic and sound hybrid
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methodology involving these elements to perform variable selection that would be appropriate
for use in large epidemiological studies.
To test the proposed hybrid methodology, data from a large cross section population based
U.S. epidemiology study was utilised to identify key biomarkers for depression. Depression is a
serious medical illness, with the World Health Organization estimating that 350 million people
worldwide are affected by depression, with depressive disorders ranking second in terms of
global disability burden and depression expected to be the number one health concern in both
developed and developing nations by 2020 [11–13].
Biomarkers are used in medicine as indicators of risk, diagnosis or trait, disease state or acu-
ity, stage of illness, treatment response and prognosis [14]. Identifying diagnostic biomarkers
of depression may help in its detection and furthermore, circumvent the onset. Despite inten-
sive approaches into the investigation of biomarkers in psychiatry, limitations of sensitivity
and specificity of single biomarkers have made it impractical to assess an individual’s clinical
situation and make determinations regarding diagnosis and prognosis on the basis of biomark-
ers. Thus, establishing key informative biomarkers would be of benefit to psychiatry [15]. The
nature of this type of data is such that missing data often needs to be accommodated using
multiple imputation and the complex survey sampling methodology taken into account. To
date, conventional variable selection methods do not deal with both these issues associated
with this type of data.
The proposed novel hybrid methodology involved a three-step approach, combining data
mining techniques using the machine learning algorithm of boosted regression and bagging,
with traditional statistical techniques. To take into account missing data and complex survey
sampling methodologies, this new three-step approach to variable selection was developed.
This methodology was effectively used to identify key biomarkers for depression in a large
cross-sectional population-based U.S. epidemiological study.
Methods
Study design and participants
Data from the National Health and Nutrition Examination Survey (NHANES) (2009–2010)
[16] were utilised. Relevant NHANES data files were downloaded from the website and inte-
grated using the Data Integration Protocol In Ten-Steps (DIPIT) [17]. NHANES is a cross-sec-
tional, population-based study of approximately 10,000 non-institutionalised U.S. civilians
aged 18 to 80 years, conducted in two-year blocks. A four-stage sampling methodology was
applied: counties; segments within counties; households within segments; and finally, individu-
als within households. Data were collected from 15 different locations across 50 states of Amer-
ica and the District of Columbia. In addition, oversampling of subgroups of the population of
particular public health interest was performed to increase the reliability and precision of pop-
ulation estimates [16]. Finally, subsamples for the mental health and laboratory components of
the survey were chosen, at random, with a sampling frame especially designed to reduce
respondent fatigue and help scheduling in the biomarker collection [16, 18].
Over 250 biomarkers were available for 5,546 participants. Duplicate biomarkers (n = 75),
biomarkers with a high missing count predominantly due to the sampling protocol (n = 94)
and low incidence (n = 26) were excluded from the analysis. The final set consisted of 67 bio-
markers for inclusion. Of the 5,546 participants, 5.6% were excluded from the analysis due to
having six or more missing data values across the 67 biomarkers, and a further six outlier cases
were removed to enable the multiple imputation to converge. The final sample size included in
this research study was 5,227.
Data Mine & Machine Learn Biomarkers of Depression
PLOS ONE | DOI:10.1371/journal.pone.0148195 February 5, 2016 3 / 23
Justice, Beyond Blue, Swinburne University of
Technology.
Abbreviations: BMI, Body Mass Index; DIPIT, Data
Integration Protocol In Ten-Steps; DSM-IV, Diagnostic
and Statistical Manual of Mental Disorder Fourth
Edition; FSSM, Food Security Survey Module; MDD,
Major Depressive Disorder; MEC, Mobile
Examination Center; MART, Multiple Additive
Regression Trees; NCHS, National Center for Health
Statistics; NHANES, National Health and Nutrition
Examination Survey; PHQ-9, Patient Health
Questonnaire-9; WHO, World Health Organization
(WHO) World Health Organization.
NHANES received approval from the National Center for Health Statistics (NCHS)
research ethics review board and informed consent was obtained for all participants. Use of
data from the NHANES 2009–2010 is approved by the National Center for Health Statistics
(NCHS) Research Ethics Review Board (ERB) Approval for NHANES 2009–2010 (Continua-
tion of Protocol #2005–06).
Study Measurements
The Patient Health Questonnaire-9 (PHQ-9) [19] was used to assess depressive symptoms
(depression). The PHQ-9 is a well-validated, self-report tool for detecting and monitoring
depression, with good concordance with a clinical diagnosis of major depressive disorder
(MDD) [20]. Items assess the presence of nine Diagnostic and Statistical Manual of Mental
Disorder Fourth Edition (DSM-IV) depression symptoms over the past two weeks, and are
scored on a four-point scale indicating the degree of severity from 0 (not at all) to 3 (nearly
every day). Items were then summed to form a total severity score ranging from 0 to 27 where
those with a total score of 10 or more were considered depressed (i.e. moderately to severely
depressed) [21].
Health report status was measured as an ordinal five-point rating scale (excellent, very
good, good, fair, poor) and incorporated as predictor in the multiple imputation models as an
indicator of general health.
Blood and urine samples were collected in the Mobile Examination Center (MEC) and
shipped weekly for laboratory analyses. Specific laboratory techniques for each test are avail-
able from the NHANES Laboratory Procedures Manual [22].
Demographic variables were self-reported and included: age, gender, and race (collapsed
into four groups: Mexican American and other Hispanic, Non-Hispanic White, Non-Hispanic
Black, and other).
Current and past smoking status was determined from self-reported questions from the
smoking cigarette use component from NHANES. Smoking status was categorized into those
who were never, former or current smokers. Physical activity was grouped into active (low to
high activity) and not active from the physical activity component from NHANES. Alcohol
regularity per month was calculated from the self-report question regarding how often alcohol
was drunk over the past 12 months, calculated from the weekly, monthly and yearly figures.
Food insecurity, a measure relating to the limited or uncertain access to food due to inade-
quate financial resources, was determined from the 10-item Food Security Survey Module
(FSSM) [23] and categorized into two groups: full food security (no affirmative response in any
of the 10 items); and food insecurity (at least one affirmative responses).
Body measurements were collected in the MEC by trained health technicians. Weight and
height were measured and body mass index (BMI) calculated as weight/height2 (kg/m2). BMI
was categorised as underweight (BMI< 18.5 kg/m2), normal (BMI between 18.5 to under 25
kg/m2), overweight (between 25 to under 30 kg/m2) and obese (BMI30kg/m2) [24].
Participants were identified as having Type 2 diabetes if they (i) reported that either a doctor
or health professional had told them they had diabetes or sugar diabetes (other than during
pregnancy); (ii) reported the use of hyperglycaemic agents, with the medication bottle seen by
the interviewer [25]; and/or (iii) diabetes based on their fasting blood glucose>126 mg/dL (7.0
mmol/L) [26–29] and glycated haemoglobin level of>6.5% [30–32].
Participants were identified as having cardiovascular disease using the self-report questions
regarding past history of heart conditions (i.e. congestive heart failure, coronary heart disease,
angina/angina pectoris, heart attack, stroke) which have been shown to have high concordance
with laboratory measures for cardiovascular disease [33, 34].
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Participants were also identified as having the inflammatory conditions of arthritis and can-
cer or malignancy using the self-report questions.
Participants were asked to bring currently used medications to the assessment. The Lexicon
Plus1 proprietary comprehensive database of Cerner Multum, Inc. was used to assist with data
collection, data editing and release of the NHANES medication data. All prescription and some
non-prescription drug products available in the U.S. were coded using the Lexicon Plus medi-
cation database. For the current analyses, Lexicon Plus medication categories with higher than
2% incidence were included: anti-infective, cardiovascular agents, central nervous system
agents, coagulation modifiers, gastrointestinal agents, hormones/hormone modifiers, meta-
bolic agents, nutritional products, psychotherapeutic agents, respiratory agents, and topical
agents.
Methodology
The proposed hybrid methodology was applied to this study to select key biomarkers associ-
ated with depression from the NHANES data set (Fig 1).
STEP 1: Multiple Imputation (MI) for Missing Data
In many ‘big data’ situations, missing data are not an issue due to the large volume of observa-
tions and variables or features available. In contrast, missing data in studies with small sample
sizes can influence the results greatly [35, 36]. There have been a number of missing data pro-
cedures suggested in the literature over the last decades: listwise deletion; pairwise deletion;
mean substitution; regression imputation; Maximum Likelihood (ML) estimation [37, 38].
However, most of these methods can only be used when there is no pattern for the missing
data. The choice of method used for dealing with missing data is often less important when the
proportion of missing data is less than 5% [39]. However, it is not unusual for the proportion
of missing data in large epidemiological studies to exceed this percentage, thereby potentially
reducing statistical power, producing biased parameters and increasing the risk of a Type I
error [35]. All these issues could be detrimental to traditional statistical multivariate regression
models.
Multiple imputation is a useful flexible strategy for addressing the missing value problem.
Multiple imputation is considered when the missingness is not totally random, depending on
observed or unobserved values. However, this method is applicable even when the pattern of
missing data is not random. Multiple imputation using chained sequences of equations is a
flexible imputation method with the ability to handle different variable types, as an imputation
model is generated for each variable with missing data [40]. This method is also referred to as
fully conditional specification [41] and sequential regression multivariate imputation [42]. A
selected imputation model generates ‘mi’ complete imputed sets of data. Analysis is then per-
formed and results are pooled. The number of ‘mi’ sets depends on the amount of missing
data, nature of the data and analysis model used. More than 50 imputed sets may be required
to obtain stable results [43], but between 5 to 20 has been considered appropriate to reduce the
imputation sampling error when fractions of missing data are low [44].
Prior to imputing the missing data, missing values are often tested for Missing At Random
(MAR) or Missing Completely At Random (MCAR) [38, 45]. MAR occurs when the probabil-
ity of being missing is dependent on the variables measured in the study, but independent of
those not measured in the study. To test MAR, logistic regression is often performed with a
missing data indicator created for each potential predictor (i.e. 1 for missing, 0 for non-miss-
ing). No significant relationship between the missingness indicators and the outcome of inter-
est suggests MAR. MCAR occurs when the probability of being missing is independent of all
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the variables in the study (those measured and not measured) The assumption that the data are
missing completely at random (MCAR) can be assessed using Little's MCAR chi-squared test,
which can be applied to a large set of variables [46, 47], including all the predictors simulta-
neously. A significant result rejects the null hypothesis that the data is MCAR. Rejection of
MAR or MCAR confirms the need for multiple imputation for the missing values in the data.
As the highest missing data percentage for this study data set was above 5% and the assump-
tions of MAR and MCAR were rejected, multiple imputation was required. The multiple impu-
tation framework of inference was developed by Rubin [38] and implemented in Stata.
Multiple imputation was performed, with chained sequences of equations [40, 48] using all bio-
markers, age, race, and a measure of self-report health status, but run separately for males and
females due to possible differences in biomarker importance between the sexes [49]. A mix of
binary logistic and linear regression, using chained equations, was used, contingent on the
nature of the biomarker imputed. This study involved 20 chained sequences with the primary
data set of 5,227 observations. Thus, the combined original and imputed data sets contained
Fig 1. Hybrid Methodology Steps.
doi:10.1371/journal.pone.0148195.g001
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109,767 observations. Convergence for each of the chained equations was achieved within an
acceptable 20 imputed data sets [44].
STEP 2: Technique for Initial Selection of Predictors (Boosted
Regression)
There are many potential statistical and machine learning algorithms available for variable
selection [2], but boosted regression is recognised as being particularly effective [50]. This tech-
nique has often been thought of as a ‘bucket’ or ensemble method (a method that averages over
multiple classifiers), and has gained popularity amongst mainstream statisticians due to its pre-
dictive accuracy and ease of interpretation [51, 52]. Boosted regression has been used in studies
involving animal ecology [53], for example to build predictive models for fish and coral metrics
[54], and to identify factors predicting the reproductive success of dominant pairs of clown
anemonefish [55]. It has also been used in the development of the Chicago Adolescent Depres-
sion Risk Assessment (CADRA) index from an array of baseline social and cognitive vulnera-
bility and mood risk factors [56].
Boosting was invented by Freund and Schapire for regression trees [57] and translated to
the logistic regression model by Hastie, Tibshirani, and Friedman [54]. One of the advantages
with boosted regression is that the algorithm can accommodate any type of variable (continu-
ous, categorical, censored), any type of likelihood loss function (Gaussian, Binomial, Poisson,
and robust), and can deal with highly correlated predictors [58]. In addition it can automati-
cally accommodate non-linearity and interaction effects between predictor variables. The
boosting regression algorithm fits a sequence of simple trees based on a set of data splitting
rules to provide a more accurate estimate of the outcome with over-fitting avoided using a vali-
dation data set and shrinkage. Each tree consists of a series of yes/no questions which is applied
to each observation in the training data. Predictions are obtained using the average of the out-
comes for the observations found in each terminal node. Residuals are computed as the differ-
ence between the true and outcome values. Each successive tree is built for the prediction of the
residuals of the preceding tree. Essentially the technique successively gives larger weights to
observations that are repeatedly misclassified.
The final classifier consists of a weighted average of previous classifiers, with lower weights
(shrinkage) for later trees in order to avoid over-fitting. Shrinkage is accomplished by adding a
parameter λ to the last regression tree of residuals, where λ = 1 corresponds to no shrinkage.
Typically λ is 0.1 or smaller, with λ = 0.01 or λ = 0.001 common. Smaller shrinkage values
require larger number of iterations which can be computationally demanding.
The steps in the boosted regression technique incorporating the shrinkage parameter:
• An initial guess for the predicted outcomes is created. Compute the residuals based on the
current model.
• For each regression tree:
• Fit a regression tree to the residuals
• Compute the predicted outcome of the residuals for each terminal node
• Use the regression tree to predict the new set of residuals
• Update the boosting regression model to reflect the current regression tree, applying the
shrinkage parameter to the last regression tree of residuals
• This model is applied to the validation data and if there is an improvement in predictive
accuracy over the results for the previous iteration the next iteration commences. If not,
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then training stops and no more iterations are executed and no more residual trees are
developed.
In order to improve the robustness of the final model without introducing bias ‘bagging’ was
used [59]. Bagging is sometimes referred to as bootstrap aggregating and was originally devel-
oped by Breiman as a method for creating multiple versions of a predictor to form an aggregated
predictor [60]. Combining this method with boosting, bagging randomly selects a proportion of
the residuals at each iteration to build a new tree. While not all observations are used in each
iteration, all observations are eventually used across all iterations. Thus, the tree analysis is run
on multiple similar datasets, and the aggregate results are used to construct the final model and
relevant statistics. Friedman recommends bagging with 50% of the database [59].
The final boosted regression tree model tends to be more robust than a single regression
tree model, enabling complex functions and interactions to be modelled without assumptions
[53]. Since no probability values (p-value) are produced from the boosted regression algorithm,
the relative importance of variables has been used to pick likely predictors [59]. Each variable is
assigned a relative importance percentage or contribution, where the sum of the standardized
values of all variable importances add to 100%. The importance is calculated from the number
of times a variable is selected for splitting, weighted by the squared improvement to the model
fit achieved from each such split, averaged over all trees. Higher values of importance indicate
stronger contributions to outcomes values. With a binary outcome measure the importance
represents the percentage of the log likelihood explained by each variable. For the proposed
methodology, the importance percentage for each predictor will be of particular interest for the
variable selection process.
The analysis approach for selecting the preliminary subset of predictors for the proposed
methodology is one of inclusion rather than exclusion. A potential predictor was selected based
on the relative importance percentage in the original data set and the average importance per-
centage statistics across the 20 imputed data sets. The cut-off relative importance percentage is
therefore relatively inclusive, ensuring that a reasonable percentage of the total log likelihood is
retained.
For the NHANES study, depression was a binary indicator. The boosted regression method
used the Multiple Additive Regression Trees (MART) boosting algorithm [54, 59] imple-
mented by Schonlau [61]. This method was performed on the original data set of 5,227 obser-
vations with missing data, then for each of the 20 imputed data sets. For each run, validation
was performed by randomly splitting each data set into 60% training and 40% validation ensur-
ing that additional boosting iterations were employed only when improved prediction accuracy
was achieved with the validation data set. After some initial testing, the final shrinkage parame-
ter used was 0.001 with the recommended 50% of the residuals used to fit each individual tree
(50% bagging) [59]. The maximum number of boosting interactions (i.e. number of terminal
nodes plus 1) allowed was 6, being marginally higher than the default (i.e. 5) and within the
recommended range by Hastie, Tibshirani and Friedman [54]. Finally, a random-number seed
was used to generate the same sequence of random numbers for bagging, ensuring that the
results could be reproduced. Biomarkers with the greatest relative importance for the predic-
tion of depression were identified.
To ensure the inclusion criterion was implemented and a reasonable proportion of the total
relative importance was retained, cut-off percentages of 4%, 3% and 2% were tested. It was
decided to use 2% to ensure more than 50% of the total relative importance was included in this
stage of variable selection. Thus, a biomarker was included in the initial biomarker selection if
its relative importance percentage in the original data set was higher than 2%, or its average
importance percentage statistics across the 20 imputed data sets yielded average of at least 2%.
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STEP 3: Traditional statistical regression
At the heart of data mining is the concept of data splitting to address overfitting the data from
the machine learning techniques used. Data are randomly split into two groups: a training set
and a validation set. Thus, the imputed data set was split into training and validation data sets.
For the NHANES study, the imputed data set was split into approximately 50% training and
50% validation data for the traditional statistical analysis. Each set maintained the balance in
regard to depression levels and imputation sets.
The standard approach of univariate regressions for each of the potential predictors selected
from step two were then performed, with the variable of interest as the outcome variable. Pre-
dictors with the strongest relationship with the outcome for both these data sets were chosen
based on traditional statistical 95% confidence (i.e. p<0.05). As required for the NHANES
data, the study’s complex survey sampling methodology was taken into account using univari-
ate weighted logistic regressions. These regressions, were conducted for each selected bio-
marker from the machine learning boosted regression algorithm with depression as the
outcome. Biomarkers having a significant relationship with depression were chosen (i.e.
p<0.05) at the final variable selection stage.
Using the selected biomarkers from the univariate analysis, a traditional statistical multivariate
regression model was then estimated for both the training and validation data sets. Multicollinear-
ity andmediation relationships were tested and predictors removed accordingly. For the NHANES
data, it was important that this step took account of the complex four-staged survey design.
Finally, demographic and medical covariates and significant interactions were included in
this multivariate model to control for any confounders and account for any moderation effect
with models fitted using both the training and validation imputed data sets. The final model
was also fitted using the original set of observations (with missing values) to obtain an indica-
tive measure for goodness of fit and to ensure consistent direction and significance for the
important biomarkers identified using the primary data set and the combined data set with
imputation for missing values.
All statistical procedures were performed using Stata V14 software (StataCorp., 2014). A
Stata plugin was used for the boosted regression component of the analysis [61].
Results
Estimated statistics for each of the covariates and the significance of the relationship with
depression for each covariate is presented in Table 1. The complex survey design of NHANES
is taken into account in these estimates.
STEP 1: Multiple Imputation results
The impact of missing data across the 67 laboratory data was quantified [17]. The results from
the imputed weighted logistic regression with the missing data indicator for each biomarker as
the outcome and depression as the predictor are reported in the last column in Table 1. Signifi-
cant results for several biomarkers indicated that missing biomarker data affected the depres-
sion status (i.e. p<0.05), confirming that the data was not MAR. Little's test also provided
evidence against the assumption that all laboratory data were MCAR (p<0.001). The missing
data were therefore imputed using multiple imputation.
STEP 2: Machine Learning boosted regression results
Multiple imputation produced 20 separate data sets with distinct imputed missing values for
the boosted regression step. The relative importance statistics are reported in Table 2 for the
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Table 1. Estimated covariate statistics.
Covariate Proportion Std Error 95% CI Low 95% CI High p-value
Depressed
Not Depressed 0.923 0.005 0.913 0.934
Depressed 0.077 0.005 0.066 0.087
Gender
Male 0.496 0.006 0.483 0.509 Reference
Female 0.504 0.006 0.491 0.517 <0.001
Age Group
18–34 years 0.329 0.009 0.309 0.348 Reference
35–44 years 0.210 0.008 0.193 0.226 0.457
45–54 years 0.223 0.007 0.207 0.238 0.117
55–64 years 0.176 0.006 0.162 0.189 0.272
65+ years 0.063 0.004 0.056 0.071 0.006
Race
Mexican American/Hispanic 0.147 0.031 0.082 0.213 0.010
Non-Hispanic White 0.678 0.035 0.602 0.753 Reference
Non-Hispanic Black 0.110 0.009 0.089 0.130 <0.001
Other 0.065 0.009 0.046 0.084 0.542
Smoking
Current Smoker 0.219 0.008 0.201 0.237 <0.001
Former Smoker 0.226 0.014 0.195 0.257 0.800
Never Smoked 0.555 0.019 0.515 0.595 Reference
Food Security
Full food security 0.782 0.013 0.755 0.809 <0.001
Food insecurity 0.218 0.013 0.191 0.245 Reference
BMI Category
Underweight 0.018 0.003 0.012 0.024 0.396
Normal 0.295 0.014 0.266 0.324 Reference
Overweight 0.331 0.011 0.307 0.355 0.358
Obese 0.356 0.011 0.333 0.379 0.035
Physical Activity
Low to high activity 0.451 0.018 0.411 0.490 Reference
No low to high activity 0.549 0.018 0.510 0.589 0.882
Diabetes Status
No Diabetes 0.910 0.005 0.900 0.920 Reference
Diabetes 0.090 0.005 0.080 0.100 0.001
Cardiovascular Disease Status
No Cardiovascular Disease 0.924 0.007 0.910 0.938 Reference
Cardiovascular Disease 0.076 0.007 0.062 0.090 0.009
Arthritis Status
No Arthritis 0.928 0.005 0.918 0.938 Reference
Arthritis 0.072 0.005 0.062 0.082 <0.001
Cancer or malignancy
No Cancer or malignancy 0.901 0.008 0.884 0.919 Reference
Cancer or malignancy 0.099 0.008 0.081 0.116 0.925
Use Central Nervous System
No 0.854 0.008 0.836 0.871 Reference
Medication(s)
(Continued)
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Table 1. (Continued)
Yes 0.146 0.008 0.129 0.164 <0.001
Use Psychotherapeutic Agents
No 0.915 0.006 0.902 0.928 Reference
Yes 0.085 0.006 0.072 0.098 <0.001
Mean Std Error 95% CI Low 95% CI High p-value
Family Poverty Income Ratio (PIR) 3.013 0.044 2.918 3.108 <0.001
Number of times drink alcohol pm 6.235 0.290 5.615 6.856 0.005
Note: Multiple-imputation, survey estimation. Based on 20 imputations, primary N = 5,227. P-value indicates the signiﬁcance of biomarker with depression.
doi:10.1371/journal.pone.0148195.t001
Table 2. Boosted regression statistics.
Biomarker Original data set Imputation sets 1 to 20
Mean Std Dev Min Max
T.gondii antibodies (IU/ml) 0.220 0.562 0.444 0.326 2.388
Blood lead (ug/dL) 1.482 1.658 0.066 1.537 1.753
Mercury, total (ug/L) 1.958 1.847 0.110 1.628 2.049
Mercury, inorganic (ug/L) 0.290 1.668 0.116 1.358 1.788
White blood cell count (1000 cells/uL) 1.243 1.126 0.065 1.000 1.277
Lymphocyte percent (%) 1.331 0.978 0.078 0.780 1.176
Monocyte percent (%) 1.996 1.595 0.172 1.371 1.904
Segmented neutrophils percent (%) 1.240 1.004 0.082 0.856 1.121
Eosinophils percent (%) 1.770 0.971 0.126 0.819 1.406
Basophils percent (%) 0.565 0.585 0.051 0.503 0.690
Lymphocyte number (1000 cells/uL) 0.754 0.912 0.171 0.691 1.559
Monocyte number (1000 cells/uL) 0.835 0.492 0.043 0.392 0.552
Segmented neutrophils num (1000 cell/uL) 1.138 1.103 0.075 0.950 1.282
Eosinophils number (1000 cells/uL) 0.229 0.129 0.026 0.052 0.157
Basophils number (1000 cells/uL) 0.069 0.084 0.012 0.056 0.100
Red blood cell count (million cells/uL) 0.829 1.083 0.148 0.898 1.595
Hemoglobin (g/dL) 1.717 2.942 0.152 2.667 3.210
Hematocrit (%) 0.847 2.798 0.148 2.533 3.103
Mean cell volume (fL) 0.494 0.943 0.082 0.853 1.154
Mean cell hemoglobin (pg) 0.848 1.307 0.045 1.251 1.432
Mean Cell hemoglobin concentration (MCHC) (g/dL) 5.139 3.380 0.105 3.195 3.610
Red cell distribution width (%) 3.423 1.918 0.105 1.685 2.058
Platelet count (1000 cells/uL) 2.395 2.632 0.112 2.443 2.842
Mean platelet volume (fL) 1.257 1.348 0.095 1.214 1.519
Blood cadmium (nmol/L) 5.306 4.159 0.136 3.908 4.447
Glycohemoglobin (%) 1.526 1.830 0.107 1.604 1.986
C-reactive protein(mg/dL) 1.877 2.264 0.107 2.024 2.405
Direct HDL-Cholesterol (mg/dL) 1.097 1.149 0.104 0.946 1.328
RBC folate (ng/mL) 0.536 0.779 0.097 0.588 1.021
Serum folate (ng/mL) 1.955 1.840 0.163 1.486 2.087
Cotinine (ng/mL) 2.011 1.982 0.277 1.542 2.739
Urinary Total NNAL (ng/mL) 3.226 5.579 0.496 4.544 6.459
(Continued)
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original data set and across the 20 imputed data sets. Based on the selection criterion explained
above, 21 biomarkers were selected for the next stage of the analysis. The selected biomarkers
consistently explained more that 50% of the total relative importance for both the original data
set (53.85%) and for the mean values computed across the 20 imputed data sets (53.33%).
Table 2. (Continued)
Biomarker Original data set Imputation sets 1 to 20
Mean Std Dev Min Max
Albumin (g/dL) 0.914 0.543 0.050 0.459 0.662
Alanine aminotransferase ALT (U/L) 0.843 0.836 0.033 0.791 0.889
Aspartate aminotransferase AST (U/L) 0.727 0.577 0.053 0.462 0.694
Alkaline phosphotase (U/L) 2.992 1.966 0.086 1.825 2.184
Blood urea nitrogen (mg/dL) 0.840 0.875 0.088 0.718 1.061
Total calcium (mg/dL) 0.671 0.610 0.053 0.528 0.753
Cholesterol (mg/dL) 0.373 0.793 0.086 0.680 1.076
Bicarbonate (mmol/L) 3.769 1.840 0.089 1.661 2.035
Creatinine (mg/dL) 3.286 3.041 0.189 2.491 3.370
Gamma glutamyl transferase (U/L) 1.023 0.689 0.045 0.628 0.823
Glucose, serum (mg/dL) 4.911 2.487 0.168 2.140 2.742
Iron, reﬁgerated (ug/dL) 1.752 1.443 0.088 1.288 1.559
Lactate dehydrogenase (U/L) 1.050 1.102 0.066 0.973 1.202
Phosphorus (mg/dL) 0.556 0.587 0.040 0.514 0.668
Total bilirubin (mg/dL) 3.366 2.555 0.291 1.841 2.853
Total protein (g/dL) 0.639 0.930 0.064 0.820 1.055
Triglycerides (mg/dL) 0.987 1.285 0.170 1.126 1.867
Uric acid (mg/dL) 2.598 2.401 0.116 2.232 2.675
Sodium (mmol/L) 0.957 0.299 0.034 0.242 0.366
Potassium (mmol/L) 0.654 0.664 0.059 0.559 0.778
Chloride (mmol/L) 2.810 1.629 0.065 1.460 1.726
Osmolality (mmol/Kg) 0.749 1.165 0.061 1.019 1.263
Globulin (g/dL) 0.501 0.679 0.062 0.529 0.778
Total Cholesterol (mg/dL) 0.457 0.609 0.058 0.488 0.714
Albumin, urine (ug/mL) 1.247 1.459 0.085 1.326 1.680
Creatinine, urine (umol/L) 0.963 0.992 0.108 0.769 1.193
First albumin creatinine ratio (mg/g) 0.723 0.787 0.118 0.636 1.110
Second albumin (ug/mL) 0.975 2.314 1.184 1.071 5.309
Second creatinine (mg/dL) 1.768 2.056 0.525 1.459 3.329
Second albumin creatinine ratio (mg/g) 1.176 3.321 0.825 1.783 5.326
The volume of urine collection #1 1.485 2.082 0.092 1.948 2.336
Urine #1 Flow Rate 3.262 2.921 0.720 1.743 4.456
Urine osmolality (mOsm/kg) 1.308 1.675 0.179 1.352 2.242
Hepatitis A Antibody 0.031 0.089 0.028 0.046 0.151
Hepatitis B surface antibody 0.034 0.051 0.018 0.023 0.082
Note: Highlighted indicate biomarker selected for univariate logistic regression. Validation on original plus each imputed data set. Random splitting of
60:40 training:validation, λ = 0.001, 50% bagging, 6 maximum number of boosting interactions. Original pseudo-R² = 0.032, imputed data set pseudo-R²
ranged from 0.044 to 0.052. Variables selected at this step accounted for more than 50% of the total relative importance: original data was 53.85%; mean
of 20 imputation sets was 53.33%.
doi:10.1371/journal.pone.0148195.t002
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STEP 3: Traditional statistical regression results
The training data yielded five biomarkers with significant univariate relationship with depres-
sion: hemoglobin (g/dL), Red cell distribution width (%), blood cadmium (nmol/L), cotinine
(ng/mL), and total bilirubin (mg/dL) (Table 3). The validation data confirmed the five bio-
markers from the training data with the addition of glucose, serum (mg/dL) (Table 3). Since
the p-value from the training data was 0.05 for this sixth biomarker it was decided to include
this variable in the final model.
A multiple logistic regression with these predictors suggested that the effect of hemoglobin
was fully mediated by total bilirubin and that cotinine was fully mediated by blood cadmium.
Both haemoglobin and cotinine were therefore excluded from the final model, leaving four key
biomarkers: red cell distribution width, blood cadmium, serum glucose and total bilirubin.
The direction and significance of the four biomarkers were tested with the combined
imputed data sets, allowing for a 50:50 random split between training and validation data. Con-
sistent results were obtained for the multiple logistic regression model in the training and vali-
dation data (Table 4).
The final model controlling for potential confounders and including significant interactions
are reported in Table 5.
Only Central nervous system medications and / or psychotherapeutic agents and diabetes
were included in the final multivariate model. The final validated model, using the original
Table 3. Univariate Logistic Regression statistics.
TRAINING VALIDATION
Biomarker Odds Ratio Std. Err. p-value CI Low CI High Odds Ratio Std. Err. p-value CI Low CI High
Hemoglobin (g/dL) 0.85 0.057 0.042 0.73 0.99 0.85 0.059 0.048 0.72 1.00
Hematocrit (%) 0.95 0.024 0.084 0.90 1.01 0.95 0.025 0.077 0.89 1.01
MCHC (g/dL) 0.85 0.115 0.261 0.63 1.15 0.89 0.131 0.454 0.65 1.23
Red cell distribution width (%) 1.20 0.080 0.024 1.03 1.40 1.20 0.079 0.023 1.03 1.40
Platelet count (1000 cells/uL) 1.00 0.002 0.058 1.00 1.01 1.00 0.002 0.083 1.00 1.01
Blood cadmium (nmol/L) 1.07 0.018 0.014 1.02 1.11 1.07 0.018 0.012 1.02 1.11
C-reactive protein(mg/dL) 1.18 0.106 0.091 0.97 1.44 1.15 0.098 0.141 0.95 1.38
Cotinine (ng/mL) 1.00 0.001 0.011 1.00 1.00 1.00 0.001 0.009 1.00 1.00
Urinary Total NNAL (ng/mL) 1.07 0.092 0.444 0.87 1.32 1.10 0.117 0.390 0.85 1.44
Alkaline phosphotase (U/L) 1.00 0.004 0.197 1.00 1.01 1.00 0.004 0.262 1.00 1.01
Bicarbonate (mmol/L) 0.93 0.045 0.156 0.83 1.03 0.92 0.044 0.133 0.83 1.03
Creatinine (mg/dL) 0.87 0.409 0.770 0.30 2.48 0.87 0.430 0.778 0.28 2.67
Glucose, serum (mg/dL) 1.00 0.002 0.050 1.00 1.01 1.01 0.002 0.039 1.00 1.01
Total bilirubin (mg/dL) 0.19 0.093 0.009 0.06 0.58 0.24 0.112 0.016 0.08 0.71
Uric acid (mg/dL) 0.97 0.069 0.655 0.83 1.13 0.94 0.062 0.345 0.81 1.08
Chloride (mmol/L) 0.98 0.039 0.700 0.90 1.08 0.98 0.038 0.624 0.90 1.07
Second albumin (ug/mL) 1.00 0.001 0.477 1.00 1.00 1.00 0.001 0.290 1.00 1.00
Second creatinine (mg/dL) 1.00 0.002 0.438 1.00 1.00 1.00 0.001 0.479 1.00 1.00
Second albumin creatinine ratio (mg/g) 1.00 0.000 0.516 1.00 1.00 1.00 0.000 0.315 1.00 1.00
The volume of urine collection #1 1.00 0.001 0.813 1.00 1.00 1.00 0.001 0.651 1.00 1.00
Urine #1 Flow Rate 0.89 0.125 0.438 0.65 1.23 0.86 0.136 0.382 0.60 1.24
Note: Bold Biomarker indicates selection. Multiple imputation logistic regression used taking account of the survey design of NHANES with 15 strata, 31
Primary Sampling Units (PSU).
doi:10.1371/journal.pone.0148195.t003
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data set of observations including missing values, took account of the complex survey data of
NHANES and the test for goodness of fit was not significant (F(9,8) = 2.05, p = 0.163) indicat-
ing that the model provided a good fit to the data (76). In addition, the odds ratios and p-values
were consistent with the final model in Table 5.
In Table 5, three of the four biomarkers remained significant predictors of depression at the
95% level (p<0.05) after controlling for the potential confounders: red cell distribution width,
serum glucose and total bilirubin. Significant interactions were found between bilirubin and
the Mexican American / Hispanic group compared to the Non-Hispanic White group, and
those who were current smokers compared to those who have never smoked.
Blood cadmium was not found to be significant in the final model (p = 0.180). However, sig-
nificant interactions (p<0.05) were found between blood cadmium and the 45–54 age group
when compared to the younger 18–34 age group, and the diabetic group when compared to the
non-diabetic group.
Discussion
The novel proposed hybrid methodology of fusing data mining techniques using a boosted
regression machine learning algorithm with traditional statistical techniques offers an inte-
grated approach to variable selection from a large number of features for large epidemiological
studies. The methodology uses a systematic stepped approach that can be applied to large epi-
demiological population-based studies using complex survey designs.
The methodology ensures that missing data are quantified and addressed using multiple
imputation techniques which are appropriate even when the data is not missing at random;
however, should multiple imputation not be required, then the methodology is still appropriate
using only the original data set. The boosted regression ensures that variable importance is reli-
ably measured taking into account observations that are difficult to predict while at the same
time shrinking the effects of these difficult observations in order to avoid over-fitting. This
method ensures that multicollinearity does not obscure the influence of important predictors,
giving all variables a chance to shine, while taking into account any non-linearity or interaction
effects.
An inclusive choice of cut-off values ensures that the regression boosting only reduces the
number of predictors from 67 to 21. However, this is enough to remove the multicollinearity
problem and to allow a conventional logistic regression analysis that takes account of the com-
plex survey sampling design to be employed in order to further reduce the number of
























1.159 0.079 0.057 0.995 1.350 1.161 0.080 0.063 0.990 1.362
Blood cadmium (nmol/
L)
1.060 0.017 0.020 1.015 1.107 1.060 0.017 0.017 1.016 1.106
Glucose, serum (mg/dL) 1.005 0.002 0.066 1.000 1.009 1.005 0.002 0.051 1.000 1.010
Total bilirubin (mg/dL) 0.241 0.112 0.016 0.082 0.703 0.315 0.143 0.034 0.111 0.895
Constant 0.017 0.014 0.001 0.002 0.116 0.012 0.011 0.001 0.002 0.094
Note: Multiple imputation logistic regression using subpopulation based on a random split of approximately 50:50 train:validation (n = 2,590 train:
n = 2,637 validation).
doi:10.1371/journal.pone.0148195.t004
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Table 5. Final Multivariate Logistic Regression.
Odds Ratio Std. Err. p-value 95% CI Low 95% CI High
Biomarkers
Red cell distribution width 1.145 0.067 0.037 1.009 1.298
Blood cadmium (nmol/L) 1.024 0.018 0.182 0.987 1.063
Glucose, serum (mg/dL) 1.005 0.002 0.009 1.001 1.008
Total bilirubin (mg/dL) 0.116 0.049 <0.001 0.047 0.284
Gender
Male (Reference) 1.000
Female 1.610 0.312 0.027 1.064 2.439
Age group (years)
18–34 (Reference) 1.000
35–44 1.287 0.346 0.364 0.724 2.288
45–54 1.993 0.419 0.005 1.271 3.124
55–64 1.475 0.398 0.171 0.828 2.627
65+ 0.660 0.421 0.525 0.169 2.585
Race
Non-Hispanic White (Reference) 1.000
Mexican Amer/Hispanic 0.409 0.150 0.029 0.186 0.898
Non-Hispanic Black 0.842 0.391 0.718 0.312 2.278
Other 1.552 1.527 0.662 0.189 12.743
Smoking
Never smoked (Reference) 1.000
Current smoker 0.382 0.162 0.039 0.154 0.946
Former smoker 0.506 0.326 0.308 0.127 2.013
Food Security
Food insecurity (Reference) 1.000
Full food security 0.492 0.093 0.002 0.328 0.737
Poverty Income Ratio (PIR) 0.787 0.058 0.006 0.671 0.923
BMI Category
Normal (Reference) 1.000
Underweight 2.497 1.630 0.182 0.617 10.101
Overweight 0.864 0.177 0.486 0.557 1.339
Obese 1.007 0.194 0.973 0.666 1.521
Inactivity
Active (Reference) 1.000
Inactive 1.104 0.135 0.431 0.850 1.433
Alcohol consumption per month 1.008 0.014 0.601 0.978 1.038
Diabetes
No (Reference) 1.000
Yes 0.798 0.210 0.407 0.454 1.403
Central Nervous System Meds
No (Reference) 1.000
Yes 2.279 0.292 <0.001 1.732 2.999
Psychotherapeutic Agents
No (Reference) 1.000
Yes 2.912 0.433 <0.001 2.118 4.002
Interactions:
Age Group by Blood cadmium
(Continued)
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predictors from 21 to 4. Interestingly no biomarker interaction or polynomial terms were
found to be significant in the final multivariate logistic regression model making this a particu-
larly simple model which was also found to be robust in relation to important possible con-
founder variables. Three of the four important biomarkers remained significant to the 95%
level despite the inclusion of several confounder covariates and several important biomarker
interaction effects with these covariates.
The flexibility of the methodology is exemplified by its ability to take account of any sam-
pling methodology used for an epidemiological study (i.e. simple random samples through to
multi-staged complex survey sampling). This was demonstrated using the well-known
NHANES data set which used a complex four-staged sampling design encompassing clustered,
stratified and weighted data. There are currently no available stepwise or regularized regression
procedures which can be applied with complex sample designs making variable selection
impossible when there are initially 67 often highly correlated predictors. The boosted regres-
sion overcomes this problem by reducing the number of predictors to 21 and ensuring that
these predictors are not highly correlated, allowing the complex survey based logistic regression
model to be used to manually select the final three predictor variables.
Validation
There are a number of approaches for assessing models in data mining. This methodology
employs the criteria of validity, reliability, parsimony and usefulness to evaluate the effective-
ness of the proposed method.
A simulation was initially used to evaluate the effectiveness of the boosted regression and
importance percentage metric over a traditional backward stepwise variable selection method
to test the impact of a highly correlated predictor in the model such as the case with the
Table 5. (Continued)
Odds Ratio Std. Err. p-value 95% CI Low 95% CI High
18–34 (Reference) 1.000
35–44 0.974 0.024 0.308 0.924 1.027
45–54 0.950 0.019 0.025 0.910 0.993
55–64 0.946 0.029 0.088 0.887 1.009
65+ 0.966 0.062 0.606 0.842 1.110
Diabetes by Blood cadmium
No (Reference) 1.000
Yes 1.115 0.049 0.025 1.016 1.225
Race by Bilirubin
Non-Hispanic White (Reference) 1.000
Mexican Amer/Hispanic 3.946 1.988 0.016 1.342 11.603
Non-Hispanic Black 1.715 1.333 0.499 0.325 9.050
Other 0.484 0.628 0.585 0.030 7.777
Smoking by Bilirubin
Never smoked (Reference) 1.000
Current smoker 9.131 4.193 <0.001 3.418 24.398
Former smoker 2.676 2.396 0.290 0.394 18.187
Constant 0.040 0.030 0.001 0.008 0.200
Note: Multiple imputation logistic regression taking account of the complex survey design of NHANES with 15 strata, 31 PSUs. (n = 3,326).
doi:10.1371/journal.pone.0148195.t005
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biomarker data in this study. A simple random sample of the same size as the original
NHANES data was generated (n = 5,227) for six potential predictors. The correlation for two
predictors was set to 0.8 to indicate multicollinearity, with the remaining correlations emulated
correlations found in the NHANES biomarker data. Two simulations were generated: one with
the same betas for all predictors; the other with varying betas. In both simulations the stepwise
regression failed to drop one of the two highly correlated predictors, indicating possible estima-
tion instability and structural misspecification [62]. In contrast, the boosted regression down-
graded the importance of one of the two highly collinear predictors and produced importance
rankings that reflected the beta values used for the other variables. This validates the use of
boosted regression for variable selection over stepwise regression.
To further assess the validity of using boosted regression, a lasso regression was used as a
comparative machine learning technique for variable selection [63, 64]. This method is similar
to boosted regression in terms of its ability to handle a large number of predictors. Using a
L1-norm penalty for shrinkage in order to prevent the problem of overfitting, the lasso regres-
sion algorithm was employed in the R statistical software using the glmnet package [65]. Con-
sistent with the boosted regression step, the algorithm was performed on the original data and
20 imputed data sets and included cross-validation on 60:40 train:test data. The lasso regres-
sion validated the results of the boosted regression analysis but provided a much less parsimo-
nious solution and it was more difficult to combine the variable selection results across the
imputed data sets. Results from the lasso analysis contained non-zero coefficients only for the
selected variables, making the number of selections a suitable variable importance measure for
each variable. Two of the final three biomarkers from the proposed methodology were chosen
by the lasso regression in at least 20 of the 21 data sets, and the other was in 16 of the 21 data
sets (Table 6). However, for the lasso regression the number of selected variables varied
between 18 and 34 for these 21 data sets, with an average of 25 variables selected, making the
lasso regression much less parsimonious than the boosted regression method.
Running a multiple regression directly on the 21 variables selected from the boosted regres-
sion on the training and validation data sets, without first using univariate regressions to reduce
Table 6. Top 15 biomarkers selected from lasso regression.
Biomarker Frequency
Blood cadmium (nmol/L) 21
Blood urea nitrogen (mg/dL) 21
Glucose, serum (mg/dL) 21
Blood lead (ug/dL) 20
Cotinine (ng/mL) 20
Total bilirubin (mg/dL) 20
Mercury, total (ug/L) 20
Platelet count (1000 cells/uL) 19
Mercury, inorganic (ug/L) 18
Globulin (g/dL) 18
Red blood cell count (million cells/uL) 17
Red cell distribution width (%) 16
Albumin (g/dL) 16
Phosphorus (mg/dL) 16
Direct HDL-Cholesterol (mg/dL) 15
Note: Bold represents the ﬁnal 3 biomarkers selected from proposed methodology.
doi:10.1371/journal.pone.0148195.t006
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the number of variables further, produced some unstable results across the training and valida-
tion data sets. The odds ratio for Haemoglobin differed drastically between the two models
which was consistent with haemoglobin having singularity with haematocrit (r = 0.968) [66]. In
addition, predictor significance was inconsistent: total bilirubin was the only significant predictor
in the training model and no predictors were significant in the validation model. Finally, the mul-
tiple regression models did not highlight mediation effects as significant univariate relationships
with the outcome were hidden when all predictors were included in the multivariate models.
Results are considered reliable if the same variables are selected regardless of the data supplied.
At step 3 this methodology employs the robust data mining technique of randomly splitting the
data into testing and validation data sets at multiple stages of the traditional statistical regression
to ensure the variables selected and significance are reliable. In addition, at step 2, validation was
performed for each run during the boosted regression by randomly splitting each data set into
training and validation sets to make sure that boosting iterations were employed only when
improved prediction accuracy was achieved with the validation data set. Usefulness relates to
evaluating if the model provides useful information. This hybrid methodology identified three
biomarkers associated with depression from an initial set of 67 in the NHANES data set: red cell
distribution width, serum glucose, and total bilirubin. The direction of the relationship between
depression and the final three biomarkers are broadly concordant with current literature.
Red cell distribution width is a marker of the variability in size of red blood cells or erythro-
cytes and used for differential diagnosis of anaemia, especially iron deficiency anaemia. This
biomarker has been found as a predictor of mortality in the general population [67] and other
conditions such as cardiovascular complications [68], Alzheimer’s disease [69] and diabetes
[70]. In addition, this biomarker has been investigated as a substitute marker for inflammatory
conditions such as inflammatory cancers [71, 72]. Many previous studies have reported the
association between inflammatory markers and depression [73, 74], with depression found to
be comorbid with both diabetes [25, 75] and cardiovascular diseases [76, 77].
Fasting plasma or serum glucose tests are used to screen for and diagnose diabetes and pre-
diabetes and to monitor for hyperglycaemia or hypoglycaemia. Diabetes is often comorbid
with major depression [78, 79], but has a complex bidirectional relationship [75]. An associa-
tion between depression and glucose utilisation dysfunction has been documented [80].
Bilirubin has been reported to be an antioxidant [81, 82]. Depression has been found to be
associated with oxidative stress [83] and mild to moderately elevated serum bilirubin levels are
associated with better outcome in diseases involving oxidative stress [82]. The significant inter-
action found between bilirubin and smoking status is consistent with previous research indicat-
ing that smoking is associated with decreased serum bilirubin concentrations [84, 85].
Hemoglobin was found to be fully mediated by total bilirubin. Red blood cells are continu-
ously being broken down, with hemoglobin splitting into globin (protein), iron and heme. The
heme initially breaks apart into biliverdin which is reduced to bilirubin. Cotinine was found to
be fully mediated by blood cadmium.
Strengths and Limitations
The strength of this hybrid methodology over other variable selection methods is the potential
to adequately handle missing data and complex survey samples using a sound and systematic
multi-stepped approach to variable selection. The application of the data mining knowledge
discovery process to large epidemiological studies allows researchers to include a large array of
data (i.e. variables and observations) to be investigated to generate hypotheses that may have
been otherwise overlooked. This is probably true for this NHANES study, particularly in regard
to the total bilirubin finding.
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The data mining method of splitting data files into training and validation minimises issues
of overfitting that is often problematic in traditional statistical techniques with a large number
of predictors. The boosted machine learning technique can accommodate different types of
variables and has been found to have high predictive accuracy, with shrinkage also used to
avoid over-fitting. The iterative learning nature of the algorithm provides researchers with rea-
sonable confidence in the results with its boosted handling of residuals at each iteration. The
relative importance measure produced by this technique has been demonstrated to be more
effective than the traditional coefficient measures produced by lasso regularized regression and
stepwise regression.
A limitation of the methodology is the potential computing power required to perform the
machine learning techniques when implementing a small shrinkage parameter. In addition,
this study implemented the recommended bagging and number of iterations for the machine
learning boosted regression algorithm, but it may be appropriate in the future to run the algo-
rithm on a number of different bagging percentages and number of iterations.
A limitation of this methodology is the complexity of the implementing a multi-stepped
variable selection approach compared to a simpler single-stepped variable selection approach.
However, unlike simpler single-stepped variable selection procedures such as stepwise regres-
sion and regularized regression this multi-stepped method can accommodate missing data
using multiple imputation combined with complex survey designs.
The NHANES study used in the example for this hybrid methodology is a large cross-sec-
tional study that contains both missing data and utilises a complex four-stage sampling meth-
odology. The limitations of this type of data restrict the ability to infer the direction of the
relationship between the key biomarkers and depression. The self-report instrument of depres-
sion, the PHQ-9, may have missed less severe cases of depression [19, 21]. It is also recognised
that the imbalance of depressive symptoms in the data set may have resulted in a prediction
bias towards the major classes [86].
Conclusion
An amalgamation of data mining techniques using a machine learning algorithm with tradi-
tional statistical techniques provided an effective systematic approach to variable selection in a
large epidemiological study, detecting three biomarkers associated with depression for future
hypothesis generation: red cell distribution width, serum glucose and total bilirubin. The use of
this novel methodology yielded results concordant with previous research, taking account of
the missing data and complex survey design of NHANES. This methodology highlights the
effectiveness of implementing a hybrid of big data and small sample techniques for variable
and potential hypothesis generation.
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Depression is commonly comorbid with many other somatic diseases and symptoms. Identi-
fication of individuals in clusters with comorbid symptoms may reveal new pathophysiologi-
cal mechanisms and treatment targets. The aim of this research was to combine machine-
learning (ML) algorithms with traditional regression techniques by utilising self-reported
medical symptoms to identify and describe clusters of individuals with increased rates of
depression from a large cross-sectional community based population epidemiological
study.
Methods
A multi-staged methodology utilising ML and traditional statistical techniques was performed
using the community based population National Health and Nutrition Examination Study
(2009–2010) (N = 3,922). A Self-organised Mapping (SOM) ML algorithm, combined with
hierarchical clustering, was performed to create participant clusters based on 68 medical
symptoms. Binary logistic regression, controlling for sociodemographic confounders, was
used to then identify the key clusters of participants with higher levels of depression (PHQ-
910, n = 377). Finally, a Multiple Additive Regression Tree boosted ML algorithm was run
to identify the important medical symptoms for each key cluster within 17 broad categories:
heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain,
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blood pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels
and urinary.
Results
Five clusters of participants, based on medical symptoms, were identified to have signifi-
cantly increased rates of depression compared to the cluster with the lowest rate: odds
ratios ranged from 2.24 (95% CI 1.56, 3.24) to 6.33 (95% CI 1.67, 24.02). The ML boosted
regression algorithm identified three key medical condition categories as being significantly
more common in these clusters: bowel, pain and urinary symptoms. Bowel-related symp-
toms was found to dominate the relative importance of symptoms within the five key
clusters.
Conclusion
This methodology shows promise for the identification of conditions in general populations
and supports the current focus on the potential importance of bowel symptoms and the gut
in mental health research.
Introduction
Depression is a debilitating illness that is estimated to affect 350 million people globally and is
frequently associated with somatic symptoms and other medical conditions [1,2]. The nature
and direction of these relationships are often complex, interrelated, and difficult to unravel.
Depression classically presents with many and diverse somatic symptoms. The comorbidity of
depression with a number of chronic medical conditions, such as Irritable Bowel Syndrome
(IBS) [3], ischemic heart disease [4], cancer [5], diabetes [6], osteoporosis [7], thyroid disease
[8], and obesity [9], has also been well established. However, these conditions often have bidi-
rectional relationships with depression such that this level of comorbidity and interrelatedness
can complicate treatment and stymie efforts to identify causal factors in depression. Thus, the
identification of individuals in clusters of comorbid symptoms in depression may reveal new
pathophysiological mechanisms and treatment targets.
Due to the complexity and heterogeneity of medical data, previous studies have primarily
investigated individual medical conditions linked to depression. The use of “big data” and
machine-learning (ML) techniques and algorithms has the ability to handle heterogeneous
data without strict constraints and have been demonstrated to unearth key patterns and inter-
actions in health data [10,11]. The mapping of multidimensional data onto two-dimensional
maps [12–14] with ML techniques allows the researcher to visualise and interpret the complex-
ity of the data and generate new hypotheses regarding depression.
ML is a vast and expanding field of artificial learning where algorithms improve perfor-
mance through experiential learning [15]. In the health arena, ML algorithms that learn by
training on subsets of data have been used to fit models using supervised ML (i.e. where the
objective of the exercise is to establish the main inputs to predict known values) [16], and to
find patterns in data using unsupervised ML (i.e. where the objective is to uncover previously
unknown patterns and clusters within the data set, without any a priori model defined) [17].
Blending of unsupervised and supervised ML techniques has been used to detect patterns and
relationships within large numbers of complex lifestyle-environ variables [18]. Notoriously
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complex in nature, medical symptom data are ideally suited to blended ML techniques. Utilis-
ing the learning properties of ML it is possible to detect, visualize and understand the composi-
tion of medical symptoms clusters for those with psychiatric disorders such as depression.
[19,20]
ML techniques have been used across a variety of disciplines to explore and model very
large quantities of data to discover patterns, unsuspected relationships and useful rules for a
specific purpose. Often novel unsuspected and novel interpretations of the data (serendipity)
are uncovered. Commercially, these techniques have been used successfully for businesses to
learn from their transaction data about the behaviour of their customers, improving their busi-
ness model by exploiting this knowledge [21]. However, it has only been over the last 10 years
that ML techniques have been used in medical research, primarily in neuroscience and bio-
medicine [22,23]. More recently ML techniques have been used in psychiatry [10], using pre-
dominantly very big data sets. Complex survey methodologies are often implemented with
population-based data (e.g. oversampling in underrepresented groups, stratification, cluster-
ing) and traditional statistical techniques are capable of dealing with this complexity [24].
However, big data techniques on their own do not adequately account for this type of sample.
Thus, a blend of both big data ML techniques with traditional statistical techniques has the
potential to uncover hidden patterns while accounting for the complex sampling.
The aim of this research was to use data from a large cross-sectional community based pop-
ulation epidemiological study to combine unsupervised and supervised ML algorithms with
traditional regression techniques by utilising self-reported medical symptoms to identify and
describe clusters of individuals with increased rates of depression from a large cross-sectional
community based population epidemiological study.
Methods
Study design and participants
The 2009–2010 National Health and Nutrition Examination Survey (NHANES) (2009–2010)
[25] cross-sectional civilian noninstitutionalized population based data were utilised for this
study. This study included 18 to 80 year old non-institutionalised US civilians (N10,000)
and applied a complex four-stage sampling methodology: counties; segments within counties;
households within segments; and, individuals within households. Data were collected from 15
locations across 50 US states, with oversampling of subgroups of the population of particular
public health interest, to increase the reliability and precision of population estimates [25]. Ques-
tionnaire data relating to medical symptoms and demographics were downloaded from the
NHANES website and integrated using the Data Integration Protocol In Ten Steps (DIPIT) [26].
Variables were initially selected based on the criterion of relevance to medical symptoms.
Analysis was performed to minimise the degree of missing data across the set of medical symp-
toms. The final set of 68 dichotomous medical symptom variables and an unweighted sample
size of 3,922 was used for clustering in this research study. There were 377 participants identi-
fied with depression, being representative of the total depressed sample for NHANES during
2009–2010 (i.e. 8% after adjustment for the complex survey sample structure). The imbalanced
nature of the data was addressed in this study by identifying clusters with high rates of depres-
sion (i.e. high risk clusters) rather than individual participants with depression. This meant
that within each high risk cluster the imbalance was much reduced. This was the primary ratio-
nale for undertaking the Self-organised Mapping (SOM) and clustering of individuals, thereby
allowing the identification of the key clusters significantly associated with depression using
binary logistic regression. Finally, the most important medical symptoms for identifying
depressed individuals were identified for each of these key clusters.
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NHANES received approval from the National Center for Health Statistics (NCHS)
research ethics review board and informed consent was obtained from all participants. Use of
data from the NHANES 2009–2010 database is approved by the National Center for Health
Statistics Research Ethics Review Board (Continuation of Protocol #2005–06).
Study Measurements
A self-reported Patient Health Questonnaire-9 (PHQ-9) [27] was used to assess depressive
symptoms (‘depression’). This questionnaire consisted of nine items that were summed to
form a total score. Those with a total score of 10 or more were considered moderately or
severely depressed [28]. The 68 medical symptom data were classified into 17 broad medical
categories: heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, pain
(i.e. neck, back, hip pain), blood pressure, cholesterol, vision, hearing, psoriasis, weight, bow-
els, urine, and if a blood transfusion was received. The self-report demographic and socio-eco-
nomic variables from the NHANES demographic and questionnaire data components were
also utilised [29].
Statistical Methodology
This research implemented two ML algorithms: an unsupervised algorithm, combined with
hierarchical clustering, to create the medical symptom clusters and a supervised algorithm to
identify and describe the key clusters with a significant relationship with depression. Due to
the complex sampling methodology of the NHANES data, traditional binary logistic regression
was implemented to identify these key clusters while controlling for potential socio-demo-
graphic confounders.
A summary of the statistical methodology, testing regime and results is outlined in Fig 1.
Medical symptom cluster identification
Self-organizing maps (SOMs) were introduced by Kohonen in 1995 [30] as a variant of artifi-
cial neural networking, inspired by biological neural networks, and have since been used in
many diverse applications across a variety of fields including bioinformatics, engineering,
financial analysis, experimental physics, and psychiatry [31,32]. SOMs provide a simple and
effective unsupervised ML algorithm for clustering individual participants and visualising high
dimensional data in a low dimensional map without any reliance on distributional
assumptions.
The SOM identifies clusters by effectively packing the dataset onto a q-dimensional plane
where data points “similar” to each other in the original multidimensional data space are then
mapped onto nearby areas of the q-dimensional output space. SOMs combine competitive
learning with dimensionality reduction by smoothing the clusters with respect to an apriori
grid. The SOM is called a topology-preserving map because multi-dimensional input data is
represented often by a two dimensional “map” of nodes where topological properties of the
input space are maintained.
The steps involved in the SOM competitive ML algorithm involve initially assigning ran-
dom vector weights to each node (or position on the grid), then randomly choosing data
points (participants) from the training data and presenting them to the SOM. The “Best
Matching Unit” (BMU) in the map is the node with a vector weight most similar to a data
point and nodes within the “neighbourhood” of each BMU are found. With each iteration, the
size of this neighbourhood decreases. The vector weights of nodes in the BMU neighbourhood
are adjusted closer to their associated data points. The size of these adjustments decrease with
each iteration and the magnitude of these adjustments is proportional to the proximity of the
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Fig 1. Flowchart of Methods, Testing and Results.
doi:10.1371/journal.pone.0167055.g001
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node to the BMU. These steps are repeated for N iterations or until the vector weights for all
the nodes converge to their final values.
For this study a hexagonal map topology was used, with five SOM grids tested (10x10,
15x15, 20x20, 25x25, 30x30) to establish a map with suitable nodes. The final solution utilised
a 15x15 grid with a learning rate for weight adjustment declining linearly from 5% to 1% over
100 iterations. The unconstrained nature of the SOM technique meant that clusters of nodes
form naturally from the medical symptom data on the grid without the influence of the partici-
pant’s depressive symptom status. Hierarchical clustering, using the complete linkage method
[33], was then utilised to group SOM nodes with similar final weights, identifying the final
clusters. Three to 12 cluster solutions were considered and the cluster solution with the most
differentiation in terms of depression was chosen for further investigation. The clusters were
numbered in order of their rates of depression (i.e. frequency and average total PHQ-9 score).
Identification of key clusters with higher depression rates
Quantitative and qualitative investigation, using exploratory statistics of the resultant clusters
was used to establish variation with respect to depression rates and demographics.
Demographic factors were included in a binary logistic regression model to identify the key
participant clusters with a significant positive relationship with depression, accounting for the
complex survey design of NHANES. This model controlled for potential confounders and
quantified the probability of depression within each cluster. The cluster with the lowest depres-
sion rate was chosen as the reference group. This stage of the analysis was used to identify par-
ticipant clusters with significant rates of depression in order to identify the important medical
symptoms from the ML boosted regression. Only these key clusters were used in the next stage
of supervised ML boosted regression. No further investigation was performed on those clusters
with non-significant odds ratios for depression.
Medical symptoms most prominent within key clusters
Supervised ML boosted regression [34], translated to a binary logistic regression analysis [35],
was implemented for each of the key clusters to identify the most prominent medical symp-
toms associated with depression within these clusters. This technique has been previously used
to identify biomarkers associated with depression [36] and to describe lifestyle clusters associ-
ated with depression [18] using data from the NHANES study. Depression was considered as a
binary outcome and run for each key cluster using Friedman’s Multiple Additive Regression
Trees (MART) boosted algorithm [37,38]. Consistent with previous research using this ML
algorithm on the 2009 to 2010 NHANES data [36], validation was performed using a random
split of each data set into 60% training and 40% validation, a regularization shrinkage parame-
ter of 0.001, with 50% of the residuals used to fit each successive tree (50% bagging) [37]. The
maximum number of boosting interactions (i.e. number of terminal nodes plus 1) allowed was
six, being marginally higher than the default (i.e. five) and within the recommended range
[35]. Whilst this technique has been used for predictive purposes [16], it also has the ability to
be used as a variable selection method [36]. This method was used as a variable selection tech-
nique to identify the prominent medical symptoms associated with depression within the key
clusters [37]. A relative importance (or contribution) of each medical symptom variable for
each of the key significant clusters was produced from the ML boosted regression. Higher val-
ues of relative importance for a medical symptom within a particular key cluster indicates a
stronger relationships with depression in this cluster. This technique for variable reduction has
been recognised as effective [39] and previously used to delineate lifestyle clusters associated
with depression [18].
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Those medical symptoms explaining at least 80% of the total log likelihood variation across
clusters were used to identify the most important medical symptoms for explaining differences
across clusters. Resultant medical symptoms were then grouped into the 17 broad medical
categories.
The SOMs and hierarchical clustering were performed in R with the SOM using the Koho-
nen package [13]. The boosted regression and binary logistic regression statistical procedures
were performed using Stata V14 software (StataCorp., 2014), with a Stata plugin for the
boosted regression component of the analysis [38].
Results
A summary of the results from the testing is presented in Fig 1.
SOM Clusters
The distance from each node’s weights to the sample of people represented by that node was
reduced to a minimum plateau as the SOM training iterations progressed, indicating that no
more iterations were required (Fig 2). Taking into account the heterogeneous nature of the
Fig 2. Training progress and SOM plots. Note: The “Training progress” graph indicates as the SOM training iterations distance from each
node’s weights to the samples represented by that node reduces and plateaus to indicate no more iterations were required. The “Counts plots”
indicates reasonable samples were mapped to each node on the map. The “Neighbour distance plot” or U-Matrix indicates the distance between
each node and its neighbours.
doi:10.1371/journal.pone.0167055.g002
Fig 3. Hierarchical Cluster Options for SOM. Note: Clusters 3 to 12 solutions mapped onto the SOM grid. Colours indicate
different clusters. The final 10 cluster solution selected for further analysis has been highlighted with a red border.
doi:10.1371/journal.pone.0167055.g003
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self-reported medical symptom data, the counts plot indicated a reasonable distribution of
people numbers across the map. The neighbour distance plot indicated the distances between
each node and its neighbours were mostly similar with only a few dissimilar nodes, later identi-
fied as outlying clusters (Fig 2).
Three to 12 cluster solutions were considered (Fig 3) and the 10 cluster solution was
selected for further investigation because of clear cluster differences in terms of depression
rates. There were some isolated nodes in this cluster solution, later confirmed as outliers.
The final 10 cluster solution contained two dominant clusters (Table 1). One cluster was
dropped from further analysis due to very low frequency (n = 8), leaving 9 of the 10 clusters
for further analysis.
Cluster validation
Initial investigation into the relationship between the remaining nine participant clusters and the
depression measures revealed that the clusters exhibited an order with respect to both the percent-
age of participants depressed within each cluster and the average depression score (Fig 4).
An initial inspection of the socio-demographics for the nine clusters (Table 2) showed clear
differences. Due to the small frequencies for many of the clusters, only a qualitative investiga-
tion of socio-demographic differences was performed. Cluster 1 (n = 3,108) exhibited socio-
demographics closest to the total across all cluster participants. Cluster 2 (n = 34) consisted of
mostly male, non-Hispanic white with a high family income poverty ratio [40,41] and who
were less likely to have never married. Cluster 3 (n = 57) consisted mostly of male, non-His-
panic white, older, married / with a partner, a household size of around two people, and a low
family income poverty ratio. Cluster 4 (n = 446) members were more likely to be female, non-
Hispanic white, middle aged, with a low family income poverty ratio, and less likely to have
never been married. Cluster 5 (n = 50) were more likely to be older, non-Hispanic black, with
a low family income poverty ratio, and less likely to never have been married. Cluster 6
(n = 83) members were more likely to be male, older, less than three members in the house-
hold, non-Hispanic white, and of low to mid family income poverty ratio, and less likely to
have never been married. Cluster 7 (n = 55) were more likely to be middle aged, Mexican /
Hispanic, with a low family income poverty ratio and less likely to have never been married.
Cluster 8 (n = 52) were more likely to be female, older, non-Hispanic white, around two mem-
bers in the household, with low family income poverty ratio and less likely to have been











10 (Dropped) 8 0.2
Total 3,922 100
Note: Dominant clusters in bold. Cluster shaded dropped due to very small base (n = 8).
doi:10.1371/journal.pone.0167055.t001
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married. Cluster 9 (n = 29) were more likely to be young Mexican / Hispanic, with a large
household and low family income poverty ratio.
Identification of key clusters with higher depression rates
The final binary logistic regression with depression as the outcome took into account the com-
plex survey data of NHANES, as well as non-linearity, interactions and potential confounders
(Table 3). The test for goodness of fit were not significant for the model indicating a good fit to
the data (F(9,8) = 1.77, p = 0.216) [42]. Clusters 4 and 6 to 9 had significantly higher rates of
depression than cluster 1 after controlling for the potential socio-demographic confounders.
These five clusters were considered the key clusters for further analysis. Since the odds ratios
for depression for clusters 2, 3 did not significantly differ from cluster 1 these clusters were
excluded from future analysis. A significant interaction was found between the cluster with the
highest rate of depression (cluster 9) and the family income poverty ratio (p = 0.036) (Fig 5).
Thus, the relationship between the probability of depression and cluster 9 varied depending
upon the rate of the family poverty income ratio.
Fig 4. Mean depression scores and percent depression across final depression clusters. Note: “Mean Depression Score” is the average total PHQ-
9 score which ranged from 0 to 27. “Percent Depressed” based on a total PHQ-9 10.
doi:10.1371/journal.pone.0167055.g004
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Medical symptoms most prominent within key clusters
ML boosted regression was used to establish which medical symptoms were associated with
depression for each of the five key significant clusters. The top medical symptom variables
explaining approximately 80% of the total log likelihood for each cluster were selected for cate-
gorisation and further investigation. Bowel symptoms (e.g. bowel movements per week, stool
type) dominated the relative importance percentage across all the five key clusters (Fig 6). Fur-
ther investigation into the top 3 to 10 ranked medical categories from the ML boosted regres-
sion found that bowel, pain and urine symptoms consistently exhibiting a relatively high
importance percentage for each of the key clusters.
The top 10 key medical symptom categories for the five key significant clusters indicated
that each cluster exhibited different medical symptoms (Fig 7). However, bowel symptoms
were consistently included in the highest ranked medical symptoms across all five significant
depressive key clusters. In addition, the bowel symptoms dominated for cluster 7 and cluster 9,
and had relatively high importance (i.e. >5%) for four of the five key clusters. Pain symptoms
had the highest relative importance in cluster 4 and urine symptoms had relatively high impor-
tance (i.e. <10%) for two of the five key clusters. Whilst hearing symptoms were important in
all five of the key clusters, they only dominated in cluster 8.
Table 2. Demographic Profile Across SOM Clusters.
CLUSTER Total 1 2 3 4 5 6 7 8 9
Sample (n)* 3,914 3,108 34 57 446 50 83 55 52 29
Demographics
Gender:
Male 49.6% 50.8% 60.4% 60.2% 38.9% 43.1% 63.9% 41.2% 31.2% 57.4%
Female 50.4% 49.2% 39.6% 39.8% 61.1% 56.9% 36.1% 58.8% 68.8% 42.6%
Mean age (years) 42.44 42.08 48.17 53.05 46.09 51.60 56.24 44.30 55.93 38.67
Marital status:
Never 19.3% 20.4% 15.0% 11.6% 15.8% 14.6% 7.8% 14.7% 7.6% 19.6%
Married/Partner 65.3% 65.5% 66.4% 76.6% 64.7% 65.2% 63.9% 66.8% 48.9% 63.6%
Widowed/Divorced/Separated 15.4% 14.1% 18.6% 11.8% 19.6% 20.3% 28.4% 18.6% 43.5% 16.8%
Mean household size 3.22 3.23 3.19 2.23 3.07 2.95 2.64 3.26 2.55 3.94
Mean family size 3.02 3.03 3.07 2.94 2.91 2.75 2.49 2.94 2.39 3.88
Race:
Mexican/Hispanic 14.3% 14.4% 6.0% 17.3% 15.3% 13.3% 5.6% 27.0% 2.6% 45.5%
Non-Hispanic white 67.5% 67.6% 78.4% 66.3% 67.3% 54.0% 74.2% 55.4% 81.3% 26.0%
Non-Hispanic black 11.4% 10.9% 15.6% 5.9% 12.8% 27.0% 17.4% 14.6% 10.1% 16.5%
Other 6.7% 7.1% 0.0% 10.4% 4.6% 5.7% 2.8% 2.9% 6.1% 12.0%
Family income poverty ratio**:
Low 31.0% 29.2% 29.9% 39.8% 35.7% 42.6% 32.7% 64.9% 58.9% 68.8%
Middle 24.0% 24.5% 10.5% 19.0% 22.9% 23.4% 31.3% 15.9% 21.5% 11.2%
High 45.0% 46.4% 59.6% 41.2% 41.5% 33.9% 36.0% 19.2% 19.6% 20.0%
Mean family income poverty ratio:
(Note: 1 = poverty line) 3.03 3.16 3.39 2.80 2.89 2.68 2.91 1.82 2.09 1.68
Note: Figures quoted take account of the survey design of NHANES with 15 strata, 31Primary Sampling Units (PSU).
*Total sample size varies per demographic as base includes all those with a depression score and valid answer given for demographic.
**Family income poverty ratio represents the ratio of family or unrelated individual income to their appropriate poverty threshold where groupings are based
on eligibility for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): Low = 0.00–1.85 family income poverty ratio, Middle =
>1.85–3.50 family income poverty ratio, and High = >3.50 and above family income poverty ratio.
doi:10.1371/journal.pone.0167055.t002
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The individual clusters showed clear delineation with respect to medical conditions. The
top three medical symptoms for cluster 4 related to the skeletal symptoms of pain, fractures
and osetoporosis, and bowel symptoms. Cluster 6 was dominated by urinary medical symp-
toms. Cluster 7 was clearly dominated by bowel medical symptoms. Cluster 8 was a generally
Table 3. Binary Logistic Regression Model Odds Ratios with 95% Confidence Intervals.
Depression OR p-value 95% CI Low 95% CI High
Cluster 1 (reference) 1.00
Cluster 2 1.67 0.341 0.55 5.04
Cluster 3 1.98 0.151 0.76 5.20
Cluster 4 2.24 <0.001 1.56 3.24
Cluster 5 2.10 0.180 0.68 6.43
Cluster 6 3.78 <0.001 2.17 6.57
Cluster 7 4.61 <0.001 2.21 9.63
Cluster 8 7.80 0.001 2.86 21.33
Cluster 9 6.33 0.010 1.67 24.02
Cluster 9 X Family income poverty ratio 2.00 0.036 1.05 3.81
Gender
Male (reference) 1.00
Female 1.86 0.002 1.31 2.64
Age group
18–24 years (reference) 1.00
25–34 1.37 0.326 0.71 2.63
35–44 1.61 0.177 0.79 3.29
45–54 1.92 0.023 1.11 3.34
55+ 1.22 0.545 0.62 2.39
Marital status
Never married (reference) 1.00
Married/living with partner 0.54 0.007 0.35 0.82
Widowed/Divorced/Separated 0.79 0.172 0.55 1.12
Gender
Race
Non-Hispanic white (reference) 1.00
Mexican American / Hispanic 0.88 0.368 0.67 1.17
Non-Hispanic Black 1.17 0.436 0.77 1.76
Other 0.77 0.391 0.42 1.43
Education
Grades 11 and below (reference) 1.00
High School / GED Equivalent 0.43 0.039 0.20 0.95
Some College / AA / College or Above 0.59 0.008 0.40 0.85
Family income poverty ratio 0.60 0.002 0.45 0.80
Education X Family income poverty ratio
Grades 11 and below (reference) 1.00
High School / GED Equivalent 1.43 0.073 0.96 2.11
Some College / AA / College or Above 1.24 0.089 0.96 1.58
Constant 0.16 <0.001 0.08 0.34
Note: OR = Odds Ratio, CI = Confidence Interval. Multivariate logistic model taking account of complex
survey methodology (N = 3,584, 15 Strata, 32 PSUs). Bold p-values indicate significant p<005. Cluster 9
OR = 12.67 (95% CI: 1.75, 91.56) taking into account the interaction.
doi:10.1371/journal.pone.0167055.t003
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Fig 5. Predicted probability of depression across age and family income poverty ratio for each cluster.
doi:10.1371/journal.pone.0167055.g005
Fig 6. Importance of medical categories that make up the key significant clusters. Note: Based on total boosted relative importance
percentage across all clusters. Summed percentage from boosted regression across all five key significant clusters, thus total >100%.
doi:10.1371/journal.pone.0167055.g006
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unwell cluster with the top five medical symptoms related to hearing, pain, bowels, respiratory
and heart. Finally the top two medical symptoms for cluster 9 related to bowels and urine.
Discussion
Irrespective of country, research has consistently found a high level of comorbidity between
specific (e.g. sleep, appetite) and nonspecific symptoms and depression [43,44] but it has been
difficult to identify the key somatic symptoms most prominent in this condition. This study
utilized two machine learning techniques, complemented by traditional binary logistic regres-
sion analyses, to detect complex interactions between large numbers of medical symptoms in
order to identify those most strongly linked to depression in an atheoretical manner. ML tech-
niques have been used in the area of big data informatics in mental health. For example, text
analysis [45] and regression models [46] have been used to predict the risk of suicide from
clinical notes, but these techniques have not previously been used to investigate the relation-
ship between depression and medical symptoms using epidemiological community based pop-
ulation data. The visual simplification of complex medical symptom data into clusters, using
SOM, allows the researcher to easily identify the strength of the similarities across the map.
The ML SOM’s intention to mimic an artificial network that learns, without supervision, has
proven effective in creating nodes, subsequently grouped into clusters identified by a standard
hierarchical clustering. Nine clusters of participants based on medical symptoms were found
using the unsupervised graphical SOM ML technique. Traditional binary logistic regression
showed that five of the nine clusters were characterised by higher rates of depression after con-
trolling for potential confounders and taking account of the complex survey methodology of
the population data.
A boosted regression ML algorithm was used to provide a relative importance percentage
for each medical symptom for each of the five key significant clusters, allowing the easy group-
ing of symptoms into medical categories. The ML boosted regression algorithm was able to
Fig 7. Total percentage importance of medical conditions for each key significant cluster. Note: Clusters presented in order of percent
depressed. Note: Percentage sum does not take account of direction of relationship.
doi:10.1371/journal.pone.0167055.g007
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untangle the array of medical symptoms and detect three key medical condition categories as
being particularly related to depression: bowel, pain and urinary symptoms. Of these catego-
ries, bowel symptoms dominated, validating previous research regarding the high comorbidity
between gut symptoms and IBS with common mental disorders, including depression [3,47].
Gut disorders in particular share links with depression. Irritable bowel syndrome (IBS) [3]
has been found to be closely associated with mental health conditions. IBS is not only comor-
bid with psychiatric conditions, but also comorbid with non-gastrointestinal somatic disorders
[48]. Crohn’s disease [49] and gastro-oesophageal reflux disease (GORD) [50] are similarly
associated with higher rates of mood disorders than would be expected by chance. All these
interrelationships impact on the quality of life, treatment compliance, length of stay in hospi-
tals, costs of health care, morbidity and possibly mortality of individuals affected.
Medical symptoms relating to stool type and frequency and constipation were included in
the bowel categorisation for this study, and these indicators have all been related to mood [51].
Recently, ML boosted regression has identified an association between the gastrointestinal bio-
marker of bilirubin with depression [36] and bilirubin has been linked to varying stool type
based on the speed at which the intestinal contents travel through the bowel [52].
There is an increasing focus in medical research on the role of symbiotic gut microbiota in
health and disease, including mental health. Indeed, the human gut microbiota, and what is
termed the ‘gut-brain axis’, are now increasingly regarded as potentially critical drivers of
mood and behaviour, with much of the biological dysregulation associated with depressive
symptoms and the diagnosis of clinical depression influenced by the gut microbiota [53]. Such
microbiota-influenced dysregulation involves inflammatory, metabolic, oxidative stress, HPA
axis, neurotransmitter/neuropeptide, brain plasticity and other systems [54]. Moreover, the
normal intestinal barrier function is compromised in depression [55]. This ‘leaky gut’ allows
intestinal-microbe-derived lipopolysaccharide (LPS), an endotoxin, to gain access to the
periphery. Even very low levels of LPS can provoke much of the aforementioned biological
dysregulation noted in depression.
Importantly, many of the lifestyle and environmental factors connected to depression have
a detrimental influence on the composition of the normal human microbiota. As just one
example, unhealthy dietary patterns that increase the risk for depression [56] also diminish
microbial diversity [57]. Long-term, habitual diets are one of the strongest influences on gut
microbial composition, determining an individual “enterotype” [58], however dietary change
can prompt change in gut microbiota composition within 24 hours [59]. The consumption of
complex carbohydrates, plant-based foods/fruits and vegetables [58,60] positively influences
microbial composition, synthesis of anti-inflammatory short chain fatty acids, and host health.
Conversely, high fat diets trigger microbial dysbiosis, intestinal permeability (‘leaky gut’) and
inflammation [61]. We have previously demonstrated that healthy dietary patterns are associ-
ated with a reduced likelihood of depressive symptoms in adults participating in the NHANES
[62]. This suggests that unhealthy dietary behaviors may be a key factor negatively influencing
both gut health and depression, with bowel symptoms signifying poor gut health.
Strengths and Limitations
The strengths of this study lie in the benefits of using both unsupervised and supervised ML
techniques to identify patterns in data, using a large number of heterogeneous self-reported
medical symptoms to form five clusters of individuals with relatively high rates of depression,
most likely to have remained hidden using traditional statistical techniques. The largest cluster
of participants (cluster 4, n = 446) comprised 7% moderately and 7% severely depressed partic-
ipants; this compares to rates of 5% and 3% respectively in the general 2009 to 2010 US
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population in NHANES. The remaining key clusters (6 to 9) consisted of smaller groups of
participants, with 15% moderately and 14% severely depressed participants overall. A main
limitation with this study is the cross-sectional nature of the NHANES data that restricts the
ability to infer causality. However, the use of this community population based survey data has
the advantage of being representative of the large US population sampled during 2009 to 2010.
The large number of participants included in this study, with its rigorous complex survey sam-
pling methodology, ensures the data possess a good description of the relative characteristics
of the civilian noninstitutionalised US population. As compared to other methods of data gath-
ering, surveys are able to extract data that closely mirror attributes of the larger population.
It is acknowledged that the PHQ-9 instrument relates to depressive symptoms, and does
not represent a clinical diagnosis of depression. Thus, this self-report instrument may have
missed less severe cases of depression [27,28] exaggerating the imbalance in the data. Further-
more, the depression symptoms picked up by the PHQ-9 instrument for this study, such as
fatigue, psychomotor problems, or insomnia are symptoms very common in medical condi-
tions. Thus, it was not surprising that the results from this study confirmed prior research
identifying depressive symptoms being often elevated in people with medical symptoms [63].
The relationship between medical symptoms and depression is complex and often bidirec-
tional. However, the identification of the dominant medical symptoms, such as those of the
bowel cluster in this study, may be used to improve screening tools for depression in medically
ill patients and to shed light on possible pathogenic processes. It is acknowledged that individ-
uals with depression are more likely to report somatic conditions, and IBS has been found to
be a disorder with a psychosomatic aspect [47]. However, the NHANES study is considered
representative of the US noninstitutionalised civilian population and has been used to produce
health statistics for the US and in many studies investigating depression (e.g. to examine the
prevalence, treatment and control of depressive symptoms [64]).
We addressed the limitation of the imbalance in the data of having only approximately 8%
of the sample classified with depression by including only those clusters with high depression
rates, hence reducing the impact of this imbalance on our analysis.
There are potential limitations in using the proposed ML techniques. The SOM can become
conceptually expensive as the number of variables and the grid size increases, causing the
number of distances the algorithm needs to compute to increase exponentially. In addition,
the SOM requires a value for each variable for each participant in order to generate a map, so
missing data poses issues for map generation with SOMs. Alternative less computer intensive
traditional statistical techniques, such as k-means clustering or latent class analysis, could have
been used. However, the SOM algorithm has been found to provide better results than either
of these methods in the case of large data sets [65–67] such as used in this study.
The ML boosted regression has the advantage of automatically incorporating interaction
effects when evaluating variable importance which is not possible with traditional statistical
regression modelling [37]. Also, variable selection processes, such as stepwise or regularized
regression make variable selection difficult when there are highly correlated predictors as is
the case with medical symptoms. The boosted regression overcomes this problem by reducing
the number of selected variables at each iteration thereby being able to deal with highly corre-
lated variables. However, ML boosted regression can fail to perform well with small data sets
[68]. In addition, the training process can be computationally memory intensive due to the
fact that trees are built sequentially, requiring advanced computing capability such as parallel
processing. In addition, the regularization implemented to reduce the effects of overfitting can
mean the optimal number of iterations for a suitable shrinkage parameter can be considerably
large [69].
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Whilst this study performed validation using a random split of data into 60% training and
40% validation at the ML boosted regression stage, no validation of the methodology was per-
formed on a separate data set using self-reported medical symptom data. However, this meth-
odology has been successfully implemented to identify lifestyle clusters associated with
depression [70].
Conclusion
This study implemented two ML algorithms and a standard binary logistic regression to iden-
tify and describe clusters of individuals with higher rates of depression based on self-reported
medical symptoms in a large, cross-sectional epidemiological community based population
study. Bowel symptoms, covering bowel frequency and stool type, were identified as the pre-
dominant concurrent symptom category for the key clusters with a significant positive rela-
tionship with depression across 17 varied medical symptom categories. This study encourages
the future use of machine learning techniques to compliment traditional statistical approaches
in the analysis of epidemiological studies to assist clinicians detect potential latent associations
that can be further refined and clarified. This study also supports a research focus on the
potential importance of the bowel symptoms, the gut and its resident microbiota in mental
health research.
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CHAPTER EIGHT: PAPER SIX: THE DEVELOPMENT OF A RISK 
INDEX FOR DEPRESSION (RID) 
This chapter presents the submitted work that addresses the primary and secondary aims to: 
 Identify significant and meaningful relationships within and across the determinants of 
depression 
 Develop an appropriate structural equation model framework for the risk index for 
depression 
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While risk factors for depression are increasingly known, there is no widely utilised 
depression risk index. Our objective was to develop a method for a flexible, modular, Risk 
Index for Depression (RID) using structural equation models (SEM) of key determinants, 
identified from published methodologies that blended machine-learning with traditional 
statistical techniques. 
Methods 
Demographic, clinical and laboratory variables from the National Health and Nutrition 
Examination Study (2009–2010,N=5,546) were utilised. Data were split 50:50 into 
training:validation data sets. Generalised structural equation models (GSEM), using logistic 
regression, were developed with a binary outcome depression measure (PHQ-9 score≥10) and 
previously-identified determinants of depression: demographics, lifestyle-environs, diet, 
biomarkers and somatic symptoms. Indicative goodness of fit statistics and Areas Under the 
receiver operator characteristic Curves (AUC) were calculated and probit regression checked 
model consistency. 
Results 
The GSEM model was built from a systematic process. Relative importance of the depression 
determinants were: diet (OR:4.09; 95%CI:2.01,8.35); lifestyle-environs (OR:2.15; 
95%CI:1.57,2.94); somatic symptoms (OR:2.10; 95%CI:1.58,2.80); demographics (OR:1.46; 
95%CI:0.72,2.95); and biomarkers (OR:1.39; 95%CI:1.00,1.93). The relationships between 
demographics and lifestyle-environs and depression indicated a potential indirect path via 
somatic symptoms and biomarkers. The path from diet was direct to depression. The AUCs 
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were good (logistic:training=0.850;validation=0.813; 
probit:training=0.849;validation=0.809). 
Conclusions 
The novel RID modular methodology developed has the flexibility to add/remove 
direct/indirect risk determinants paths to depression using a structural equation model on data 
sets that take account of a wide range of known risks. RID shows promise for future clinical 
use by providing indications of main determinant(s) associated with a patient’s predisposition 
to depression and has the ability to be translated for the development of risk indices for other 
affective disorders 
Key words 
Depression, psychiatry, index, structural equation modelling, machine-learning. 
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With approximately 300 million cases estimated worldwide in 2010 (Ferrari et al., 2013), 
depression is a global health concern and is the second leading cause of years lived with a 
disability (Whiteford et al., 2013). Depression is associated with debilitating symptoms 
that not only affect the individual, but their family and community, and is expected to be 
the number one health concern in both developed and developing nations by 2020 (Lim et 
al., 2013). As exists for other well-known global health concerns, such as diabetes and 
cardiovascular disease, the development of a risk index to estimate individuals’ risk for 
depression would have overt benefits. However, the development of such a risk index 
requires a systematic and defensible methodological approach based on sound research. 
A number of health risk indices currently available have primarily drawn on traditional 
statistical techniques for their development. For example, the Framingham Risk Score 
(FRS) was developed to measure the 10-year risk of cardiovascular disease (Dawber and 
Kannel, 1966) and utilised a logistic regression model for conditional risk using Walker-
Duncan estimation, and updated to use Cox proportional-hazards regression in order to 
produce sex-specific prediction functions for assessing risk (D’Agostino et al., 2008). The 
Reynolds Risk Score (RRS) was developed as an alternative to the FRS for 
cardiovascular risk assessment (Ridker et al., 2007) and used a mix of Cox proportional 
hazards models, stepwise selection procedures, and multiple additive regression trees to 
derive a set of models.  
The Postoperative Vomiting (PV) score (Apfel et al., 1999) split data into approximately 
equal random training and validation sets. Binary logistic regression was run to develop 
the risk score on the training set and the models were validated using the validation 
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dataset with the original coefficients. The area under a receiver operation characteristic 
(ROC) curve was used to assess the performance of the models. 
The late-life dementia index was developed with the objective to accurately stratify older 
adults into low, moderate, or high risk groups for developing dementia within six years 
and used logistic regression for its development (Barnes et al., 2009). The ROC curve 
was used to assess discrimination and for calibration purposes. A bipolar disorder risk of 
attempting suicide score was developed by a group based in Thailand (Ruengorn et al., 
2012) using logistic regression to finalise the set of risk factors and developed a weighted 
total score split into low, moderate and high. The Chicago Adolescent Depression Risk 
Assessment (CADRA) used the boosted classification and regression trees machine 
learning (ML) technique to develop a prediction index (Van Voorhees et al., 2008). Data 
were split 60% training and 40% test, with the validity of the model being based on the 
sensitivity and specificity of the prediction model based with an optimal cut-off on the 
ROC curve. 
Many of the current health risk indices implemented the approach of randomly splitting 
the data into training and validation or test sets and applying traditional statistical 
techniques to develop the indices. However, none have blended big data ML algorithms 
with traditional statistical techniques for the variable selection process in order to develop 
sets of domains, and establish their relative importance weightings for depression. This 
approach would enable a flexible, ‘modular’ aspect to the index, where determinants can 
be added/ removed to a structural equation model to estimate their simultaneous impact 
on the risk for depression. 
1.1.Blending machine-learning with traditional statistical techniques 
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The blending of unconstrained ML with constrained traditional statistical techniques in 
mental health research has considerable potential. ML algorithms have been implements 
for a pilot study into identifying risk of suicidality among patients with mood disorders 
(Passos et al., 2016). We have previously developed and applied a hybrid methodology 
that combined ML algorithms with traditional statistical modelling for variable selection, 
to detect key biomarkers associated with depression (Dipnall et al., 2016a). A blend of 
ML unsupervised Self-organised Mapping (SOM), supervised boosted regression 
algorithms with logistic regression has been used to create, describe and validate 
depression clusters based on lifestyle-environs (Dipnall et al., 2017) and somatic 
symptoms (Dipnall et al., 2016b). These techniques have the benefits of achieving deep 
exploration of heterogeneous data to uncover the key relationships with depression. 
This research builds upon our previously developed blended models that identified five 
domains of risk factors which we call “determinants” from systematic variable selection 
strategies that blended data mining with ML algorithms with traditional statistical 
techniques. The use of classes of risk factors in the construction of a risk index is novel. 
This study aims to develop a generalised structural equation model (GSEM) that utilises 
five previously identified determinants of depression to establish their relative importance 
and test a theoretical Risk Index for Depression (RID) model. Each determinant will be 
constructed from a separate structural equation model (SEM). The GSEM will compute a 
(RID), measured on a scale of 0 to 100. The five depression determinants are represented 
as four separate formative depression models (demographics, lifestyle-environs, 
biomarkers somatic symptoms) and a reflective diet depression model. Each determinant 
represents the probability of having depressive symptoms, based on the previous models 
derived. 
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The flexible approach allows further determinants to be added to the model without 
impacting on the methodology. Many known depression risk factors are not available in 
the dataset used in this study (e.g. stressful events), but our modular methodology allows 
additional determinants to be added from future data sets that possess data on these 
variables. This methodology also enables the relative strength of each determinant of 
depression to be established. 
1.2.The theoretical RID model 
The GSEM RID framework is represented in Figure 1. Prior research identified the risk 
factors associated with each determinant. it is anticipated that the probability of 
depression associated with all five determinants will model a path to the outcome of 
depression. However, for the first time it is anticipated potential indirect paths exist from 
the probability of depression associated with demographics, lifestyle and diet through the 
impact these have on the probability of depression due to biomarkers and somatic 
symptoms. Indicative mediation effects using cross-sectional data have been used in other 
studies relating to depression such as to examine depression severity and associated  risk 
factors for survivors of the 2008 Wenchuan earthquake in China (Xu et al., 2013) and to 
explore the specific indirect effects influencing the association between sex and 
established depression subtypes (Rodgers et al., 2016). An individual’s demographics can 
impact on their biomarkers (Van Spil et al., 2012) so it is conceivable this impacts impact 
on their probability of being depressed. Research has indicated positive associations 
between lifestyle factors and a depression risk (e.g. exercise has been shown to influence 
brain health, plasticity and depression risk (Thomson et al., 2015; Jacka FN, 2011; Van 
Praag et al., 2005), as has diet (Dipnall et al., 2015)). Reduced blood flow and 
metabolism has also been associated in patients with bipolar disorder and depression 
(Baxter et al., 1989). Lifestyle and diet impact on somatic symptoms (Janssens et al., 
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2014). For example, for type 2 diabetes mellitus and metabolic syndrome, diet is an 
important element of the management of this disease (Salas-Salvadó et al., 2016). 
 
Figure 1. Generalised Structural Equation Model (GSEM) Risk Index for Depression (RID) path 
model 
Note: Rectangles denote observed variables, circles represent measurement error, single-arrowed 
lines represent direct paths to observed variables and double arrowed lines represent covariance. 
The aim of this research was to develop a flexible, modular RID from epidemiological 
data using a systematic GSEM modelling approach building on previously published 
work.  
2. Methods 
2.1. NHANES study design and participants 
Community-based data from the 2009-2010 National Health and Nutrition Examination 
Survey (NHANES) (2009-2010) (Centers for Disease Control and Prevention National 
Center for Health Statistics, 2013) were used for this cross-sectional study (N=5,546, age 
range 18-80 years). The NHANES applied a complex four-stage sampling methodology: 
counties; segments within counties; households within segments; and, individuals within 
households. Data were collected from 15 locations across 50 US states, with 
oversampling of subgroups of the population of particular public health interest, to 
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increase the reliability and precision of population estimates (Centers for Disease Control 
and Prevention National Center for Health Statistics, 2013). 
Use of data from the NHANES 2009–2010 database is approved by the National Center 
for Health Statistics (NCHS) Research Ethics Review Board (Continuation of Protocol 
#2005-06). 
2.2. Outcome measure  
A self-reported Patient Health Questonnaire-9 (PHQ-9) (Kroenke and Spitzer, 2002) was 
used to assess depressive symptoms (‘depression’). This questionnaire consisted of nine 
items that were summed to form a total score, where a total score of 10 or more was 
considered moderately or severely depressed. 
2.3. Statistical methodology 
The five-stage statistical process performed for this research is outlined in Figure 2. The 
different GSEM models are indicated, where rectangles represent observed variables, the 




Figure 2. Five Staged Methodology for the final Generalised Structural Equation Model (GSEM) 
Risk Index for Depression (RID) path model. 
Note: Rectangles denote observed variables and single-arrowed lines represent direct paths to 
observed variables. Large circle denotes latent “Diet” variable and small circles represent 
measurement error. Depression = Logit(Depression).Depression = Logit(Depression). 
2.3.1. Stage 1 integrating NHANES data 
Questionnaire and laboratory data were downloaded from the NHANES website and 
integrated using the Data Integration Protocol In Ten Steps (DIPIT) methodology 
(Dipnall et al., 2014). 
2.3.2. Stage 2 data splitting 
Data were randomly split into two data sets. At each stage of the analysis, 50% of the data 
was used to formulate each of the models (training) and the remaining 50% was used to 
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validate the training models. Training and validation data sets were checked for similarity 
on depression, age, gender and predictor variables. 
The stages of the GSEM in Figure 1 were performed with depression as a binary outcome 
assuming a Bernoulli distribution and running logistic regression. All GSEM models took 
account of the complex sampling methodology of the NHANES data. A GSEM probit 
model was also run for the final stage model with the binary depression dependent 
variable and assumed that the probability of a positive outcome was determined by the 
standard normal cumulative distribution function. This was performed to further validate 
the GSEM logistic model. 
2.3.3. Stage 3 individual GSEM determinant models 
At the first stage of the analysis, separate GSEM models were run for the demographics, 
diet, lifestyle-environs, biomarkers, and somatic symptoms determinants (Culbertson, 
1997; Mirowsky and Ross, 1992; Riolo et al., 2005; Dipnall et al., 2015; Dipnall et al., 
2016a; Dipnall et al., 2016b; Dipnall et al., 2017) (Figure 2). The Variables used for the 
diet, lifestyle-environ, biomarkers, somatic symptoms determinant models was based on 
our previous research, which utilised big data mining and ML techniques applied to a 
greater number of possible risk factors. Formative path models were run for the 
demographics, lifestyle-environs, biomarkers and somatic symptoms determinants. A 
Confirmatory Factor Analysis (CFA) was run for the diet determinant to afford a better 
measure of the latent variable (Diet), by isolating the shared variance of the five food 
frequency items in the latent variable from their unique variance. Predicted probabilities 
of depression were generated from each of the five determinant models for both the 
training and validation data sets. These probabilities were then converted to logits order to 
ensure that a linear combination of determinants could be applied to obtain the logit for 
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depression for the final RID model. Similarly, probit conversions were applied to obtain 
the final probit depression model. 
2.3.3.1. Demographics determinant of depression 
The demographics determinant model was a GSEM recursive model (i.e. no feedback 
loops or correlated errors). The following socio-demographic predictors of depression 
were isolated from the NHANES questionnaire data: gender (male, female), age in years, 
family poverty income ratio (PIR), and race (non-Hispanic white, other), as shown in the 
model in stage 2 of Figure 2. Age-squared was included in the demographic determinant 
GSEM path model to ensure a better fit. 
2.3.3.2. Diet determinant of depression 
The primary dietary data were originally derived from a 24-hour dietary recall interview 
for NHANES participants, conducted in person by trained dietary interviewers 
(Thompson and Byers, 1994). A second dietary interview for all participants who 
complete the in-person recall was collected by telephone approximately 3–10 days later, 
yielding information on the regular consumption of the five key dietary components of 
fruit, leafy/lettuce salad, other vegetables, cooked whole grain, and whole grain bread. 
Previous Exploratory  Factor Analysis (EFA) identified five healthy dietary components 
to form the latent Diet factor, which was inversely associated with depression (Dipnall et 
al., 2015) ( Diet model, stage 2, Figure 2). The current study used CFA to obtain a 
measurement model for this dietary factor. The circle labelled Diet on the diagram was 
the unobserved, latent variable and the circles attached to each of the five observed 
dietary components are their unique measurement errors. The weight for the observed 
fruit component was fixed to 1 in order to make estimation possible. The concept of a 
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latent diet factor has previously been applied to dietary data from the Reasons for 
Geographic and Racial Differences in Stroke (REGARDS) study (Judd et al., 2015). 
2.3.3.3. Lifestyle-environs determinant of depression 
Eleven key lifestyle-environs variables used for this study were identified our previous 
research from 96 original NHANES lifestyle-environ self-report variables that covered a 
broad cross-section of categories: work status, physical activity, healthcare usage, sleep, 
smoking, blood donation, sexual activity, drug usage, diet, grocery shopping habits, meal 
habits, pesticide usage, air quality, and home attributes (Dipnall et al., 2017). 
Unsupervised and supervised ML techniques were previously used to identify the 
lifestyle-environs risk factors associated with depression. The well-established risk 
factors for depression, including sleep problems (Berk, 2009), unhealthy snacks in the 
home (Camilleri et al., 2014), and lack of physical recreational activity (Jacka FN, 2011) 
were identified. The potential risk factors of exposure to fumes at work for depression 
were included in this study, being consistent with previous research relating to links to 
depression (Nel, 2005). The links to depression relating to the age of the home and short 
period of time residing in the home (≤2 years) are thought to be related to instability in 
home and/or working life (Weissman and Paykel, 1972) and potentially lower monthly 
family income. The inclusion of sexual activity at an early age (i.e. <14 years) as a 
potential risk factor for depression was consistent with research indicating an association 
between adolescent sexual activity and an increased likelihood of depression (Hallfors et 
al., 2005). Smoking status (0=never smoked, 1=smoker) was also included in the 
lifestyle-environs determinant model as research has shown that cigarette smoking has 
been associated with depression (Boden et al., 2010). The lifestyle-environs predictors 
were initially compiled using a recursive SEM path model where each of the 11 observed 
variables had a direct path to depression (Lifestyle-environs model, stage 2, Figure 2). 
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2.3.3.4. Biomarkers determinant of depression 
We previously applied  a blend of supervised ML boosted regression algorithm with 
traditional binary logistic regression to 67 original NHANES blood and urine samples to 
identify four key biomarkers most strongly associated with depression (Dipnall et al., 
2016a): red cell distribution width (%); blood cadmium (nmol/L), total bilirubin (mg/dL); 
and serum glucose (mg/dL). The original laboratory samples were collected in the 
NHANES Mobile Examination Center (MEC) and shipped weekly for laboratory 
analyses. Specific laboratory techniques for each test are available from the NHANES 
Laboratory Procedures Manual ((CDC). 2009-2010). For this study, the biomarker 
predictors were initially compiled using a recursive SEM path model where each of the 
four observed variables had a direct path to depression (Biomarker model, stage 3, Figure 
2). 
2.3.3.5. Somatic symptoms determinant of depression 
There is a high level of comorbidity between somatic symptoms and depression 
(Kapfhammer, 2006). Using  68 self-reported medical symptom questions from the 
NHANES questionnaire data, and applying a blend of unsupervised self-organized 
mapping (SOM), hierarchical clustering and supervised ML boosted regression 
algorithms with traditional logistic regression, we previously identified 11 key somatic 
symptom categories of pain, bowels, urine, vision, respiratory, hearing, liver, thyroid, 
arthritis, fracture, and psoriasis, as most strongly associated with depression (Dipnall et 
al., 2016b). The 11 observed somatic symptom variables in this study were compiled 
using a recursive SEM path model representing a direct association with depression 
(Somatic symptom model, stage 2, Figure 2). 
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2.3.4. Stage 4 direct GSEM path model 
The stage 4 preliminary GSEM path model incorporated all the determinant logits 
generated from stage 3 as observed exogenous variables (i.e. determined outside the 
current model, represented by the rectangles, stage 4 model, Figure 2). Correlations 
between the errors of all of the observed determinants of depression were included (i.e. 
curved arrows). All paths at stage 4 were direct to the depression logit outcome binary 
variable. Odds ratios (ORs) and 95% confidence intervals (95% CI) for each determinant 
from this model represented its relative importance association with depression. 
2.3.5. Stage 5 GSEM RID model 
The stage 4 GSEM model was modified to define the biomarker and symptom 
determinant models as observed endogenous variables (i.e. rectangles, Figure 1). The 
correlation between the errors of biomarkers and somatic symptoms determinant logits 
were included. The demographics, lifestyle-environs and determinant logits had direct 
paths to depression, as well as indirect paths to depression through their impact on 
biomarkers and somatic symptoms determinant logits. Thus, all possible relationships 
amongst the risk variables with depression were able to be explored (i.e. direct, indirect 
and total relationships). Predicted probabilities for total depression risk were generated 
from the final model for both the training and validation data sets 
2.4. Fit indices 
The nature of the NHANES data, with its complex survey structure, meant that the 
standard absolute and comparative fit indices (e.g. model χ2, root mean square error of 
approximation (RMSEA), goodness-of-fit statistic (GFI), adjusted goodness-of-fit 
statistic (AGFI), normed-fit index (NFI) and comparative fit index (CFI)) could not be 
produced. The use of the actual Akaike information Criterion (AIC) and Bayesian 
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information Criterion (BIC) and Sample-Size Adjusted BIC was not possible for the same 
reason. 
The dilemma of finding appropriate fit statistics was resolved by using the Hosmer & 
Lemeshow goodness of fit F-test (Hosmer and Lemesbow, 1980) only for the stage 4 path 
modelas the stage 3 models did not control for potential demographic confounders. A 
model was deemed a good fit if the p-value for this statistic was not significant (p>0.05, 
preferably p>0.10). In addition, consistent with other health indices, the ROC Area Under 
the Curve (AUC) (i.e. C-Statistic) was also used as an indication of fit for the training and 
validation models at every stage of the analysis (Linden, 2006). This is a standard 
measure of the predictive accuracy of a binary logistic regression model to determine how 
good the model will be at distinguishing (or "discriminating") between those with and 
without depression, and has been used to evaluate other health risk index models. This 
measure takes values from 0 to 1 where a value of above 0.7 is considered acceptable. 
3. Results 
3.1. Stage 2 data splitting 
The data were randomly split, with 50% for training (n=2,773) and 50% for validation 
(n=2,773), and the split was found to be approximately consistent across the binary 




Unweighted and Estimated mix of training compared to validation data sets. 
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(9.6%)  226 (7.8%) 250 (8.3%) 
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Family Poverty Income Ratio 
(PIR), mean (SD/SE)* 
 2.48 
(1.64)   2.44 (1.62)  3.05 (0.05) 3.02 (0.05) 
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Lifestyle         
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(12.8%)  256 (9.2%) 265 (9.5%) 






























Diet         
How often eat fruit? mean 
(SD/SE)* 
 0.70 
(0.02)   0.72 (0.02)  0.74 (0.03) 0.75 (0.02) 
How often eat leafy/lettuce 
salad? mean (SD/SE)* 
 0.38 
(0.01)   0.36 (0.01)  0.41 (0.01) 0.39 (0.02) 
How often eat other vegetables? 
mean (SD/SE)* 
 0.63 
(0.01)   0.63 (0.01)  0.70 (0.02) 0.71 (0.02) 
How often eat cooked whole 
grains? mean (SD/SE)* 
 0.09 
(0.01)   0.09 (0.01)  0.08 (0.01) 0.09 (0.01) 
How often eat whole grain 
bread? mean (SD/SE)* 
 0.46 
(0.01)   0.46 (0.01)  0.48 (0.01) 0.49 (0.02) 
Biomarkers         










Blood cadmium (nmol/L), mean 
(SD/SE)* 
 4.40 
(4.56)   4.63 (5.12)  4.18 (0.14) 4.44 (0.13) 
Total bilirubin (mg/dL), mean 
(SD/SE)* 
 0.76 
(0.32)   0.76 (0.28)  0.77 (0.01) 0.77 (0.01) 



























































































Psoriasis Group  79 (2.8%)   81 (2.9%)  68 (3.2%) 64 (2.8%) 
Note: * Standard deviation for unweighted data and standard error calculated estimated 
data taking account of the NHANES complex survey sample. ** Estimation calculated 
estimated data taking account of the NHANES complex survey sample. 
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3.2. Stage 3 individual GSEM determinant models 
The ROC analysis results for the individual depression determinant models are 
summarised in Table 2. The AUC for the individual demographics, diet and biomarker 
determinants were all below 0.7. The AUC were acceptable at above 0.7 for both the 
somatic symptoms (AUC=0.741) and lifestyle-environs (AUC=0.780) determinant 
models. 
  
Probabilities were generated from each determinant model and transformed into logits. In 
order to establish associations and check for multicollinearity, the correlations between 
the logit probabilities (logits) are presented (Table 3). With the exception of diet and 
somatic symptoms determinant logits, where there was no significant correlation 
(r=0.030, p=0.112), all pairs of determinant logits had very weak to weak but signficant 
positive correlations with depression. This statistically justifies the inclusion of 
biomarkers and somatic symptoms as potential mediators for the demographics and 
lifestyle determinants in the final GSEM model at stage 5 (Hayes, 2009). Although there 
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was a significant correlation between the diet and biomarkers determinant logits, the 
strength of the correlation for these variables indicated virtually no linear relationship 
(r=0.052, p=0.007). These results indicated that mediation relationships between the diet 
logit determinant and both biomarkers and somatic symptoms logit determinants were 
unlikely. 
 
3.3. Stage 4 direct GSEM path model 
The results from the direct GSEM path model is presented in Figure 3. The odds ratios for 
the direct paths from each logit determinant to depression indicated the relative 
importance of each determinant on the depression logit. Of highest rank was the diet 
determinant, with OR 4.09 (95% CI 2.01, 8.35), then lifestyle-environs (OR 2.15; 95% CI 
1.57, 2.94), somatic symptoms (OR 2.10; 95% CI 1.58, 2.80), demographics (OR 1.46; 
95% CI 0.72, 2.95) and lastly biomarkers (OR 1.39; 95% CI 1.00, 1.93). All relationships 
were positive due to the determinents representing the probability of being depressed, 
generated from Stage 3 models. The direct path from the demographics logit to 
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depression was not significant (p=0.276) and the direct path from the biomarker logit to 
depression was of borderline significance (p=0.052). 
 
Figure 3. Stage 4 Direct Generalised Structural Equation Model (GSEM) path model 
Note: Rectangles denote observed variables, double arrowed lines represent covariance. Black 
figures to direct paths to depression are odds ratios. Blue figures with two-headed arrows are the 
error covariances. Green figures to right of small circles are the error variances. Demographic = 
Logit(Pr(Depress-demo)), Lifestyle-evirons = Logit(Pr(Depress-lifest)), Diet = Logit(Pr(Depress-
diet)), Biomarkers = Logit(Pr(Depress-bio)), Somatic symptoms = Logit(Pr(Depress-som)). 
Depression = Logit(Depression). 
The ROC analysis results from for the stage 4 preliminary GSEM path model were very 
good (AUC training = 0.854, validation = 0.827). However, the goodness of fit test was 
significant (p=0.001) which suggested that the direct model was not a good fit. 
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3.4. Stage 5 GSEM RID model 
The proposed stage 5 GSEM RID path model was fitted for both logistic regression and 
probit regression to test consistency. The direct path from the demographics logit 
determinant to depression was removed, as this path was found to be not significant for 
both the logistic regression (p= 0.276) and probit regression (p=0.219) GSEM path 
models. Thus, the probability of depression due to demographics potentially only affected 
depression indirectly through its impact on the probability of depression due to 
biomarkers and somatic symptoms. In addition, the indirect paths from the probability of 
depression due to diet to the probability of depression due to biomarkers (logistic 
regression: p= 0.845; probit regression: p=0.981) and somatic symptoms (logistic 
regression: p= 0.933; probit regression: p=0.872) were removed from the model because 
they were not significant. This was consistent with the low correlation between the diet 
and biomarkers and somatic symptom determinant logit (Table 3). 
The revised and final GSEM RID logit path model is presented in Figure 4. All 
correlations and direct and possible indirect paths to the depression logit were significant 
at α=0.05. The logits from the biomarker and somatic symptom determinant models were 
kept as observed endogenous variables. The correlation between the errors of biomarkers 
and somatic symptoms logit determinants were maintained as they were found to be 
significant (logistic regression: p= 0.010; probit regression: p=0.011). Direct paths to 
depression were maintained for the lifestyle-environs and diet determinant logits. The 
final probit model is also shown in Figure 4. 
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Figure 4. Stage 5 Final Generalised Structural Equation Model (GSEM) Risk Index for 
Depression (RID) path models for logistic and probit regression 
Note: Note: Rectangles denote observed variables, double arrowed lines represent covariance. 
Black figures to direct paths to depression are odds ratios. Blue figures with two-headed arrows 
are the error covariances. Green figures to right of small circles are the error variances. 
Demographic = Logit(Pr(Depress-demo)), Lifestyle-evirons = Logit(Pr(Depress-lifest)), Diet = 
Logit(Pr(Depress-diet)), Biomarkers = Logit(Pr(Depress-bio)), Somatic symptoms = 
Logit(Pr(Depress-som)). Depression = Logit(Depression). AUC refers to the area under the ROC 
curve. 95% CI refers to the 95% confidence interval for the AUC. 
The ROC analysis results from both the logistic and probit regression models for the final 
stage 5 GSEM RID path model are included at the bottom of Figure 4. In general, the 
AUC results were consistent for both the logistic and probit models (Logistic: 
training=0.850, validation=0.813; Probit: training=0.849, validation=0.809). Even though 
there was a reduction in the AUC from stage 4 to stage 5, the difference was not 
significant and all paths in the final model were significant. The predicted probabilities of 
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depression from this GSEM ranged from 0 to 1 and were consistent across logistic and 
probit regressions. 
4. Discussion 
To our knowledge this is the first study that has blended ML with traditional statistical 
techniques, including structural equation modeling, to formulate a RID. The five 
identified determinants on their own are not enough to provide a holistic prediction of 
depression as other known risks are not available in this dataset, but together they formed 
a consistent model for RID, with significant direct and indirect pathing and a good AUC. 
The modular structure of the method allows future research to strengthen the RID by 
including other known or potential risk factors for depression not available in the 
NHANES data. For this study, the indicative importance ranking of the individual 
determinants of depression, where diet was ranked first, followed by lifestyle-environs, 
somatic symptoms, demographics and biomarkers, represents new research findings. 
However, these rankings may alter once other determinants are added to the GSEM. 
Our results indicate that only diet has a direct association with depression. The diet 
determinant was comprised of fibre-rich foods such as leafy green salad, vegetables and 
whole grains. Such dietary components have been consistently associated with a reduced 
risk for depression. Moreover, dietary fibre appears central to gut health, which has 
recently been a key focus of depression research (Dash et al., 2015). Indeed, we have very 
recently identified bowel symptoms as the most prominent somatic symptom associated 
with depression (in press) and our findings provide further support for diet as a key 
modifiable factor in depression risk. 
The lifestyle-environ determinant was found to have both a direct association with 
depression and also an indirect association via symptoms and biomarkers. Lifestyle 
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factors, such as sleep problems (Berk, 2009), tobacco smoking (Taylor et al., 2014), 
snacking behavior and exercise activity (Pasco JA, 2010), have all been found to be 
associated with individuals’ physical and mental health. 
This study found that the demographic determinant was related to depression only 
indirectly via symptoms and biomarkers. Differences in biomarkers and somatic 
symptoms according to age, gender, race and socio-economic status are well established. 
For example, increasing age is associated with a higher likelihood of chronic disorders. 
The direct path from biomarkers and somatic symptoms to depression in the RID model 
confirmed prior research identifying that depressive symptoms are often elevated in 
people with medical symptoms (Olver and Hopwood, 2012). 
While research has indicated there are possible bidirectional relationships of some of the 
key risk determinants with depression (e.g. diet), this study focused on the outcome of the 
probability of depression. With further development of the RID, it is anticipated the 
future use of this index could focus on identifying risk determinants to inform prevent 
strategies for depression onset  
4.1. Strengths and limitations 
A key limitation of our study is the cross-sectional nature of the NHANES data, which 
restricts the ability to infer causality; thus the RID requires further validation in 
longitudinal datasets. Furthermore, data on many important and known risk factors were 
not available in this dataset. However, this methodology has the potential to be used in 
future datasets with a wider range of variables. The use of this large community-based 
survey dataset has the advantage of being representative of the large US population 
sampled during 2009 to 2010. The rigorous complex survey sampling methodology also 
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ensured the data represent the relative characteristics of the civilian noninstitutionalised 
US population.  
Due to the nature of the complex survey data structure, conventional fit statistics for the 
structural equation models were not available. However, the AUC for both training and 
validation and across two types of regression models (logistic and probit) was utilised. 
The PHQ-9 instrument is limited by being a self-report measure of depressive symptoms 
rather than a clinical diagnosis of depression, thereby potentially biasing case 
ascertainment (Kroenke and Spitzer, 2002; Kroenke et al., 2001). However, the NHANES 
study is considered representative of the US noninstitutionalised civilian population and 
has been used to produce health statistics for the US and in many studies investigating 
depression (e.g. to examine the prevalence, treatment and control of depressive symptoms 
(Shim et al., 2011)). 
The data were split 50% training and 50% validation, ensuring that a reasonable 
proportion of those with depressive symptoms was included in each set. This allowed the 
GSEM models to be validated using a random portion of the NHANES data. However, 
the RID was not validated using a separate data set but there is potential to apply this 
methodology to other data, including longitudinal data, for validation purposes. 
Often the limitations of SEM relate to sample size, which needs to be large enough to 
obtain stable estimates of the covariances/correlations. In general, a model requires at 
least 200 participants and for a path model the sample size should be at least 20 times 
larger than the number of estimated paths to ensure reliable results (Jeon, 2015). Even 
with the splitting of the data, the sample size for this study met the SEM requirements. It 
could be argued that a limitation is that that the model may omit some variables that are 
of theoretical relevance. However, selection of the variables constituting the depression 
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determinants for this research was based on our previous research, which utilised big data 
mining and machine learning techniques applied to a much larger number of possible risk 
factors. Last, this paper provides a modular methodology for the development of the risk 
index; the nature of the NHANES data, as previously outlined, limits the extent to which 
the results might represent a definitive and accurate summative risk profile for 
depression. 
5. Conclusion 
This study developed a flexible modular methodology for the development of a RID, with 
foundations for a future more complex structural equation model. The preliminary model 
used in this study was developed using complex cross-sectional survey data, based on 
previous research that utilised both ML and traditional statistical techniques to formulate 
the depression risk determinants. An indicative importance ranking of the individual 
determinants of depression was produced. From the NHANES data, diet was ranked first, 
then lifestyle-environs, somatic symptoms, demographics and biomarkers. Our 
preliminary results suggest that diet has a direct association with depression, but other 
lifestyle-environ and demographic factors appear to be associated indirectly with 
depression via somatic symptoms and biomarkers. However, further validation is 
required, including refinement by using datasets that include a wider range of variables. 
The RID has the potential to assist clinicians with the identification of people at risk of 
depression, and potentially other affective disorders, while prioritising risk determinants 
in terms a focus for prevention and of future. 
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CHAPTER NINE: DISCUSSION AND CONCLUSIONS 
With depression being a major health concern, for both the individual and globally for society 
as a whole, there is an overdue need for the development of tools that can assess an individual’s 
risk for depression: a risk index for depression (RID). Initial investigation of the potential risk 
factors for depression reveals this mental disorder as complex, covering a broad range of 
potential risk factors, and it is regularly comorbid with somatic diseases and symptoms (1, 2). 
Most prior research concerning depression has evaluated groups of potential risk factors, such 
as diet and biomarkers, separately, but none has dealt with them all together in a theoretically-
defensible structural model. This is primarily due to the within and across heterogeneous nature 
of the group’s risk factors, and the constraints of traditional statistical techniques (3-6). This 
thesis presents a defensible and rigorous rationale, methodology and process for the 
development of a RID that holds considerable promise for both clinical and population health 
applications. By first using unconstrained big data techniques to formulate the risk determinants 
of depression, the final structural equation model for the RID methodology is easily transported 
to other mental health outcomes and data sets. 
The overwhelming majority of currently available health risk indices are underpinned by 
traditional statistical techniques. For example, the Framingham Risk Score (7) utilised a 
traditional logistic regression method using Walker-Duncan estimation (8) and traditional Cox 
proportional-hazards regression (9) to measure the sex-specific 10-year risk of cardiovascular 
disease. Even though the alternative Reynolds Risk Score (10) utilised a mix of methods to 
derive a set of models (i.e. Cox proportional hazards models, stepwise selection procedures, 
and multiple additive regression trees) (11) it still only formulated one model that considered 
all risk factors together. None of the indices used the benefit of first categorising risk factors 
into determinants to then form a theoretical structural model for the risk index so as to establish 
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relative importance weightings for each determinant for the outcome. This is the strength of our 
research methodology. 
In psychiatry, the many potential non-uniform risk factors associated with mental disorders 
means that current risk indices have been constrained by the traditional statistical methods used 
to define the index, raising the potential to introduce variable selection bias due to only those 
variables a researcher expects to be included in the model. For example, the late-life dementia 
index (12) and bipolar attempted suicide index (13) were constrained using traditional logistic 
regression for their development. The result is an incomplete risk profile for these outcomes. 
In contrast, the Chicago Adolescent Depression Risk Assessment (CADRA) index was 
developed using the boosted classification and regression trees machine learning (ML) 
technique (14). This index was developed from an initial 52 variables covering a wide variety 
of risk groupings that covered demographics, general health, interpersonal relations (peers and 
family), cognitive, behavioural activation, delinquency, affect regulation, anxiety, and 
depressed mood. However, all the potential risk variables, apart from demographics, related to 
psychiatric measures and did not consider external exposures, biomarkers or comorbid somatic 
symptoms. Whilst the initial investigation contained all the 52 variables, it was no surprise that 
the final 20 risk variables were heavily biased to the depression variables. In addition, this index 
did not delineate groups of risk factors, but bundled them all together, making it difficult to 
attribute the relative importance of each group of variables to the risk for depression. 
Up until this research, there existed no health or psychiatric index that had blended big data ML 
algorithms with traditional statistical techniques for the variable selection process, in order to 
develop sets of risk determinants. The benefit of having sets of risk determinants lies in the 
ability to define their relative importance weightings for the outcome, in this case depression. 
The flexible, ‘modular’ aspect of being able to add or remove sets of determinants to a 
theoretical structural equation model to estimate the simultaneous impact of various risk 
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determinants on the risk for depression means the index is not constrained to any particular data 
set or set of risk factors. This means that it can be adapted to future needs and datasets with a 
range of different available variables. 
Importantly, as seen with previous health risk indices, the development of such an index using 
traditional statistical techniques alone is susceptible to model constraints, is vulnerable to 
multicollinearity between predictors (6), and is likely to fall victim to overfitting (3). Big data 
mining methods with ML algorithms are regularly utilised with databases that feature these 
characteristics, rendering these techniques beneficial for variable selection in this situation (15). 
Previously, the benefits of big data techniques for the task of creating groups or determinants 
of potential risk factors for depression have not been recognised or acted upon by medical 
researchers. 
The development of the relevant determinants of depression for the RID takes an unconstrained 
approach to the variable selection process for the risk factors associated with each risk 
determinant for depression. This required integrating large numbers of data sets into one reliable 
data file to mine for the risk factors. As there was no clear protocol for the integration of data 
sets to ensure that the final data set was of high quality, the ten-step protocol was developed for 
this research, named DIPIT (Paper 1, Chapter 3). The useful and practical set of 10 systematic 
methodological steps ensures that the final integrated data used in this research is appropriate 
for an analysis to meet the research objectives, that the legal and ethical requirements are met, 
and that the data definitions are clear, concise and comprehensive. This protocol is applicable 
to multiple outcomes of interest with differing units of measurement, with the aim of answering 
a range of research questions without a specific target in mind. DIPIT was designed to be easy 
to implement for individuals with limited familiarity with working with datasets and to ensure 
key issues such as the handling of missing data is addressed. For the first time, a number of risk 
factors, obtained from the separate variable selection processes that blended ML with traditional 
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statistical techniques, were compartmentalised into determinants. An indicative ordering of 
each group of risk factors on the likelihood of depression in the final RID model was then able 
to be established. Based on the literature review of potential risk factors for depression, the 
following determinant categories were identified: lifestyle-environs, biomarkers, somatic 
symptoms, and other environmental exposures (e.g. stressful events). A separate group was 
created to treat demographics as a demographic confounding determinant. Each of the risk 
factors found from the variable selection processes was consistent with research findings 
published elsewhere. 
This study supports previous research in showing that a healthy diet is associated with a reduced 
probability of depression (16) (Paper 2, Chapter 4). This research viewed diet from a new 
perspective. A latent diet determinant was created representing an individual’s predisposition 
to eating a healthy diet. This subtle difference is a new way of both modelling and viewing how 
eating behaviour relates to depression.  
Various Lifestyle-environ factors have been found to be operative for depression, but there has 
been a lack of clarity surrounding how these risk factors cluster. The use of the unsupervised 
self-organised mapping (SOM) ML technique, combined with hierarchical clustering, 
successfully clusters NHANES participants based on their lifestyle-environ factors (Paper 3, 
Chapter 5). A Multiple Additive Regression Tree boosted ML algorithm (MART) takes account 
of potential interactions and describes the lifestyle-environ makeup of these clusters. No 
previous research has mined large arrays of self-reported lifestyle-environ variables (i.e. 96) in 
such an unconstrained fashion. The multivariate binary logistic regression validates the final 
clusters and controls for potential sociodemographic confounders, making it easily understood 
by the health research community. The lifestyle-environs risk factors detected were consistent 
with prior research.  Variables such as poor sleep quality, unhealthy snacks, physical inactivity, 
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age at first sexual experience, and exposure to fumes were confirmed as risk factors for 
depression. 
Biomarker data (e.g. blood and urine samples) are notoriously collinear, heterogeneous and 
subject to issues with missing data. The large volume of missingness and collinearity associated 
with the 67 biomarker data in the NHANES data was accounted for in this study, when mining 
for those biomarkers which were identified as associated with the risk for depression (Paper 4, 
Chapter 6). The four biomarkers from the ML process included in the biomarker determinant 
are plausible. Red cell distribution width is used for differential diagnosis of anaemia, especially 
iron deficiency anaemia, and found to be associated with many medical conditions comorbid 
with depression (e.g. cardiovascular complications, diabetes, inflammatory bowel disease) (17-
19). This biomarker has also been investigated as a substitute marker for inflammatory 
conditions, which are regularly found to be comorbid with depression. Fasting plasma or serum 
glucose tests are used to screen for and diagnose diabetes and prediabetes, and diabetes is 
known to be comorbid with depression (20). Bilirubin is an antioxidant and mild to moderately 
elevated serum bilirubin levels are associated with better outcomes in diseases involving 
oxidative stress (21); depression has been found to be associated with oxidative stress. There is 
a considerable body of literature regarding the adverse effects of cadmium contents of foods 
grown in contaminated areas (22-24) . Cadmium has also been linked to tobacco smoking where 
this habit can more than double the average person's daily cadmium intake. From the variable 
selection process, blood cadmium was found to fully mediate the relationship between cotinine 
and depression. Since, cotinine is an alkaloid found in tobacco and is the predominant 
metabolite of nicotine, this mediation effect is understandable (25). 
Comorbidity between depression and somatic symptoms is common. However, identification 
of which somatic symptoms are most prominent for depression is notoriously difficult to isolate. 
The NHANES medical symptom data are categorical, numerous (i.e. 68 variables), and 
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heterogeneous in nature (Paper 5, Chapter 7). The important medical symptoms for each key 
cluster from the unsupervised ML techniques were found to lie within 17 broad categories: 
heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain, 
blood pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels and 
urinary. However, three medical symptom clusters were particularly related to depression: 
bowel, pain and urinary symptoms. Of these categories, bowel symptoms dominate. These 
findings support the increasing focus in medical research on the role of symbiotic gut 
microbiota in health and disease, including mental health (26, 27). However, it is acknowledged 
that bowel symptoms do not necessarily equate to gut disorders as these symptoms could reflect 
other issues such as appetite changes, anxiety, medication side-effects, etc. In addition, the 
relationship could be bidirectional where depression leads to bowel problems due to appetite 
changes and medication side-effects. 
The novel blending of models for these five groups of risk determinants of depression into a 
statistical structural equation model is new to this area of mental health research (Paper 6, 
Chapter 8). Meaningful relationships within and across these determinants of depression were 
detected and the relative strength of each determinant of depression was identified for future 
clinical practitioner management and health policy strategy.  
Preliminary results from this structural equation model indicate that the risk for depression 
associated with attitudes towards a healthy diet related directly to the overall risk for depression. 
This strengthens the research indicating the positive effects of adhering to a healthy diet for 
avoiding depression, with the potential to inform both clinicians and policy makers in 
mechanisms to improve patient trajectories in depression through dietary interventions. 
Further results from the structural equation model indicate that the risks for depression 
associated with lifestyle-environs potentially affects the overall risk for depression both directly 
and indirectly via the risk of depression associated with biomarkers and somatic symptoms. 
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Identification of these pathways has the potential for clinicians to focus on the clinical factors 
of a patient’s biomarkers and/or somatic symptoms for managing depression when the lifestyle-
environs are out of their control. 
The structural equation model also indicates that the risk for depression associated with 
biomarkers relates directly to the overall risk for depression. In addition, this model uniquely 
detects a potential mediation role of biomarkers with the risk for depression associated. The 
relationship between an individual’s risk of depression due to demographics or lifestyle 
environs potentially relates indirectly to their overall risk of depression through their effect on 
biomarkers. This research supports the potential use of blood tests for screening patients for 
depression and offers the potential for policy makers to consider regular blood testing to 
facilitate the management of this mental disorder. 
The structural equation model indicates that the risk for depression associated with somatic 
symptoms directly affects the overall risk for depression. This indicates the need for clinicians 
to consider the risk for depression in patients not only with chronic illnesses, but also with other 
not-so-obvious somatic symptoms. For example, informing clinicians about the nature and 
management of patient stool profile as a potential risk factor for depression, may be considered 
a beneficial addition to standard patient management. As with the biomarker determinant, this 
structural equation model uniquely detects a potential mediation role for the risk for depression 
associated with somatic symptoms. The relationship between an individual’s risk for depression 
due to demographics or due to lifestyle environs is indirectly related to overall risk for 
depression through depression risk associated with somatic symptoms. 
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9.1 Strengths of the Research 
The strengths of this study lie in the benefits of using both unsupervised and supervised ML 
techniques to identify unknown patterns in data, using a large number of heterogeneous self-
reported data (e.g. 96 lifestyle-environ variables, 68 somatic symptoms, 67 biomarkers) with 
differing scales (e.g. metric, categorical), which would have otherwise remained hidden using 
traditional statistical techniques. These big data techniques are not hypothesis driven, but 
extract hidden predictive information from large databases that is often missed by the traditional 
statistical techniques because it lies outside the researcher’s expectations. The training and 
validation process applied in data mining, where data are randomly split into training and 
validation sets to run the ML algorithms, strengthens the acceptability of the study results by 
establishing the model on the training set and validating the results on the validation set. 
The unsupervised ML clustering algorithm of SOM provides a simple and effective method for 
clustering, visualization and dimension reduction for high dimensional data, without any 
reliance on distributional assumptions. The visual map makes it easy to present the results for 
the health community to understand. The supervised ML boosted regression algorithm ensures 
that variable importance is reliably measured taking into account observations that are difficult 
to predict while at the same time shrinking the effects of these difficult observations in order to 
avoid over-fitting. This method ensures that multicollinearity does not obscure the influence of 
important predictors, giving all variables a chance to shine, while taking into account any non-
linearity or interaction effects. 
A major benefit of the proposed methodology resides with the portability of the systematic 
stepped approach used. The methodology of utilising data mining and ML for the variable 
selection process can be applied to a variety of studies such as retrospective large scale medical 
cohort database retrievals (e.g. hospital records). Blending the traditional statistical techniques 
with ML techniques means that there are no problems should the data be a large epidemiological 
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population-based study using complex survey designs. This has been achieved in this study 
with the use of the NHANES data, which had used complex survey sampling methodology for 
its data collection. In addition, this research shows that the application of multiple imputation, 
to deal with issues surrounding missing data, does not inhibit the use of this methodology. For 
the first time, this research blends machine learning, multiple imputation and binary logistic 
regression for the identification of biomarkers associated with depression. 
Up until now, many sets of medical variables, such as biomarkers, have restricted the use of 
standard variable selection techniques, such as stepwise and regularized regression, due to 
problems with multicollinearity. This research demonstrates that this restriction is overcome by 
using supervised ML techniques. These techniques allow the existence of multicollinearity 
without obscuring the influence of the important predictors, giving all variables a chance to be 
selected. Two simulations using random samples were generated to mimic the NHANES data 
to evaluate the effectiveness of the ML boosted regression algorithm and importance percentage 
metric over a traditional backward stepwise variable selection method. In both simulations the 
stepwise regression fails to drop one of the two highly correlated predictors, indicating possible 
estimation instability and structural misspecification using this traditional statistical technique 
for variable selection. This problem is overcome in the ML boosted regression algorithm which 
requires no matrix inversions, which cause serious problems in a standard regression analysis 
with highly correlated predictor variables (division by a determinant close to zero). Non-
linearity and complex interaction effects (e.g. three way interactions) are often overlooked by 
mental health researchers as interpreting these effects can be daunting and confusing. However, 
the ML boosted regression used in this research automatically accommodates non-linearity and 
interaction effects between predictor variables and produces easy to interpret relative 
importance percentages for each of the variables in order to pick the most important predictors. 
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The large number of NHANES participants included in this study ensures the data possess a 
good description of the relative characteristics of the civilian noninstitutionalised US 
population. This research addressed the potential complexities of using health data from multi-
staged survey sampling (e.g. NHANES) and accounted for this complexity in the development 
of the RID. The methodology was not constrained to this type of data, and can be used for many 
types of research data. 
The imbalance of depressive diagnosis in the categorical data sets is addressed in the 
unsupervised ML algorithm by using well-populated, more depressed clusters relating to 
lifestyle-environs or somatic symptoms in order to identify the important predictors of 
depression. This reduced the impact of the sample imbalance on prediction bias. 
The utilisation of structural equation modelling for the development of the final RID model 
allows for both observed sets of risk factor determinants (e.g. biomarkers), in the form of a 
formative model for depression, as well as the construction of an unobserved latent risk factor 
determinant that takes account of measurement error (e.g. diet) (Paper 6, Chapter 8). This thesis 
makes an important contribution by suggesting that different risk factors are likely to play a 
role in the development of depression in specific subgroups. This means that an index with 
identical weights for all factors is unlikely to perform as well as indices specifically tailored for 
individual subgroups, and some factors may be more powerful across the board than others. 
Another major benefit of the RID is that it takes into account environmental factors, not just 
medical factors. 
The flexible modularity of this method, whereby risk determinants can be easily added with 
both direct and indirect paths to the depression outcome, means that the current RID can be 
strengthened by further integration of potential risk factor determinants (e.g. psychiatric 
measures such as stressful events) and expanded to other types of data sets (e.g. hospital registry 
data, longitudinal data) and other types of models such a multilevel models and latent growth 
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models. The identification of a patient’s potential risk of depression would greatly benefit from 
the integration of a number of aspects of their psychiatric history, other mental disorders, 
personality traits, biological characteristics, and lifestyle situation to obtain a more holistic RID 
for future clinical use. 
9.2 Limitations of the Proposed Methodology 
A limitation of this study relates to the individual risk factors, which are based on data from the 
US-only NHANES cross-sectional sample. The nature of these data restricts the ability to infer 
the direction of the relationship among the risk factors and restricts the ability to infer causality 
or detect bidirectional or reverse causation. 
The self-report nature of the NHANES questionnaire, diet and somatic symptom data, with 
specific demographic and dietary patterns, is also a limitation of this research. The self-report 
nature of the depression instrument (i.e. the PHQ-9), may have missed less severe cases of 
depression thereby exaggerating the imbalance of depression in the data. The data used for the 
construction of the diet factors are limited to those derived from a 24-hour recall. Available 
research suggests this method can produce accurate and reproducible estimates of the mean 
intake of groups of individuals if standardized procedures and close interviewer monitoring are 
used during data gathering, such as was performed with the NHANES study. 
A potential limitation of the unsupervised ML methods lies with these methods potentially 
becoming conceptually expensive as the number of variables increases. The supervised ML 
boosted regression can fail to perform well with small data sets. The potential for the training 
process can become computationally memory intensive due to the fact that trees are built 
sequentially, requiring advanced computing capability such as parallel processing. In addition, 
the regularization implemented to reduce the effects of overfitting can mean the optimal number 
of iterations for a suitable shrinkage parameter can be considerably large. However, the 
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continuous improvements in computation power available suggest that any such problems are 
likely to be short-lived. 
Whilst the data mining procedures used in this study performed model validation using a 
random split of data into training and validation, no validation of the methodology is performed 
on a separate data set using self-reported medical symptom data. This is recommended for the 
acquisition of reliable goodness of fit measures in the future. However, there is a problem with 
the evaluation of goodness of fit statistics for data collected using a complex sample design 
(such as NHANES) which will need to be addressed in the future. 
As with much statistical modelling of observational data, there is the chance that possible 
confounders have not been identified and controlled. For example, the potential effects of other 
environmental exposure events (e.g. stressful events), mood disorders and genetics on the risk 
for depression is not included as a risk determinant due to the lack of this information in the 
NHANES data. However, should future data sets be utilised to further develop the RID, then 
the addition of other potential confounding determinants such as these could readily be added 
to the current theoretical structural model. Finally, it is acknowledged there is the potential for 
publication bias, where there is a higher tendency for studies with significant outcomes to be 
published compared to those not exhibiting this feature. 
9.3 Future Research 
Many of the issues dealt with in this study offer a pathway for future research to be conducted 
in the further development of RID. There is an opportunity to utilise this methodology to expand 
the current theoretical structural equation RID model to contain larger integrated longitudinal 
health data, which contain indices of depression. These integrated data could contain richer 
variables for the current determinants from this research, and also expand to include genetics 
and other environmental exposure data determinants.  
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The elegance of the proposed methodology used to develop RID lies in its modular format and 
in its ability to be easily transported to other psychiatric and general medical disorders such as 
bipolar, schizophrenia and post-traumatic stress disorder. The blending of the unsupervised and 
supervised ML techniques with traditional statistical techniques to form theoretical structural 
equation models containing direct and indirect paths is easily transported to other large datasets 
to create future risk indices.  
The future development of the RID has the potential for the development of a depression self-
management computer app for individuals identified at risk of depression. Alternatively, the 
RID could be developed as an online or paper based tool for clinicians to identify high-risk 
groups in order to refer them for more thorough assessment or deliver targeted prevention 
programs. The modular determinant component of the RID has the future ability to raise 
knowledge around the independent risk determinants, and independent risk factors, for 
depression so that clinicians can target these areas for specific interventions. It would also be 
beneficial to operationalise the impact of the effects of each determinant using epidemiological 
indices such as attributable fraction in the future, to determine whether modifying a determinant 
would have a meaningful impact on depression prevalence.  
Finally, there is an opportunity for further development of goodness of fit statistics for data 




The possible increasing prevalence of mental health conditions across the western world over 
past decades (28) has meant these societies are being faced with the ever-increasing costs, both 
medically and economically, associated with debilitating mental health conditions. This study 
encourages the future use of machine learning techniques to complement traditional statistical 
approaches to assist health researchers and clinicians to detect potential latent associations that 
can be further refined and clarified by the use of estimated depression probabilities for a variety 
of depression determinants. The development of this methodology for a RID is easily 
transferred to the development of other risk indices for mental health disorders and health 
outcomes in general. This methodology is not data dependent, being able to be utilised with 
data of varying complexities. However, as with other well-known established health indices, 
the expansion of RID into a usable and defensible index requires further development, testing 
and validation with other samples and other populations. RID has great potential to better 
inform both clinical practitioners and policy makers about the risk factors for depression, 
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